JP4840884B2 - Liquid filled chewing gum composition - Google Patents
Liquid filled chewing gum composition Download PDFInfo
- Publication number
- JP4840884B2 JP4840884B2 JP2008556455A JP2008556455A JP4840884B2 JP 4840884 B2 JP4840884 B2 JP 4840884B2 JP 2008556455 A JP2008556455 A JP 2008556455A JP 2008556455 A JP2008556455 A JP 2008556455A JP 4840884 B2 JP4840884 B2 JP 4840884B2
- Authority
- JP
- Japan
- Prior art keywords
- gum
- composition
- weight
- region
- ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 265
- 239000007788 liquid Substances 0.000 title claims description 104
- 235000015218 chewing gum Nutrition 0.000 title description 73
- 229940112822 chewing gum Drugs 0.000 title description 73
- 239000004615 ingredient Substances 0.000 claims description 138
- 239000000796 flavoring agent Substances 0.000 claims description 100
- 235000019634 flavors Nutrition 0.000 claims description 84
- 238000000576 coating method Methods 0.000 claims description 61
- 239000011248 coating agent Substances 0.000 claims description 59
- 235000003599 food sweetener Nutrition 0.000 claims description 58
- 239000003765 sweetening agent Substances 0.000 claims description 58
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 43
- 238000011049 filling Methods 0.000 claims description 43
- 235000010449 maltitol Nutrition 0.000 claims description 38
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 37
- 239000000600 sorbitol Substances 0.000 claims description 37
- 235000010356 sorbitol Nutrition 0.000 claims description 37
- 239000000126 substance Substances 0.000 claims description 35
- 239000000845 maltitol Substances 0.000 claims description 33
- 229940035436 maltitol Drugs 0.000 claims description 32
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 31
- 239000003086 colorant Substances 0.000 claims description 29
- 229920005862 polyol Polymers 0.000 claims description 26
- 150000003077 polyols Chemical class 0.000 claims description 26
- 229920002472 Starch Polymers 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 18
- 239000008107 starch Substances 0.000 claims description 18
- 235000019698 starch Nutrition 0.000 claims description 18
- 239000003623 enhancer Substances 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 16
- 239000002830 appetite depressant Substances 0.000 claims description 14
- 239000011785 micronutrient Substances 0.000 claims description 11
- 235000013369 micronutrients Nutrition 0.000 claims description 11
- 239000008188 pellet Substances 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 230000001953 sensory effect Effects 0.000 claims description 8
- 235000008216 herbs Nutrition 0.000 claims description 6
- 235000007983 food acid Nutrition 0.000 claims description 5
- 150000002303 glucose derivatives Chemical class 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 5
- 239000004909 Moisturizer Substances 0.000 claims description 4
- 230000001333 moisturizer Effects 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- 229920000591 gum Polymers 0.000 description 262
- 238000013329 compounding Methods 0.000 description 56
- -1 polyethylene Polymers 0.000 description 54
- 239000002585 base Substances 0.000 description 49
- 239000010410 layer Substances 0.000 description 47
- 239000003795 chemical substances by application Substances 0.000 description 38
- 239000000463 material Substances 0.000 description 33
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 32
- 229960002920 sorbitol Drugs 0.000 description 32
- 239000002253 acid Substances 0.000 description 28
- 239000003814 drug Substances 0.000 description 28
- 238000009472 formulation Methods 0.000 description 25
- 230000008447 perception Effects 0.000 description 25
- 229940079593 drug Drugs 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 238000010792 warming Methods 0.000 description 22
- 239000000284 extract Substances 0.000 description 21
- 239000002826 coolant Substances 0.000 description 20
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 19
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 19
- 229920001971 elastomer Polymers 0.000 description 19
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 19
- 239000001993 wax Substances 0.000 description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000000806 elastomer Substances 0.000 description 18
- 235000013355 food flavoring agent Nutrition 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- 239000004094 surface-active agent Substances 0.000 description 16
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 15
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 15
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 14
- 229940041616 menthol Drugs 0.000 description 14
- 229940032147 starch Drugs 0.000 description 14
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000008123 high-intensity sweetener Substances 0.000 description 13
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 13
- 239000004014 plasticizer Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 239000008199 coating composition Substances 0.000 description 11
- 239000003995 emulsifying agent Substances 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 229940088594 vitamin Drugs 0.000 description 11
- 229930003231 vitamin Natural products 0.000 description 11
- 235000013343 vitamin Nutrition 0.000 description 11
- 239000011782 vitamin Substances 0.000 description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 10
- 150000007513 acids Chemical class 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000000945 filler Substances 0.000 description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- 235000000346 sugar Nutrition 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 9
- 229940124584 antitussives Drugs 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 239000004067 bulking agent Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 235000010447 xylitol Nutrition 0.000 description 9
- 239000000811 xylitol Substances 0.000 description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 9
- 229960002675 xylitol Drugs 0.000 description 9
- 239000004386 Erythritol Substances 0.000 description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 235000009499 Vanilla fragrans Nutrition 0.000 description 8
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 8
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 8
- 239000003434 antitussive agent Substances 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 239000001506 calcium phosphate Substances 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 8
- 239000001913 cellulose Substances 0.000 description 8
- 235000010980 cellulose Nutrition 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 235000019414 erythritol Nutrition 0.000 description 8
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 8
- 229940009714 erythritol Drugs 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000035807 sensation Effects 0.000 description 8
- 235000019615 sensations Nutrition 0.000 description 8
- 239000002023 wood Substances 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 7
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 7
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 7
- 244000263375 Vanilla tahitensis Species 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 230000000954 anitussive effect Effects 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000008376 breath freshener Substances 0.000 description 7
- 235000010634 bubble gum Nutrition 0.000 description 7
- 235000010216 calcium carbonate Nutrition 0.000 description 7
- 229930002875 chlorophyll Natural products 0.000 description 7
- 235000019804 chlorophyll Nutrition 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 230000002272 anti-calculus Effects 0.000 description 6
- 239000000739 antihistaminic agent Substances 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 229940106705 chlorophyll Drugs 0.000 description 6
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 239000011247 coating layer Substances 0.000 description 6
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 6
- 230000035597 cooling sensation Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 238000005187 foaming Methods 0.000 description 6
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000008601 oleoresin Substances 0.000 description 6
- 239000011118 polyvinyl acetate Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229920003048 styrene butadiene rubber Polymers 0.000 description 6
- 239000011975 tartaric acid Substances 0.000 description 6
- 235000002906 tartaric acid Nutrition 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- 235000010215 titanium dioxide Nutrition 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 5
- 241000167854 Bourreria succulenta Species 0.000 description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 5
- 244000131522 Citrus pyriformis Species 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 5
- 235000010358 acesulfame potassium Nutrition 0.000 description 5
- 239000000619 acesulfame-K Substances 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 5
- 229940069428 antacid Drugs 0.000 description 5
- 239000003159 antacid agent Substances 0.000 description 5
- 239000000730 antalgic agent Substances 0.000 description 5
- 229940125715 antihistaminic agent Drugs 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 5
- 235000019693 cherries Nutrition 0.000 description 5
- 235000017803 cinnamon Nutrition 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 229940108928 copper Drugs 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 229960001031 glucose Drugs 0.000 description 5
- 239000000905 isomalt Substances 0.000 description 5
- 235000010439 isomalt Nutrition 0.000 description 5
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 5
- 239000001630 malic acid Substances 0.000 description 5
- 235000011090 malic acid Nutrition 0.000 description 5
- 239000000594 mannitol Substances 0.000 description 5
- 229960001855 mannitol Drugs 0.000 description 5
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 150000005846 sugar alcohols Chemical class 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 238000013268 sustained release Methods 0.000 description 5
- 239000012730 sustained-release form Substances 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 4
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 4
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 4
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- 101800000112 Acidic peptide Proteins 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 229920000161 Locust bean gum Polymers 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- ZPXSCAKFGYXMGA-UHFFFAOYSA-N Mazindol Chemical compound N12CCN=C2C2=CC=CC=C2C1(O)C1=CC=C(Cl)C=C1 ZPXSCAKFGYXMGA-UHFFFAOYSA-N 0.000 description 4
- 235000014749 Mentha crispa Nutrition 0.000 description 4
- 244000078639 Mentha spicata Species 0.000 description 4
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 4
- 239000004384 Neotame Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002174 Styrene-butadiene Substances 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 235000011941 Tilia x europaea Nutrition 0.000 description 4
- 240000006909 Tilia x europaea Species 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000001361 adipic acid Substances 0.000 description 4
- 235000011037 adipic acid Nutrition 0.000 description 4
- 229940072056 alginate Drugs 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 235000010210 aluminium Nutrition 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000003474 anti-emetic effect Effects 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 239000002111 antiemetic agent Substances 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 235000012677 beetroot red Nutrition 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 4
- 229940117916 cinnamic aldehyde Drugs 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- ICFXZZFWRWNZMA-UHFFFAOYSA-N diethylpropion hydrochloride Chemical compound [Cl-].CC[NH+](CC)C(C)C(=O)C1=CC=CC=C1 ICFXZZFWRWNZMA-UHFFFAOYSA-N 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 4
- 235000002780 gingerol Nutrition 0.000 description 4
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 150000002314 glycerols Chemical class 0.000 description 4
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 235000010420 locust bean gum Nutrition 0.000 description 4
- 239000000711 locust bean gum Substances 0.000 description 4
- 239000001656 lutein Substances 0.000 description 4
- 229960005375 lutein Drugs 0.000 description 4
- 235000012680 lutein Nutrition 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 229930007503 menthone Natural products 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000019412 neotame Nutrition 0.000 description 4
- 108010070257 neotame Proteins 0.000 description 4
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 235000007686 potassium Nutrition 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 235000012141 vanillin Nutrition 0.000 description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 3
- 244000145321 Acmella oleracea Species 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 3
- 240000003291 Armoracia rusticana Species 0.000 description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 3
- 240000002943 Elettaria cardamomum Species 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000016278 Mentha canadensis Nutrition 0.000 description 3
- 244000245214 Mentha canadensis Species 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- 235000004357 Mentha x piperita Nutrition 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 240000000111 Saccharum officinarum Species 0.000 description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000001670 anatto Substances 0.000 description 3
- 235000012665 annatto Nutrition 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000001961 anticonvulsive agent Substances 0.000 description 3
- 229940125683 antiemetic agent Drugs 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000001654 beetroot red Substances 0.000 description 3
- 229910052797 bismuth Inorganic materials 0.000 description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 235000012709 brilliant black BN Nutrition 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 235000005300 cardamomo Nutrition 0.000 description 3
- 235000012730 carminic acid Nutrition 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 3
- 229960004126 codeine Drugs 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 3
- 229960001985 dextromethorphan Drugs 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 235000019264 food flavour enhancer Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000008369 fruit flavor Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229950006191 gluconic acid Drugs 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 229960002449 glycine Drugs 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 239000000416 hydrocolloid Substances 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 235000010448 lactitol Nutrition 0.000 description 3
- 239000000832 lactitol Substances 0.000 description 3
- 229960003451 lactitol Drugs 0.000 description 3
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 235000001055 magnesium Nutrition 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229960002900 methylcellulose Drugs 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000008368 mint flavor Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- 229940066491 mucolytics Drugs 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229930004008 p-menthane Natural products 0.000 description 3
- 235000012658 paprika extract Nutrition 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000011698 potassium fluoride Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000000021 stimulant Substances 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229940033134 talc Drugs 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 210000003901 trigeminal nerve Anatomy 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- VEPOHXYIFQMVHW-PVJVQHJQSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(2s,3s)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 VEPOHXYIFQMVHW-PVJVQHJQSA-N 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 2
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WXUAQHNMJWJLTG-VKHMYHEASA-N (S)-methylsuccinic acid Chemical compound OC(=O)[C@@H](C)CC(O)=O WXUAQHNMJWJLTG-VKHMYHEASA-N 0.000 description 2
- IGOUMBTVEMUDSU-UHFFFAOYSA-N 1-(1-carboxyethyl)-6-(hydroxymethyl)pyridin-1-ium-3-olate Chemical compound OC(=O)C(C)[N+]1=CC([O-])=CC=C1CO IGOUMBTVEMUDSU-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000193749 Bacillus coagulans Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000193417 Brevibacillus laterosporus Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 2
- 239000001329 FEMA 3811 Substances 0.000 description 2
- 239000004211 Flavoxanthin Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- AKDLSISGGARWFP-UHFFFAOYSA-N Homodihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCCC(C)C)=CC=C1O AKDLSISGGARWFP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101710084933 Miraculin Proteins 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 description 2
- 244000227633 Ocotea pretiosa Species 0.000 description 2
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 2
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- CMCJFUXWBBHIIL-UHFFFAOYSA-N Propylene glycol stearate Chemical compound CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004216 Rhodoxanthin Substances 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 235000000760 Wasabia japonica Nutrition 0.000 description 2
- 244000195452 Wasabia japonica Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- CZNLTCTYLMYLHL-UHFFFAOYSA-N [6]-Paradol Chemical compound CCCCCCCC(=O)CCC1=CC=C(O)C(OC)=C1 CZNLTCTYLMYLHL-UHFFFAOYSA-N 0.000 description 2
- 229960004998 acesulfame potassium Drugs 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000924 antiasthmatic agent Substances 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000000164 antipsychotic agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940043671 antithyroid preparations Drugs 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 2
- 229940054340 bacillus coagulans Drugs 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 2
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 2
- 235000021029 blackberry Nutrition 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 229940046049 bontril Drugs 0.000 description 2
- 239000004126 brilliant black BN Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000019805 chlorophyllin Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 239000008373 coffee flavor Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 108010010165 curculin Proteins 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical class NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000006240 deamidation Effects 0.000 description 2
- 239000000850 decongestant Substances 0.000 description 2
- 229940124581 decongestants Drugs 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- SSNZFFBDIMUILS-UHFFFAOYSA-N dodec-2-enal Chemical compound CCCCCCCCCC=CC=O SSNZFFBDIMUILS-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 229940093503 ethyl maltol Drugs 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- NNYBQONXHNTVIJ-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=C1C(C=CC=C1CC)=C1N2 NNYBQONXHNTVIJ-UHFFFAOYSA-N 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229940066493 expectorants Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000019243 flavoxanthin Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- 229940074774 glycyrrhizinate Drugs 0.000 description 2
- 235000013761 grape skin extract Nutrition 0.000 description 2
- 235000012701 green S Nutrition 0.000 description 2
- 239000004120 green S Substances 0.000 description 2
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 235000021073 macronutrients Nutrition 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 229940043353 maltol Drugs 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 229960000299 mazindol Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000003533 narcotic effect Effects 0.000 description 2
- 239000000133 nasal decongestant Substances 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 2
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 2
- 235000010434 neohesperidine DC Nutrition 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 2
- 150000002937 p-menthane derivatives Chemical class 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 239000001688 paprika extract Substances 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000001499 parasympathomimetic effect Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012169 petroleum derived wax Substances 0.000 description 2
- 235000019381 petroleum wax Nutrition 0.000 description 2
- 229960003742 phenol Drugs 0.000 description 2
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 235000019246 rhodoxanthin Nutrition 0.000 description 2
- 235000009514 rubixanthin Nutrition 0.000 description 2
- 239000000455 rubixanthin Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 235000019643 salty taste Nutrition 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 229960001516 silver nitrate Drugs 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 229940034887 tenuate Drugs 0.000 description 2
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 2
- 235000010436 thaumatin Nutrition 0.000 description 2
- 239000000892 thaumatin Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 2
- 229940117960 vanillin Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- BXJYLJLZLMXRSH-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) 3-hydroxybutanoate Chemical compound CC(O)CC(=O)OC1(C)CCC(C(C)C)CC1 BXJYLJLZLMXRSH-UHFFFAOYSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- WQFGPARDTSBVLU-UHFFFAOYSA-N (1R,2S,3S,4R)-p-Menthane-2,3-diol Chemical compound CC(C)C1CCC(C)C(O)C1O WQFGPARDTSBVLU-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical class OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000001112 (2E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene Substances 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 1
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 1
- DNKVJLHNJMSZEO-WLYNEOFISA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;hydrate Chemical compound O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C DNKVJLHNJMSZEO-WLYNEOFISA-N 0.000 description 1
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- BCXHDORHMMZBBZ-DORFAMGDSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;sulfuric acid Chemical compound OS(O)(=O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC BCXHDORHMMZBBZ-DORFAMGDSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- NTXGFKWLJFHGGJ-ACCUITESSA-N 1,1-Diethoxy-3,7-dimethyl-2,6-octadiene Chemical compound CCOC(OCC)\C=C(/C)CCC=C(C)C NTXGFKWLJFHGGJ-ACCUITESSA-N 0.000 description 1
- UENOQWSWMYJKIW-UHFFFAOYSA-N 1,2,2-trimethylcyclohexan-1-ol Chemical compound CC1(C)CCCCC1(C)O UENOQWSWMYJKIW-UHFFFAOYSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- MFWNKCLOYSRHCJ-AGUYFDCRSA-N 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide Chemical compound C1=CC=C2C(C(=O)NC3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-AGUYFDCRSA-N 0.000 description 1
- CCFAGRVEHSCROQ-UHFFFAOYSA-N 1-phenylpropane-1,2,3-triol Chemical compound OCC(O)C(O)C1=CC=CC=C1 CCFAGRVEHSCROQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- 229940029225 2,6-dimethyl-5-heptenal Drugs 0.000 description 1
- CBOBADCVMLMQRW-UHFFFAOYSA-N 2,6-dimethyloctanal Chemical compound CCC(C)CCCC(C)C=O CBOBADCVMLMQRW-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- UNNGUFMVYQJGTD-UHFFFAOYSA-N 2-Ethylbutanal Chemical compound CCC(CC)C=O UNNGUFMVYQJGTD-UHFFFAOYSA-N 0.000 description 1
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical class CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- DEOUZFWSQWEPGE-UHFFFAOYSA-N 2-methylheptanamide Chemical compound CCCCCC(C)C(N)=O DEOUZFWSQWEPGE-UHFFFAOYSA-N 0.000 description 1
- YTAQZPGBTPDBPW-UHFFFAOYSA-N 2-phenylchromene-3,4-dione Chemical compound O1C2=CC=CC=C2C(=O)C(=O)C1C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 1
- UOXYCZBLTLAQBY-UHFFFAOYSA-N 2-sulfanylcyclodecan-1-one Chemical compound SC1CCCCCCCCC1=O UOXYCZBLTLAQBY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- AYERSDHOTKHEDA-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxybutan-1-ol Chemical compound CC(C)C1CCC(C)(OC(C)CCO)CC1 AYERSDHOTKHEDA-UHFFFAOYSA-N 0.000 description 1
- DCNFPFNLHFFBFM-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropan-1-ol Chemical compound CC(C)C1CCC(C)(OCCCO)CC1 DCNFPFNLHFFBFM-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- BVUSNQJCSYDJJG-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 BVUSNQJCSYDJJG-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- DCTLYFZHFGENCW-UUOKFMHZSA-N 5'-xanthylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 DCTLYFZHFGENCW-UUOKFMHZSA-N 0.000 description 1
- CTMTYSVTTGVYAW-FRRDWIJNSA-N 5-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxy-5-oxopentanoic acid Chemical class CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCCC(O)=O CTMTYSVTTGVYAW-FRRDWIJNSA-N 0.000 description 1
- FINKDHKJINNQQW-UHFFFAOYSA-N 5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical class CC(C)C1CCC(C)CC1C(N)=O FINKDHKJINNQQW-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- DFMMVLFMMAQXHZ-DOKBYWHISA-N 8'-apo-beta,psi-caroten-8'-al Chemical compound O=CC(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-DOKBYWHISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000906543 Actaea racemosa Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 229940124717 Alzheimer's therapeutics Drugs 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 description 1
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000007034 Carum copticum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- ZCKAMNXUHHNZLN-UHFFFAOYSA-N Chlorphentermine Chemical compound CC(C)(N)CC1=CC=C(Cl)C=C1 ZCKAMNXUHHNZLN-UHFFFAOYSA-N 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000911175 Citharexylum caudatum Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000012848 Dextrorphan Substances 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010066671 Enalaprilat Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- JUTKIGGQRLHTJN-UHFFFAOYSA-N Eugenyl formate Chemical compound COC1=CC(CC=C)=CC=C1OC=O JUTKIGGQRLHTJN-UHFFFAOYSA-N 0.000 description 1
- 239000001336 FEMA 3807 Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 244000215562 Heliotropium arborescens Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241000282821 Hippopotamus Species 0.000 description 1
- 241001504226 Hoodia Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 208000013038 Hypocalcemia Diseases 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 108010007859 Lisinopril Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000002636 Manilkara bidentata Species 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 235000019596 Masking bitterness Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- LMXFTMYMHGYJEI-UHFFFAOYSA-N Menthoglycol Natural products CC1CCC(C(C)(C)O)C(O)C1 LMXFTMYMHGYJEI-UHFFFAOYSA-N 0.000 description 1
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 1
- KNVPMEZIMFVWMD-UHFFFAOYSA-N Menthyl pyrrolidone carboxylate Chemical compound CC(C)C1CCC(C)CC1OC(=O)N1C(=O)CCC1 KNVPMEZIMFVWMD-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000000866 Neuromuscular Agent Substances 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- MFOCDFTXLCYLKU-CMPLNLGQSA-N Phendimetrazine Chemical compound O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 MFOCDFTXLCYLKU-CMPLNLGQSA-N 0.000 description 1
- ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004392 Polyglycitol syrup Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- SMTZFNFIKUPEJC-UHFFFAOYSA-N Roxane Chemical compound CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1 SMTZFNFIKUPEJC-UHFFFAOYSA-N 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 229910008449 SnF 2 Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930184148 Spiranthol Natural products 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000204115 Sporolactobacillus inulinus Species 0.000 description 1
- 241001464969 Sporolactobacillus laevolacticus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000219 Sympatholytic Substances 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 240000004984 Trachyspermum ammi Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- MKWSZTVOJKTLPX-HZSPNIEDSA-N [(1r,2s,5r)-2-isopropyl-5-methyl-cyclohexyl] 4-(dimethylamino)-4-oxo-butanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCC(=O)N(C)C MKWSZTVOJKTLPX-HZSPNIEDSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- SAFQLZACCVYKID-UHFFFAOYSA-N [K].CC1=COS(=O)(=O)NC1=O Chemical compound [K].CC1=COS(=O)(=O)NC1=O SAFQLZACCVYKID-UHFFFAOYSA-N 0.000 description 1
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- QFYJRROWSOMHGM-UHFFFAOYSA-L [Zn+2].[O-]S(=O)(=O)S([O-])(=O)=O Chemical compound [Zn+2].[O-]S(=O)(=O)S([O-])(=O)=O QFYJRROWSOMHGM-UHFFFAOYSA-L 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940092980 adalat Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 description 1
- 229940064063 alpha tocotrienol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- QQQCWVDPMPFUGF-ZDUSSCGKSA-N alpinetin Chemical compound C1([C@H]2OC=3C=C(O)C=C(C=3C(=O)C2)OC)=CC=CC=C1 QQQCWVDPMPFUGF-ZDUSSCGKSA-N 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940009859 aluminum phosphate Drugs 0.000 description 1
- JIFPTBLGXRKRAO-UHFFFAOYSA-K aluminum;magnesium;hydroxide;sulfate Chemical compound [OH-].[Mg+2].[Al+3].[O-]S([O-])(=O)=O JIFPTBLGXRKRAO-UHFFFAOYSA-K 0.000 description 1
- SEIGJEJVIMIXIU-UHFFFAOYSA-J aluminum;sodium;carbonate;dihydroxide Chemical compound [Na+].O[Al+]O.[O-]C([O-])=O SEIGJEJVIMIXIU-UHFFFAOYSA-J 0.000 description 1
- 229960005174 ambroxol Drugs 0.000 description 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000320 anti-stroke effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000003208 anti-thyroid effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 229940124433 antimigraine drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 239000007961 artificial flavoring substance Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000016302 balata Nutrition 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
- YXKTVDFXDRQTKV-HNNXBMFYSA-N benzphetamine Chemical compound C([C@H](C)N(C)CC=1C=CC=CC=1)C1=CC=CC=C1 YXKTVDFXDRQTKV-HNNXBMFYSA-N 0.000 description 1
- 229960002837 benzphetamine Drugs 0.000 description 1
- ANFSNXAXVLRZCG-RSAXXLAASA-N benzphetamine hydrochloride Chemical compound [Cl-].C([C@H](C)[NH+](C)CC=1C=CC=CC=1)C1=CC=CC=C1 ANFSNXAXVLRZCG-RSAXXLAASA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- DFMMVLFMMAQXHZ-UHFFFAOYSA-N beta-apo-8-carotenal Chemical compound O=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- YZXZAUAIVAZWFN-UHFFFAOYSA-N bis(5-methyl-2-propan-2-ylcyclohexyl) butanedioate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(=O)OC1C(C(C)C)CCC(C)C1 YZXZAUAIVAZWFN-UHFFFAOYSA-N 0.000 description 1
- 229940104825 bismuth aluminate Drugs 0.000 description 1
- 229940036348 bismuth carbonate Drugs 0.000 description 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 description 1
- 229940036358 bismuth subcarbonate Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229940088033 calan Drugs 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- FDSDTBUPSURDBL-DKLMTRRASA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-DKLMTRRASA-N 0.000 description 1
- 229940097633 capoten Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000001325 capsicum annuum l. var. longum oleoresin Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 235000009132 capsorubin Nutrition 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000004091 cariogenic agent Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 108010019954 casein phosphopeptide-amorphous calcium phosphate nanocomplex Proteins 0.000 description 1
- 108010067454 caseinomacropeptide Proteins 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000017168 chlorine Nutrition 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 229950007046 chlorphentermine Drugs 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
- 229960002881 clemastine Drugs 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 229940068796 clozaril Drugs 0.000 description 1
- 238000010073 coating (rubber) Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229960003871 codeine sulfate Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical class [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 235000013712 corn endosperm oil Nutrition 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000001081 curcuma longa l. root oleoresin Substances 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- YVWBQGFBSVLPIK-UHFFFAOYSA-N cyclohex-2-ene-1-carboxylic acid Chemical compound OC(=O)C1CCCC=C1 YVWBQGFBSVLPIK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- JAQUASYNZVUNQP-PVAVHDDUSA-N dextrorphan Chemical compound C1C2=CC=C(O)C=C2[C@@]23CCN(C)[C@@H]1[C@H]2CCCC3 JAQUASYNZVUNQP-PVAVHDDUSA-N 0.000 description 1
- 229950006878 dextrorphan Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940099371 diacetylated monoglycerides Drugs 0.000 description 1
- TXGQALXWGNPMKD-UHFFFAOYSA-L diazanium;zinc;disulfate;hexahydrate Chemical compound [NH4+].[NH4+].O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O TXGQALXWGNPMKD-UHFFFAOYSA-L 0.000 description 1
- GMZOPRQQINFLPQ-UHFFFAOYSA-H dibismuth;tricarbonate Chemical compound [Bi+3].[Bi+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O GMZOPRQQINFLPQ-UHFFFAOYSA-H 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 1
- 229940120144 didrex Drugs 0.000 description 1
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 description 1
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 1
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- MZDOIJOUFRQXHC-UHFFFAOYSA-N dimenhydrinate Chemical compound O=C1N(C)C(=O)N(C)C2=NC(Cl)=N[C]21.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 MZDOIJOUFRQXHC-UHFFFAOYSA-N 0.000 description 1
- 229960004993 dimenhydrinate Drugs 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960001583 diphenhydramine citrate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000004194 disodium inosinate Substances 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- YSVBPNGJESBVRM-UHFFFAOYSA-L disodium;4-[(1-oxido-4-sulfonaphthalen-2-yl)diazenyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].C1=CC=C2C(N=NC3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)O)=CC=C(S([O-])(=O)=O)C2=C1 YSVBPNGJESBVRM-UHFFFAOYSA-L 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229960001971 ebastine Drugs 0.000 description 1
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
- 229950002377 ebrotidine Drugs 0.000 description 1
- ZQHFZHPUZXNPMF-UHFFFAOYSA-N ebrotidine Chemical compound S1C(N=C(N)N)=NC(CSCCN=CNS(=O)(=O)C=2C=CC(Br)=CC=2)=C1 ZQHFZHPUZXNPMF-UHFFFAOYSA-N 0.000 description 1
- 235000020694 echinacea extract Nutrition 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 235000012656 ethyl ester of beta-apo-8'-carotenic acid Nutrition 0.000 description 1
- 239000001684 ethyl ester of beta-apo-8'-carotenic acid (C30) Substances 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000002871 fertility agent Substances 0.000 description 1
- 229960003592 fexofenadine Drugs 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000005454 flavour additive Substances 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 239000001806 glycerol esters of wood rosin Substances 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229960002146 guaifenesin Drugs 0.000 description 1
- 229940095895 haldol Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PDSAKIXGSONUIX-UHFFFAOYSA-N hexaaluminum;dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Bi+3].[Bi+3] PDSAKIXGSONUIX-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- MLJGZARGNROKAC-VQHVLOKHSA-N homocapsaicin Chemical compound CCC(C)\C=C\CCCCC(=O)NCC1=CC=C(O)C(OC)=C1 MLJGZARGNROKAC-VQHVLOKHSA-N 0.000 description 1
- JKIHLSTUOQHAFF-UHFFFAOYSA-N homocapsaicin Natural products COC1=CC(CNC(=O)CCCCCC=CC(C)C)=CC=C1O JKIHLSTUOQHAFF-UHFFFAOYSA-N 0.000 description 1
- JZNZUOZRIWOBGG-UHFFFAOYSA-N homocapsaicin-II Natural products COC1=CC(CNC(=O)CCCCC=CCC(C)C)=CC=C1O JZNZUOZRIWOBGG-UHFFFAOYSA-N 0.000 description 1
- GOBFKCLUUUDTQE-UHFFFAOYSA-N homodihydrocapsaicin-II Natural products CCC(C)CCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 GOBFKCLUUUDTQE-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000017277 hoodia Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- GPGMRSSBVJNWRA-UHFFFAOYSA-N hydrochloride hydrofluoride Chemical compound F.Cl GPGMRSSBVJNWRA-UHFFFAOYSA-N 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 239000000864 hyperglycemic agent Substances 0.000 description 1
- 230000000705 hypocalcaemia Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940005632 indigotindisulfonic acid Drugs 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 229910001506 inorganic fluoride Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940036543 ionamin Drugs 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- 239000004407 iron oxides and hydroxides Substances 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 239000000177 juniperus communis l. berry Substances 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 239000008374 liqueur flavor Substances 0.000 description 1
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
- 239000004335 litholrubine BK Substances 0.000 description 1
- 235000010187 litholrubine BK Nutrition 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229940063718 lodine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 229960004018 magaldrate Drugs 0.000 description 1
- 150000002680 magnesium Chemical class 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 229940004916 magnesium glycinate Drugs 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- AACACXATQSKRQG-UHFFFAOYSA-L magnesium;2-aminoacetate Chemical compound [Mg+2].NCC([O-])=O.NCC([O-])=O AACACXATQSKRQG-UHFFFAOYSA-L 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229960001474 meclozine Drugs 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229940099214 melfiat Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229950008866 mifentidine Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 239000004239 monopotassium glutamate Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOZUADYOHPCXLE-UHFFFAOYSA-N n-[4-(1h-imidazol-5-yl)phenyl]-n'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=CN1 GOZUADYOHPCXLE-UHFFFAOYSA-N 0.000 description 1
- ILCQYORZHHFLNL-UHFFFAOYSA-N n-bromoaniline Chemical compound BrNC1=CC=CC=C1 ILCQYORZHHFLNL-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 1
- ZVKDZYPEJXGLJG-UHFFFAOYSA-N n-tert-butyl-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC(C)(C)C ZVKDZYPEJXGLJG-UHFFFAOYSA-N 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960003940 naproxen sodium Drugs 0.000 description 1
- CDBRNDSHEYLDJV-FVGYRXGTSA-M naproxen sodium Chemical compound [Na+].C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CDBRNDSHEYLDJV-FVGYRXGTSA-M 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000000974 natural food coloring agent Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003880 negative regulation of appetite Effects 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960002085 oxycodone Drugs 0.000 description 1
- 229940105606 oxycontin Drugs 0.000 description 1
- 229960001528 oxymetazoline Drugs 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- DYUUPIKEWLHQGQ-SDXBLLFJSA-N paprika oleoresin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-SDXBLLFJSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960000436 phendimetrazine Drugs 0.000 description 1
- 229960003534 phenindamine Drugs 0.000 description 1
- 229960003562 phentermine Drugs 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- XMGMFRIEKMMMSU-UHFFFAOYSA-N phenylmethylbenzene Chemical group C=1C=CC=CC=1[C]C1=CC=CC=C1 XMGMFRIEKMMMSU-UHFFFAOYSA-N 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- 229960001526 phenyltoloxamine Drugs 0.000 description 1
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001894 piper nigrum l. oleoresin black Substances 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 229940081310 piperonal Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229940124837 pisatidine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000019451 polyglycitol syrup Nutrition 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229940094025 potassium bicarbonate Drugs 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- HQEROMHPIOLGCB-DFWYDOINSA-M potassium;(2s)-2-aminopentanedioate;hydron Chemical compound [K+].[O-]C(=O)[C@@H](N)CCC(O)=O HQEROMHPIOLGCB-DFWYDOINSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 229940089949 procardia Drugs 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 229940063566 proventil Drugs 0.000 description 1
- 229940035613 prozac Drugs 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 150000003267 reducing disaccharides Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229940087462 relafen Drugs 0.000 description 1
- 230000000395 remineralizing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229960003320 roxatidine Drugs 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000035909 sensory irritation Effects 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 229940107518 slippery elm bark Drugs 0.000 description 1
- 229940124535 smoking cessation aid Drugs 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- IJRHDFLHUATAOS-DPMBMXLASA-M sodium ricinoleate Chemical compound [Na+].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O IJRHDFLHUATAOS-DPMBMXLASA-M 0.000 description 1
- 229940080350 sodium stearate Drugs 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229940071182 stannate Drugs 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000015260 sugar-free gum Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013759 synthetic iron oxide Nutrition 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000007852 tooth bleaching agent Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- KNXVOGGZOFOROK-UHFFFAOYSA-N trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane Chemical compound [Mg+2].[Mg+2].[Mg+2].O[Si]([O-])=O.O[Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O KNXVOGGZOFOROK-UHFFFAOYSA-N 0.000 description 1
- NDJGQNJPALSQEN-UHFFFAOYSA-N trioxido-1kappa(2)O,2kappaO-dinitrate(N--N)(2-) Chemical compound [O-]N([O-])N=O NDJGQNJPALSQEN-UHFFFAOYSA-N 0.000 description 1
- 229960003223 tripelennamine Drugs 0.000 description 1
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 1
- 229960001128 triprolidine Drugs 0.000 description 1
- CBEQULMOCCWAQT-WOJGMQOQSA-N triprolidine Chemical compound C1=CC(C)=CC=C1C(\C=1N=CC=CC=1)=C/CN1CCCC1 CBEQULMOCCWAQT-WOJGMQOQSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013975 turmeric oleoresin Nutrition 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 230000002620 ureteric effect Effects 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- KOCVACNWDMSLBM-UHFFFAOYSA-N vanillyl alcohol ethyl ether Natural products CCOCC1=CC=C(O)C(OC)=C1 KOCVACNWDMSLBM-UHFFFAOYSA-N 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229940099270 vasotec Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229940063674 voltaren Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 235000019648 warmth Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 229940074158 xanax Drugs 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 229940072252 zestril Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- AGFGXVAAIXIOFZ-UHFFFAOYSA-L zinc;butanedioate Chemical compound [Zn+2].[O-]C(=O)CCC([O-])=O AGFGXVAAIXIOFZ-UHFFFAOYSA-L 0.000 description 1
- NDKWCCLKSWNDBG-UHFFFAOYSA-N zinc;dioxido(dioxo)chromium Chemical compound [Zn+2].[O-][Cr]([O-])(=O)=O NDKWCCLKSWNDBG-UHFFFAOYSA-N 0.000 description 1
- 239000001432 zingiber officinale rosc. oleoresin Substances 0.000 description 1
- 229940020965 zoloft Drugs 0.000 description 1
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
- A23G4/205—Hollow products, e.g. with inedible or edible filling, fixed or movable within the cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Confectionery (AREA)
Description
(関連出願についての相互参照)
本願は、2006年2月24日出願の米国仮出願第60/776748号の利益を主張し、且つ2005年8月24日出願の米国特許出願第11/210954号の一部継続出願であり、これは2004年8月25日出願の米国特許出願第10/925822号の一部継続出願であって、これら全ての内容を、本願に引用して援用する。
(Cross-reference for related applications)
This application claims the benefit of US Provisional Application No. 60/767748 filed on Feb. 24, 2006, and is a continuation-in-part of U.S. Patent Application No. 11/210754 filed Aug. 24, 2005, This is a continuation-in-part of US patent application Ser. No. 10 / 925,822, filed Aug. 25, 2004, the entire contents of which are incorporated herein by reference.
(技術分野)
本発明は、相当期間その流動性を維持する、液体中央充填多層チューインガム用組成物を含む。本発明の組成物を含む個々のガム片は、結晶性ソルビトールと、任意に水素化デンプン加水分解物とを含む液体中央を含む。ガム片は、更に外側コーティング層で任意にコーティングしてもよい。
(Technical field)
The present invention includes a liquid center-filled multilayer chewing gum composition that maintains its flowability for a substantial period of time. Individual gum pieces comprising the composition of the invention comprise a liquid center comprising crystalline sorbitol and optionally hydrogenated starch hydrolysate. The gum pieces may optionally be further coated with an outer coating layer.
液体又は中央充填のガム及び他の菓子製品は昨今、好評で需要がある。典型的に、これらの製品は固体の外側部分と、軟質又は液体型の中心を備える。外側部分は、ある種のチューインガム又は風船ガムであることができ、一方液体中央部分は、典型的にはシロップ様の粘稠度を有する香味材料であることができる。 Liquid or center-filled gums and other confectionery products are currently popular and in demand. Typically, these products comprise a solid outer portion and a soft or liquid center. The outer portion can be some kind of chewing gum or bubble gum, while the liquid central portion can be a flavoring material that typically has a syrup-like consistency.
チューインガム又は風船ガムコアを、外側の硬質糖又は無糖シェルと共に備える製品もある。これらの製品として、例えばChiclets(登録商標)、Clorets(登録商標)、及びDentyne−Ice(登録商標)の商品名で販売される、周知のペレットガム製品が挙げられる。液体充填とコーティングの双方がなされたガム製品が、好評で需要がある。 Some products have a chewing gum or bubble gum core with an outer hard sugar or sugar-free shell. These products include, for example, the well-known pellet gum products sold under the trade names of “Chillets®”, “Clorets®”, and “Dentyne-Ice®”. Gum products that are both liquid filled and coated are popular and in demand.
液体充填中央部分と、液体を囲むチューインガム又は風船ガム材料の第二層と、硬質の外側シェル又はコーティングとを備えた従来の中央充填ガム製品では、ガムベース領域内への液体の望ましくない移動が起こってしまう。これにより、商業上容認できない製品が生じる。中央充填がなくなることは、ガムの初期の知覚刺激性(即ち、初期液体「破裂」)に影響を及ぼすだけでなく、製品の物理的な外観及び全保存寿命安定性も変化させることがある。 In conventional center-filled gum products with a liquid-filled central portion, a second layer of chewing gum or bubble gum material surrounding the liquid, and a hard outer shell or coating, undesirable movement of the liquid into the gum base region occurs. End up. This results in a product that is not commercially acceptable. The loss of center filling not only affects the initial sensory irritation of the gum (ie, the initial liquid “rupture”), but may also change the physical appearance and overall shelf life stability of the product.
中央充填の流動性喪失の一因として考えられるのは、中央充填から周りのガム層への水分の移動によるものである。この問題は、中央充填組成物の変更によって対処されることが最も多い。 One possible cause of the loss of fluidity in the center filling is due to the transfer of moisture from the center filling to the surrounding gum layer. This problem is most often addressed by changing the center-fill composition.
流動性の喪失の問題を解決すべく特に処方された中央充填組成物を含む特許として、中央充填が水素化デンプン加水分解物を含む、Cifreseらの米国特許第4466983号;水と水素化デンプン加水分解物との組み合わせを含む中央充填を提供する、Frielloの米国特許第4250196号;及びプロピレングリコールとソルビトールとを含む中央充填処方を開示するTerrevazziの米国特許第4252829号(「Terrevazzi」)が挙げられる。 Patents containing a center-fill composition specifically formulated to solve the problem of loss of fluidity include Cifres et al. US Pat. No. 4,466,983, where the center-fill includes a hydrogenated starch hydrolyzate; US Pat. No. 4,250,196 to Friello, which provides a center fill comprising a combination with a degradation product; and US Pat. No. 4,252,829 (“Terrevazzi”), which discloses a center fill formulation comprising propylene glycol and sorbitol. .
流動性の喪失に対処する他の試みで、中央充填の水分含量を制御することを意図した処方が提供されている。具体的には、Glassらの米国特許第4683138号明細書は、低水分の液体中央充填ガム組成物を提供する。 In other attempts to address the loss of fluidity, formulations have been provided that are intended to control the water content of the center fill. Specifically, US Pat. No. 4,683,138 to Glass et al. Provides a low moisture liquid center-filled gum composition.
市販の中央充填ガム組成物に共通する一因子は、ガム片の大きさである。このようなチューインガム片の重量は平均して、Terrevazziに開示されたもののように約5グラムである。本発明までは、更に小さい中央充填ガム片、即ち1片当たり3グラム未満のものは製造されておらず、よって、このような小片では中央充填ガムに関わる問題はなかった。2〜3グラムのサイズのものなどの小さなガム片、及びペレットガムなどの構造は、液体充填に対する表面積が大きく、そのため中央充填の流動性の維持、及び周りのガム領域内への移動やこれを通過する移動の防止が、より重要で難題になる。 One factor common to commercially available center-filled gum compositions is the size of the gum pieces. The weight of such chewing gum pieces averages about 5 grams, as disclosed in Terrevazzi. Until the present invention, smaller center-filled gum pieces, i.e. less than 3 grams per piece, have not been produced, so such pieces have no problems with the center-filled gum. Small gum pieces, such as those with a size of 2-3 grams, and structures such as pellet gums have a large surface area for liquid filling, thus maintaining the fluidity of the center filling and moving it into the surrounding gum area. Preventing movement through is a more important and challenging task.
新しいガム組成物、及び特に硬質又は歯ごたえのあるコーティングを施したガムであって、流動性の喪失を阻止しつつ、中央充填ガムと組み合わせて所望の硬質シェルコーティング層を備えたものが必要とされている。製造中及びその保存寿命中に、中央の液体を保持し、且つ液体の中央充填の性質を喪失することなく小さい片のサイズで製造できる中央充填ガムも必要とされている。 There is a need for new gum compositions, and particularly hard or crunchy coated gums, with the desired hard shell coating layer in combination with a center-filled gum while preventing loss of fluidity. ing. There is also a need for a center-filled gum that retains the center liquid during manufacture and during its shelf life and can be manufactured in small piece sizes without losing the center-fill nature of the liquid.
ある実施形態では、それらの流動性の少なくとも一部を長期間保持し、且つ経時的な中央充填の固化、及び/又は液体中央充填を囲む領域内への液体中央充填の移動を阻止する、液体中央充填組成物を含有する組成物及び製品を提供する。ある実施形態では、組成物及び製品の液体充填領域は、部分的又は完全に1種以上の液体で構成されてもよい。ある実施形態では、組成物は、水素化デンプン加水分解物及び結晶性ソルビトールを含む中央充填組成物を囲むガム領域を含んでもよい。ガム領域は、ガムベースを含む。ガム領域は、25℃で72質量%未満の水溶性を有するポリオール組成物を含んでもよい。ガム領域を囲む硬質シェルコーティングが、組成物に含まれてもよい。 In certain embodiments, liquids that retain at least some of their fluidity for a long period of time and prevent solidification of the center fill over time and / or movement of the liquid center fill into the area surrounding the liquid center fill. Compositions and products containing a center-fill composition are provided. In certain embodiments, the liquid-filled regions of the composition and product may be partially or completely composed of one or more liquids. In certain embodiments, the composition may include a gum region surrounding a center-fill composition comprising a hydrogenated starch hydrolyzate and crystalline sorbitol. The gum region includes a gum base. The gum region may include a polyol composition having a water solubility of less than 72% by weight at 25 ° C. A hard shell coating surrounding the gum region may be included in the composition.
ある実施形態では、中央充填の流動性の喪失を阻止する結晶性ソルビトールを含む中央充填組成物が提供される。ある実施形態では、組成物は中央充填組成物を囲むガム領域を含んでもよく、そのガム領域はガムベースを含む。ガム領域は、第一層の約30〜約80質量%の量でマルチトールを含む In certain embodiments, a center-fill composition comprising crystalline sorbitol that prevents loss of center-fill fluidity is provided. In certain embodiments, the composition may include a gum region surrounding the center-fill composition, the gum region including a gum base. The gum region includes maltitol in an amount of about 30 to about 80% by weight of the first layer.
ある実施形態では、ガム組成物は、結晶性ソルビトールを含み前記チューインガム組成物の0より多く約10質量%までの中央充填層と、前記チューインガム組成物の約55〜約65質量%で含まれるガム層と、前記チューインガム組成物の約25〜約35質量%で含まれるコーティングとを含んでもよく、前記ガム組成物には更に、約3グラム以下のガム片が含まれる。 In certain embodiments, the gum composition comprises crystalline sorbitol and a midfill layer of greater than 0 up to about 10% by weight of the chewing gum composition and from about 55 to about 65% by weight of the chewing gum composition A layer and a coating comprised between about 25 and about 35% by weight of the chewing gum composition, the gum composition further comprising up to about 3 grams of gum pieces.
ある実施形態では、ガム領域を囲む硬質シェルコーティングも組成物に含めてもよい。 In certain embodiments, a hard shell coating surrounding the gum region may also be included in the composition.
ある実施形態では、ガム組成物は、中央充填組成物と、結晶性ソルビトール及び水素化デンプン加水分解物を含む前記中央充填組成物を囲むガム層と、前記ガム層を囲むコーティングとを含み、ガム層は、高密度に充填した結晶構造を有するポリオール組成物を含む防湿成分を含む。 In certain embodiments, the gum composition comprises a center-fill composition, a gum layer surrounding the center-fill composition comprising crystalline sorbitol and hydrogenated starch hydrolysate, and a coating surrounding the gum layer, The layer comprises a moisture barrier component comprising a polyol composition having a densely packed crystal structure.
ある実施形態では、中央充填多層ガムを調製する方法は、以下の工程:(a)液体充填組成物と、チューインガム層(前記ガム層の約30〜約80質量%の量のマルチトールを含むポリオールを含む)とを含む液体充填ロープを押し出し;(b)前記ロープをサイジングし;(c)前記ロープをタブレット成型機構に供給し;(d)前記ロープを冷却し;(e)前記液体充填ロープの個片を形成し;(f)前記個片を冷却し;そして(g)前記個片を硬質コーティングでコーティングする、工程を含み、前記液体充填組成物は、結晶性ソルビトール及び水素化デンプン加水分解物を含む。 In one embodiment, the method of preparing a center-filled multilayer gum comprises the following steps: (a) a polyol comprising a liquid-filled composition and a chewing gum layer (maltitol in an amount of about 30 to about 80% by weight of the gum layer). (B) sizing the rope; (c) feeding the rope to a tablet-forming mechanism; (d) cooling the rope; (e) the liquid-filled rope And (g) coating the piece with a hard coating, wherein the liquid-filled composition comprises crystalline sorbitol and hydrogenated starch hydrolyzed. Includes degradation products.
ある実施形態では、ガム組成物は、中央充填組成物と、結晶性ソルビトール及び水素化デンプン加水分解物を含む前記中央充填組成物を囲むガム層と、前記ガム層を囲むコーティング層とを含んでもよく、前記中央充填組成物は、前記ガム領域以下の水分活性を有する。或いは、ある実施形態で、中央充填の水分活性は、周りのガム層より高くてもよい。 In certain embodiments, the gum composition may comprise a center-fill composition, a gum layer surrounding the center-fill composition comprising crystalline sorbitol and hydrogenated starch hydrolysate, and a coating layer surrounding the gum layer. Well, the center filling composition has a water activity below the gum region. Alternatively, in some embodiments, the water activity of the center fill may be higher than the surrounding gum layer.
ある実施形態では、ガム組成物は、結晶性ソルビトール及び水素化デンプン加水分解物を含む中央充填組成物と、ガム層と、前記ガム層を囲むコーティング層を含んでもよく、前記ガム層は、マルチトールを含むポリオール組成物を含み;前記ガム領域は更に、スチレン−ブタジエン共重合体(SBR)、ポリイソブチレン、イソブチレン−イソプレン共重合体、ポリエチレン、ポリ酢酸ビニル(PVA)及びこれらの組み合わせから選択されるガムベースを含む。 In certain embodiments, the gum composition may include a center-fill composition comprising crystalline sorbitol and hydrogenated starch hydrolysate, a gum layer, and a coating layer surrounding the gum layer, the gum layer comprising a multi-layer The gum region is further selected from styrene-butadiene copolymer (SBR), polyisobutylene, isobutylene-isoprene copolymer, polyethylene, polyvinyl acetate (PVA), and combinations thereof. Including gum base.
ある実施形態で、結晶性ソルビトール及び任意に水素化デンプン加水分解物を含む液体充填組成物と、ガムベースを含むガム領域とを含むチューインガム又は風船ガム組成物を提供する。結晶性ソルビトールと水素化デンプン加水分解物との組み合わせは、流体移動又は液体充填の減少の阻止を補助する。 In certain embodiments, a chewing gum or bubble gum composition comprising a liquid fill composition comprising crystalline sorbitol and optionally a hydrogenated starch hydrolysate and a gum region comprising a gum base is provided. The combination of crystalline sorbitol and hydrogenated starch hydrolyzate helps to prevent fluid transfer or liquid filling loss.
本願明細書の、移行句「comprising(有している)」(「comprises」(有する)等も同様)は、「including(含んでいる)」「containing(含有している)」又は「characterized by(特徴とする)」と同義で、包括的即ちオープンエンド型であり、請求項の前提部又は本文いずれでの使用に関わらず、付加的な、記載していない要素又は方法における工程を除外しない。 In the present specification, the transitional phrase “comprising” (similarly “comprises”, etc.) means “including”, “containing”, or “characterized by”. Is synonymous with “characteristic” and is comprehensive or open-ended, and does not exclude additional, undescribed elements or steps in the method, regardless of whether used in the preamble of the claim or in the text. .
本願明細書の、「風船ガム」及び「チューインガム」という用語は同義的に用いられ、両者とも任意のガム組成物を含むことを意図する。 As used herein, the terms “bubble gum” and “chewing gum” are used interchangeably and are both intended to include any gum composition.
本願明細書の、「第一領域」、「液体充填」及び「中央充填」の用語は同義的に用いられ、組成物の最内部領域を言う。「中央充填」という用語は、ガム片の対称性を含意せず、「中央充填」がガム片の別の領域内にあることを含意するにすぎない。更に、「液体充填」及び「中央充填」の用語は、側面全体にて封入又は閉じ込められた、ガム片の別の領域によって包囲又は被包された領域を含む。更に、「液体充填」の用語は、完全に液体でなくてもよい領域を含む。例えば、「液体充填」の用語は、溶液、懸濁液、乳濁液、半固体、クリーム、ゲル等が存在してもよい領域を含む。「液体充填」領域は、固体粒子又は気体などの非液体成分を含んでもよい。ある実施形態では、1より多くの中央充填又は液体充填が存在してもよい。 As used herein, the terms “first region”, “liquid fill” and “center fill” are used interchangeably and refer to the innermost region of the composition. The term “center filling” does not imply symmetry of the gum pieces, but only implies that “center filling” is within another region of the gum pieces. Furthermore, the terms “liquid filling” and “center filling” include a region enclosed or encapsulated by another region of gum pieces that is enclosed or confined across the sides. Furthermore, the term “liquid filling” includes areas that may not be completely liquid. For example, the term “liquid filling” includes areas where solutions, suspensions, emulsions, semi-solids, creams, gels and the like may be present. A “liquid-filled” region may contain non-liquid components such as solid particles or gases. In some embodiments, there may be more than one center fill or liquid fill.
本願明細書の「第二領域」及び「ガム領域」の用語は同義的に用い、中央充填、又は最内部領域に、隣接又は少なくとも部分的にこれを囲んでもよい組成物の領域を言う。 As used herein, the terms “second region” and “gum region” are used interchangeably and refer to a region of the composition that may be adjacent to or at least partially surrounding the center-fill, or innermost region.
本願明細書の「第三領域」及び「コーティング」の用語は同義的に用い、組成物の最外部領域を言う。 The terms “third region” and “coating” herein are used interchangeably and refer to the outermost region of the composition.
本願明細書の「囲む」、「囲んでいる」等の用語は、包囲することに限定されない。これらの用語は、側面全体にて封入又は閉じ込めること、包囲又は被包することを言ってもよく、ガム製品内での一領域に対する対称性又は同一厚みに限定されない。 The terms “enclose”, “enclose”, and the like in this specification are not limited to enclosing. These terms may refer to enclosing or confining, enclosing or encapsulating across the sides, and are not limited to symmetry or the same thickness for a region within the gum product.
本願明細書の「液体」の用語は、中央充填領域からガム領域に水分を移行できる組成物を含む。この用語は、限定しないが、室温及び圧力にて容易に流動するか、又は流動性を維持するであろう組成物を含む。「液体」の用語は、完全に液体でなくてもよいが、それでも中央充填領域からガム領域への水分の移行が原因となって流動性を喪失する可能性がある溶液、懸濁液、乳濁液、半固体、クリーム、ゲル等を含んでもよい。「液体」は、水性又は非水性であってもよい。また、「液体」は、固体粒子又は気体などの非液体成分を含んでもよい。 As used herein, the term “liquid” includes a composition that can transfer moisture from the central filling region to the gum region. The term includes, but is not limited to compositions that will readily flow or maintain fluidity at room temperature and pressure. The term “liquid” does not have to be completely liquid, but is still a solution, suspension, milk that may lose fluidity due to the transfer of moisture from the central filling area to the gum area. Suspensions, semi-solids, creams, gels and the like may be included. “Liquid” may be aqueous or non-aqueous. “Liquid” may also include non-liquid components such as solid particles or gases.
本願明細書の、「配合成分」の用語、及び「成分」の用語は同義的に用い、添加剤、固着剤、物質、材料、作用物、活性物、要素、又はある実施形態のガム組成物に含めてもよい部分のいずれもを言う。 As used herein, the terms “formulation component” and “component” are used interchangeably and refer to additives, stickers, substances, materials, agents, actives, elements, or a gum composition of an embodiment. Say any of the parts you may include.
本願明細書のある実施形態は、少なくとも1つの液体充填領域と、ガムベースを含むガム領域とを含む多成分組成物を提供する。ガム領域は、少なくとも2層を含み、ここで第一層は液体充填領域に隣接する。第一層は、マルチトールを含むことになる。液体充填領域及びガム領域は、個々のガム片に成形してもよい。 Certain embodiments herein provide a multi-component composition that includes at least one liquid-filled region and a gum region that includes a gum base. The gum region includes at least two layers, where the first layer is adjacent to the liquid filled region. The first layer will contain maltitol. The liquid filled region and gum region may be formed into individual gum pieces.
個々のガム片は、外側ゴムコーティング又はシェルを含んでもよく、これは概して、ガム片を最初に噛む際にバリバリ感をもたらす。個々のガム片は、例えばペレット、タブレット、ボール、まくら、大型塊、スティック及び厚板を含む種々の形状に成形してもよい。 Individual gum pieces may include an outer rubber coating or shell, which generally provides a sense of crunch when the gum pieces are first chewed. Individual gum pieces may be formed into various shapes including, for example, pellets, tablets, balls, pillows, large chunks, sticks and planks.
例えば、ある実施形態では、個々のガム片は図1に示すように厚板10に成形してもよい。厚板10は、それぞれの端部12を境として、長さ(l)、幅(w)及び厚さ(t)を有してもよい。厚板の長さは、約20mm〜約80mm、詳細には約25mm〜約55mm、更に詳細には約25mm〜約45mmであってもよい。厚板の幅は、約5mm〜約50mm、詳細には約10mm〜約30mm、更に詳細には約10mm〜約15mmであってもよい。厚板の厚さは、約0.5mm〜約30mm、詳細には約0.5mm〜約20mm、更に詳細には約0.5mm〜約10mmであってもよい。厚板10の1以上の端部12は、図2及び3にそれぞれ示すように、丸みを帯びたコーナー12a又は角張ったコーナー12bを含むものなどの、チューインガム片に好適な何れの構成を有してもよい。図4に示す断面図で示すように、厚板10は液体充填組成物中央100、及びその液体充填組成物中央を囲んでいるガム領域200を含む。
For example, in one embodiment, individual gum pieces may be formed into
ある実施形態では、外側コーティングは、少なくとも部分的に厚板を囲んでもよい。特に、厚板の1つの側面がコーティングされてもよく、厚板の2つの側面がコーティングされてもよく、又はコーティングがガム厚板全体を囲んでもよい。厚板に付すコーティングは、約1ミクロン〜約7mmの厚さを有してもよい。好適なコーティング組成物については、以下に更に詳説する。 In certain embodiments, the outer coating may at least partially surround the slab. In particular, one side of the plank may be coated, two sides of the plank may be coated, or the coating may surround the entire gum plank. The coating applied to the slab may have a thickness of about 1 micron to about 7 mm. Suitable coating compositions are described in further detail below.
ある実施形態では、組成物の成分は、ガム組成物全体の所望の形状により異なる構成にしてもよい。液体充填部位は、ガム領域に対して同心構成か、又は層状構成のいずれかであってもよい。同心構成は、ボール、まくら又はペレット形状で許容でき、層状構成は厚板又はスティック形状に対してより好適であるかもしれない。 In some embodiments, the components of the composition may be configured differently depending on the desired shape of the overall gum composition. The liquid filling site may be either a concentric configuration or a layered configuration with respect to the gum region. Concentric configurations are acceptable in the form of balls, pillows or pellets, and a layered configuration may be more suitable for planks or stick shapes.
本願明細書に記載の中央充填ガム組成物及び他の組成物は、Degadyらの米国特許第6280780号明細書(「Degady」、本願に引用してその全体を援用する)に記載の方法を含む当該技術分野で公知の任意の技術によって形成してよい。Degadyは、中央充填ガムペレットを形成するための装置及び方法を記載する。この方法は、先ずチューインガム層の液体充填ロープを押し出し、一連の対合するプーリ型のローラ部材を含むサイジング機構にロープを通す工程を含む。ローラ部材は、タブレット成型機構に入れるのに望ましいサイズ及び形状で一連のローラから離れるように、ガム材料のロープ又はストランドを「サイジング」する。 The center-filled gum composition and other compositions described herein include the methods described in US Pat. No. 6,280,780 to Degady et al. (“Degady”, incorporated herein by reference in its entirety). It may be formed by any technique known in the art. Degady describes an apparatus and method for forming center-filled gum pellets. The method includes first extruding a liquid-filled rope of the chewing gum layer and passing the rope through a sizing mechanism that includes a series of mating pulley-type roller members. The roller member “sizes” the rope or strand of gum material away from the series of rollers in the desired size and shape for entry into the tablet molding mechanism.
ロープは次いで、エンドレス鎖機構であり、両者がモータ及びギア機構により同じ速度で回転する一対の回転鎖ダイ部材を含むタブレット成型機構に導かれる。鎖機構の各々は、噛合して、その中でガム材料の片(ペレット又はタブレット)を形成するダイキャビティを形成する、複数の解放弯曲ダイ溝部材を含む。Degadyはペレット又はタブレット形状の片の形成に限定しているが、ガム片は前記のような他の形状であってもよい。ダイ溝部材の形状は、任意の所望形状を提供するように変更してもよい。 The rope is then an endless chain mechanism that is led to a tablet molding mechanism that includes a pair of rotating chain die members that both rotate at the same speed by a motor and gear mechanism. Each of the chain features includes a plurality of open-curved die groove members that engage to form a die cavity that forms a piece of gum material (pellets or tablets) therein. Although Degady is limited to the formation of pellets or tablet-shaped pieces, the gum pieces may have other shapes as described above. The shape of the die groove member may be varied to provide any desired shape.
ガムは任意に、タブレット成型機構に入る前、タブレット成型機構を出た後、又はその両方、のいずれかに冷却トンネルを通してもよい。タブレット成型機構に入る前にロープを冷却することは、個片の反跳を防ぎ、従ってその生産性を高めるのに役立ち得る。 The gum may optionally be passed through a cooling tunnel either before entering the tablet forming mechanism, after exiting the tablet forming mechanism, or both. Cooling the rope before entering the tablet forming mechanism can help to prevent the pieces from recoiling and thus increase their productivity.
ガム材料の冷却した片は、その後コンディショニング及び更なる加工のために保存容器に入れる。この際、ガム材料の冷却片は、回転トンネル機構などのコーティングトンネル機構に直接入れることもできる。 The cooled piece of gum material is then placed in a storage container for conditioning and further processing. At this time, the cooling piece of the gum material can be directly put into a coating tunnel mechanism such as a rotating tunnel mechanism.
形成したガム材料の片を、先ず保存した場合、保存容器に移した場合、又はコーティングトンネル若しくは機構に直接入れた場合のいずれでも、ガム材料の個片はその後、液体充填ガム材料に硬質外装シェルを形成するために従来の糖又は無糖コーティングプロセスに付してもよい。このタイプの種々のコーティングプロセス又は機構が知られている。パニングとして公知のプロセスの一種では、適切に均一コーティングされた、仕上げ品質の表面をガム製品に形成するために、材料の多数の薄層にてコーティングを付す。硬質コーティング材料は、砂糖、マルチトール、ソルビトール又は他の任意のポリオール(本願明細書に記載のものを含む)、及び任意に香味料を含んでもよく、コーティング機構又はコーティングトンネルをガム材料のペレットが通過する際にスプレーされ、その中で混転及び回転させる。また、形成した製品上の連続コーティング層の各々を乾燥させるために、コーティングトンネル又は機構に調整空気を循環させるか又は送り込む。ある実施形態では、コーティング、又は最外領域は、積層、二軸若しくは多軸押し出し、又は最外領域を作り出す他の任意のプロセスによって形成できる。 Whether the formed piece of gum material is first stored, transferred to a storage container, or placed directly into a coating tunnel or mechanism, the piece of gum material is then placed into a liquid-filled gum material with a rigid outer shell. To form a conventional sugar or sugar-free coating process. Various coating processes or mechanisms of this type are known. In one type of process known as panning, the coating is applied in multiple thin layers of material to form a properly uniform, finished, quality surface on the gum product. The hard coating material may include sugar, maltitol, sorbitol, or any other polyol (including those described herein), and optionally flavoring, and the coating mechanism or coating tunnel is formed by pellets of gum material. Sprayed as it passes, tumbles and rotates in it. Also, conditioned air is circulated or sent through the coating tunnel or mechanism to dry each of the continuous coating layers on the formed product. In certain embodiments, the coating, or outermost region, can be formed by lamination, biaxial or multiaxial extrusion, or any other process that creates the outermost region.
ある実施形態では、コーティング組成物は、中央充填、ガム領域及びコーティングを含む個々のガム片の約2〜約60質量%、より詳細には、約20〜約40質量%の範囲で、更に詳細には、25%〜35質量%、より一層詳細にはおよそ30質量%程度であってもよい。コーティングは、主成分として砂糖又はマルチトールなどのポリオールを含んでもよいが、後述のガム領域の場合と同様に、香味料、着色料等も含んでもよい。コーティング又は最外領域は、結晶性又は無定形であってもよい。 In certain embodiments, the coating composition is more detailed in the range of about 2 to about 60%, more specifically about 20 to about 40% by weight of the individual gum pieces including the centerfill, gum region and coating. May be about 25% to 35% by mass, and more specifically about 30% by mass. The coating may contain a polyol such as sugar or maltitol as a main component, but may also contain a flavoring agent, a coloring agent, etc., as in the case of the gum region described below. The coating or outermost region may be crystalline or amorphous.
ある実施形態では、中央充填チューインガムは、液体充填に隣接する層がマルチトールを含む多層状ガム領域組成物を備えることによって、ガム領域の中央充填からの水分の移動を阻止する。マルチトールは、層の約30〜約80質量%の量、更に詳細には層の約40〜約60質量%の量で、層内に存在してもよい。 In some embodiments, the center-filled chewing gum prevents moisture migration from the center fill of the gum region by providing a multilayer gum region composition in which the layer adjacent to the liquid fill comprises maltitol. Maltitol may be present in the layer in an amount of about 30 to about 80% by weight of the layer, more particularly in an amount of about 40 to about 60% by weight of the layer.
ある実施形態では、液体充填に隣接するガム層は、マルチトールガム領域又はガム層とも称されるであろう。マルチトールガム層は、約0.5mm〜約5mm、更に詳細には約1mm〜約3mmなどの好適な厚さを有してもよい。マルチトール層及び任意の非マルチトール層を含むガム領域全体につき、マルチトール層は、ガム領域全体の約25〜約100質量%、詳細にはガム領域全体の約40〜約95質量%、更に詳細にはガム領域全体の約50%〜約75%の量で存在してもよい。 In certain embodiments, the gum layer adjacent to the liquid fill will also be referred to as a maltitol gum region or gum layer. The maltitol gum layer may have a suitable thickness, such as from about 0.5 mm to about 5 mm, more particularly from about 1 mm to about 3 mm. For the entire gum region including the maltitol layer and any non-maltitol layer, the maltitol layer is about 25 to about 100% by weight of the total gum region, specifically about 40 to about 95% by weight of the total gum region, Specifically, it may be present in an amount of about 50% to about 75% of the entire gum area.
本発明のある実施形態で、更に小さいサイズの片が含まれる。例えば、市販のガムで最も小さいサイズの従来の片は、通常ペレット形状を取っている。これらの片のサイズは現在のところ、約5〜7グラムの範囲にある。ある実施形態で、実質的に更に小さいサイズの片、即ち50〜60質量%小さいものを用いて、流動性の喪失、又はガム領域内への、若しくはこれを超えてコーティング内への液体の移動を伴わない液体充填製品が作られている。本発明のある実施形態は、外側硬質コーティングシェル追加分を含めて約0.5グラムを上回る、更に詳細には1.5グラムを上回り約3グラムまでの範囲のサイズの液体充填ガム片を提供する。更に、ある実施形態では、ガム片は中央充填と、ガムベースを含むガム領域と、外側コーティングとを含んでもよい。かかるガム片は、1片あたり総重量が約2.2グラムであってもよい。 In some embodiments of the invention, smaller sized pieces are included. For example, the smallest piece of commercially available gum is usually in the form of a pellet. The size of these pieces is currently in the range of about 5-7 grams. In certain embodiments, substantially smaller sized pieces, i.e., 50-60% by weight smaller, are used to lose fluidity or move liquid into or beyond the gum region into the coating. Liquid-filled products that are not accompanied by Certain embodiments of the present invention provide liquid-filled gum pieces of a size in the range of greater than about 0.5 grams including the addition of the outer hard coating shell, more specifically greater than 1.5 grams and up to about 3 grams. To do. Further, in certain embodiments, the gum pieces may include a center fill, a gum region that includes a gum base, and an outer coating. Such gum pieces may have a total weight of about 2.2 grams per piece.
このように小さいサイズの片、そして特に、液体自体の重量に比べて比例的に大きい液体充填表面積を有するガム形状又は構成の片は、異なる因子の相互作用に起因して中央の流動性を喪失する傾向が更に大きくなることが発見されている。単一の理論に限定せず、これらの因子として挙げらるのは、液体充填が直接接触するガム領域の表面に比べて液体充填が少ないこと、その型のエラストマーと中央充填との相互作用(即ち[SBR]対[非SBR])、ガム領域成分の液体充填成分との適合性、及びガム領域で使用されるポリオールの潜在的な毛細管作用である。例えば、米国でガム処方に慣例的に使用されるソルビトールの構造は、密に充填した結晶構造をもたらさず、ほぼスポンジ状の外観を与える。従って、約3グラム未満の中央充填ガム片を提供するために、本発明は、流動性の喪失を阻止する中央充填ガム片を提供すべく、従来のソルビトールガム領域処方でのスポンジ状の構造とは異なる、濃く、密に充填した結晶構造を有するポリオール組成物を含むようにガム及びガムベースを変更する。 Such small sized pieces, and especially pieces of gum shape or composition with a liquid-filled surface area proportionally larger than the weight of the liquid itself, lose central fluidity due to the interaction of different factors. It has been discovered that the tendency to do is even greater. Without being limited to a single theory, these factors include the fact that there is less liquid filling compared to the surface of the gum area where the liquid filling is in direct contact, and the interaction between that type of elastomer and the center filling ( Ie, [SBR] vs. [non-SBR]), the compatibility of the gum region components with the liquid fill component, and the potential capillary action of the polyols used in the gum region. For example, the structure of sorbitol, customarily used in gum formulations in the United States, does not result in a tightly packed crystal structure and gives a generally spongy appearance. Thus, to provide a center-filled gum piece of less than about 3 grams, the present invention provides a sponge-like structure with conventional sorbitol gum region formulations to provide a center-filled gum piece that prevents loss of fluidity. The gum and gum base are modified to include polyol compositions having different, dense, closely packed crystal structures.
他の有用な中央充填ガム組成物及び/又はその組成物中で使用するための成分に関しては、以下の共通の所有者による特許出願(その内容全体を本願に引用して援用する):名称「液体充填チューインガム組成物」である2006年2月24日に出願の米国出願第60/776642号明細書;名称「液体充填チューインガム組成物」である2006年2月24日に出願の米国出願第60/776641号明細書、名称「中央充填チューインガム組成物」である2006年2月24日に出願の米国出願第60/776637号明細書;名称「バリア層を備えた中央充填チューインガム」である2006年2月24日出願の米国出願第60/776508号明細書;名称「中央充填チューインガム組成物」である2006年2月24日出願の米国出願第60/776382号明細書;及び名称「多様式チューインガム組成物」である2006年2月24日出願の米国出願第60/776699号明細書を参照されたい。 For other useful center-filled gum compositions and / or ingredients for use in the compositions, the following commonly owned patent application (the entire contents of which are incorporated herein by reference): No. 60 / 77,642, filed Feb. 24, 2006, which is a “liquid-filled chewing gum composition”; U.S. application No. 60, filed on Feb. 24, 2006, which is named “liquid-filled chewing gum composition”. No. 776641, U.S. Application No. 60/776637, filed Feb. 24, 2006, entitled "Center Filled Chewing Gum Composition"; Named 2006, "Center Filled Chewing Gum with Barrier Layer" US Application No. 60/776508 filed Feb. 24; US filed Feb. 24, 2006 with the name “Center Filled Chewing Gum Composition” See and names U.S. Application No. 60/776699 of "multimodal chewing gum composition" is a February 24, 2006 filed; Application No. 60/776382 Pat.
(ガム領域)
請求項で第二領域とも称するガム領域は、液体バリアを提供して、液体充填を囲み、低減し、そしておそらくは均一化し、また液体充填の移動及び早期放出を防止する。1以上のキャビティをガム領域内に存在させて、液体中央充填を収納できる。キャビティの形状は、概ね、チューインガム片の最終的な構成によって決定付けられるであろう。所望のキャビティ表面積の液体充填重量に対する比率の選択によって、ガム領域の部位内への潜在的な液体充填の移動が至適に低減できるようになる。これは、ガム片のサイズが従来の市販のガム片よりも実質的に小さいことが求められる場合に、特に有用である。特に、ガム片全体の重量で2〜3グラムのサイズを有する液体充填ペレットガムが成功裡に作製されている。しかし、約0.5グラムという小ささの更に小さいガム片が考えられる。
(Gum area)
The gum region, also referred to as the second region in the claims, provides a liquid barrier to surround, reduce, and possibly homogenize the liquid fill, and prevent migration and premature release of the liquid fill. One or more cavities can be present in the gum region to accommodate the liquid center fill. The shape of the cavity will generally be determined by the final configuration of the chewing gum pieces. Selection of the desired cavity surface area to liquid fill weight ratio can optimally reduce the transfer of potential liquid fill into the gum region site. This is particularly useful when the gum piece size is required to be substantially smaller than conventional commercially available gum pieces. In particular, liquid filled pellet gums having a size of 2-3 grams by weight of the entire gum piece have been successfully made. However, smaller gum pieces as small as about 0.5 grams are contemplated.
ある実施形態では、ガム領域は厚さが不均一であってもよい。特に、層状構成の実施形態におけるガム領域は、ガム片の側部より端部で薄くなっていてもよい。 In certain embodiments, the gum region may be non-uniform in thickness. In particular, the gum region in the layered embodiment may be thinner at the end than the side of the gum piece.
前記のとおり、ある実施形態では、ガム領域は1より多くの層を含んでもよい。第一層は、マルチトールを含み、液体充填領域に隣接してもよい。 As noted above, in certain embodiments, the gum region may include more than one layer. The first layer may include maltitol and be adjacent to the liquid filled region.
このような実施形態で、本願明細書のガム領域は、マルチトール層及び非マルチトール層の両者を言う。ガム領域に添加してもよい全ての成分は、それらの層の一方又は両方に存在してもよい。追加のガム領域層も、含んでもよい(即ち、3以上の別々のガム層を含むガム組成物)。 In such embodiments, the gum region herein refers to both maltitol and non-maltitol layers. All ingredients that may be added to the gum region may be present in one or both of those layers. Additional gum region layers may also be included (ie, gum compositions that include three or more separate gum layers).
ガム領域は、ガムベースを含んでもよい。ガムベースは、チューインガムの技術分野で公知の、任意の成分を含んでもよい。例えば、ガム領域は、エラストマー、増量剤、ロウ、エラストマー溶媒、乳化剤、可塑剤、充填剤、及びこれらの混合物を含んでもよい。ここで、ガム領域は、中央充填、ガム領域及びコーティング層を含む3成分組成物に含められ、このガム領域は、チューインガム片の約40〜約97質量%、更に詳細には約55〜約65質量%、更に一層詳細には約62質量%含まれてもよい。 The gum region may include a gum base. The gum base may include any ingredients known in the chewing gum art. For example, the gum region may include elastomers, fillers, waxes, elastomer solvents, emulsifiers, plasticizers, fillers, and mixtures thereof. Here, the gum region is included in a three-component composition comprising a center fill, a gum region and a coating layer, the gum region comprising about 40 to about 97% by weight of the chewing gum piece, more particularly about 55 to about 65%. % By weight, and more particularly about 62% by weight.
ガム領域は、このガム領域の約30〜約80質量%、詳細には50〜約60質量%である少なくとも1つのポリオールを含む特定のポリオール組成物も含んでもよい。ポリオール組成物は、限定しないが、マルチトール、ソルビトール、エリスリトール、キシリトール、マンニトール、イソマルト、ラクチトール及びこれらの組み合わせを含む、当該技術分野で公知の任意のポリオールを含んでもよい。ソルビトール及びマルチトールを含む水素化デンプン加水分解物であるLycasin(登録商標)も、使用してもよい。 The gum region may also include certain polyol compositions that include at least one polyol that is from about 30 to about 80 weight percent of the gum region, in particular from 50 to about 60 weight percent. The polyol composition may comprise any polyol known in the art including, but not limited to, maltitol, sorbitol, erythritol, xylitol, mannitol, isomalt, lactitol, and combinations thereof. Lycasin®, a hydrogenated starch hydrolyzate containing sorbitol and maltitol, may also be used.
マルチトールは、飲料及び食品の調製で増量剤として有用な、甘い水溶性の糖アルコールであって、米国特許第3708396号明細書に更に十分に記載されており、この開示を本願に引用して援用する。マルチトールは、最も普及している還元二糖であり、デンプン及び他の天然産物に認められるマルトースの水素化によって製造される。 Maltitol is a sweet, water-soluble sugar alcohol useful as a bulking agent in the preparation of beverages and foods and is more fully described in US Pat. No. 3,708,396, the disclosure of which is hereby incorporated by reference. Incorporate. Maltitol is the most popular reducing disaccharide and is produced by the maltose hydrogenation found in starch and other natural products.
ポリオール組成物は、種々のサイズの粒子を含んでもよい。詳細には、ポリオール組成物の平均粒子径は、約30ミクロン〜約600ミクロン、更に詳細には約30ミクロン〜約200ミクロンの範囲とする。 The polyol composition may include particles of various sizes. Specifically, the average particle size of the polyol composition ranges from about 30 microns to about 600 microns, and more specifically from about 30 microns to about 200 microns.
ガム領域に存在するガムベースの量も、変化してもよい。ガムベースは、ガム領域の約25〜約45質量%の量で、ガム領域中に配合してもよい。ガムベースの更に詳細な範囲は、ガム領域の約28〜約42質量%である。更に一層詳細には、その範囲は、約28%〜約35%、又は約28%〜約30%であってもよい。 The amount of gum base present in the gum region may also vary. The gum base may be incorporated into the gum region in an amount of about 25 to about 45% by weight of the gum region. A more detailed range of gum base is from about 28 to about 42% by weight of the gum region. Even more particularly, the range may be from about 28% to about 35%, or from about 28% to about 30%.
ガムベースに使用するエラストマー(ゴム)は、所望のガムベースの種類、所望のガム組成物の整合性、及びチューインガムの最終製品を製造するためにガム組成物に使用する他の成分等の種々の要因によって極めて多様である。エラストマーは、当技術分野で公知の任意の水不溶性のポリマーであってもよく、チューインガム及び風船ガムに利用されるガムポリマーを含む。ガムベースの適切なポリマーの例として、天然及び合成のエラストマーが挙げられる。例えば、ガムベース組成物において適切なポリマーとしては、限定されるものではないが、チクル、天然ゴム、クラウンガム、ニスペロ、ロシジンハ、ジェルトン、ペリロ、ニガーグッタ、トゥーヌ、バラタ、グッタペルカ、レチ−カプシ、ソルバ、グッタ−カイ等、及びこれらの組み合わせのような(植物由来の)天然物質が挙げられる。合成エラストマーの例としては、限定されるものではないが、スチレン−ブタジエン共重合体(SBR)、ポリイソブチレン、イソブチレン−イソプレン共重合体、ポリエチレン、ポリ酢酸ビニル等、及びこれらの組み合わせが挙げられる。 The elastomer (rubber) used in the gum base depends on various factors such as the type of gum base desired, the consistency of the desired gum composition, and other ingredients used in the gum composition to produce the final chewing gum product. It is extremely diverse. The elastomer may be any water insoluble polymer known in the art, including gum polymers utilized in chewing gum and bubble gum. Examples of suitable polymers for gum base include natural and synthetic elastomers. For example, suitable polymers in a gum base composition include, but are not limited to, chicle, natural rubber, crown gum, nispero, rosinha, gelton, perillo, niger gutta, thun, balata, gutaperca, retino-capsi, solver, And natural substances (derived from plants) such as Gutta-chi and the like, and combinations thereof. Examples of synthetic elastomers include, but are not limited to, styrene-butadiene copolymer (SBR), polyisobutylene, isobutylene-isoprene copolymer, polyethylene, polyvinyl acetate, and the like, and combinations thereof.
追加の有用なポリマーとして、架橋したポリビニルピロリドン、ポリメチルメタクリレート;乳酸の共重合体、ポリヒドロキシアルカノエート、可塑化エチルセルロース、ポリビニルアセテートフタレート、及びこれらの組み合わせが挙げられる。 Additional useful polymers include cross-linked polyvinyl pyrrolidone, polymethyl methacrylate; copolymers of lactic acid, polyhydroxyalkanoates, plasticized ethyl cellulose, polyvinyl acetate phthalate, and combinations thereof.
ガムベースに使用するエラストマーの量は、使用するガムベースの種類、所望のガム組成物の整合性、及びチューインガムの最終製品を製造するために、組成物に使用する他の成分等の種々の要因によって変えてもよい。一般的に、エラストマーは、ガムベース中に、ガム領域の約10〜60質量%、望ましくは約35〜40質量%の量で存在するであろう。 The amount of elastomer used in the gum base will vary depending on various factors such as the type of gum base used, the consistency of the desired gum composition, and other ingredients used in the composition to produce the final chewing gum product. May be. Generally, the elastomer will be present in the gum base in an amount of about 10-60% by weight of the gum region, desirably about 35-40% by weight.
ある実施形態では、ガムベースはロウを含んでもよい。ロウは、高分子エラストマー混合物を軟化させ、ガムベースの弾性を高める。存在する場合、使用するロウは、約60℃未満、好ましくは45℃〜55℃までの融点を有してもよい。低融点ロウは、パラフィンロウであってもよい。ロウの量は、ガムベースに対して、約6質量%〜約10質量%、好ましくは約7質量%〜約9.5質量%であってもよい。 In certain embodiments, the gum base may include wax. The wax softens the polymer elastomer mixture and increases the elasticity of the gum base. If present, the wax used may have a melting point of less than about 60 ° C, preferably from 45 ° C to 55 ° C. The low melting wax may be a paraffin wax. The amount of wax may be about 6% to about 10% by weight, preferably about 7% to about 9.5% by weight, based on the gum base.
低融点ロウに加えて、更に高い融点を有するロウを、ガムベースの約5質量%までの量でガムベースにて用いてもよい。このような高融点ロウとして、ミツロウ、モクロウ、カンデリラロウ、カルナバロウ、ほとんどの石油ロウ等、及びこれらの混合物が挙げられる。 In addition to the low melting wax, waxes with higher melting points may be used in the gum base in amounts up to about 5% by weight of the gum base. Such high melting waxes include beeswax, mole, candelilla wax, carnauba wax, most petroleum waxes, and the like, and mixtures thereof.
上記の成分のほかに、ガムベースは、エラストマー溶媒、乳化剤、可塑剤、充填剤、及びこれらの混合物から選択される成分等の種々の他の成分を含んでもよい。 In addition to the above components, the gum base may include various other components such as components selected from elastomer solvents, emulsifiers, plasticizers, fillers, and mixtures thereof.
ガムベースは、エラストマー成分の軟化を補助するように、エラストマー溶媒を含有してもよい。かかるエラストマー溶媒としては、当技術分野において公知のエラストマー溶媒、例えば、α−ピネン又はβ−ピネンのポリマー等のテルピネン樹脂、ロジン及び修飾ロジンのメチル、グリセロール及びペンタエリスリトールエステル、並びに水素添加ロジン、二量体化ロジン及び重合ロジン等のガムと、それらの混合物が挙げられる。本願明細書での使用に好適なエラストマー溶媒の例としては、部分的に水素化されたウッドロジン及びガムロジンのペンタエリスリトールエステル、ウッドロジン及びガムロジンのペンタエリスリトールエステル、ウッドロジンのグリセロールエステル、部分的に二量体化されたウッドロジン及びガムロジンのグリセロールエステル、重合されたウッドロジン及びガムロジンのグリセロールエステル、タル油ロジンのグリセロールエステル、ウッドロジン及びガムロジンのグリセロールエステル、部分的に水素化されたウッドロジン及びガムロジン、木及びロジンの部分的な水素化メチルエステル等、並びにこれらの混合物が挙げられる。エラストマー溶媒は、ガムベースに対して約2〜約15質量%、より好ましくは約7〜約11質量%の量で使用してもよい。 The gum base may contain an elastomer solvent to help soften the elastomer component. Such elastomer solvents include elastomer solvents known in the art, such as terpinene resins such as α-pinene or β-pinene polymers, methyl, glycerol and pentaerythritol esters of rosin and modified rosin, and hydrogenated rosin, two Examples thereof include gums such as monomerized rosin and polymerized rosin, and mixtures thereof. Examples of elastomer solvents suitable for use herein include partially hydrogenated wood rosin and gum rosin pentaerythritol esters, wood rosin and gum rosin pentaerythritol esters, wood rosin glycerol esters, partially dimers Glycerol esters of polymerized wood rosin and gum rosin, glycerol esters of polymerized wood rosin and gum rosin, glycerol esters of tall oil rosin, glycerol esters of wood rosin and gum rosin, partially hydrogenated wood rosin and gum rosin, wood and rosin parts And hydrogenated methyl esters, as well as mixtures thereof. The elastomer solvent may be used in an amount of about 2 to about 15% by weight, more preferably about 7 to about 11% by weight, based on the gum base.
また、ガムベースは、単一の安定システムに非混合成分を分散させるのに役立つ乳化剤を含んでもよい。本発明で有用な乳化剤としては、モノステアリン酸グリセリン、レシチン、脂肪酸モノグリセリド、ジグリセリド、プロピレングリコールモノステアリン酸等、及びそれらの混合物が挙げられる。乳化剤を、ガムベースに対して約2〜約15質量%、より詳細には約7〜約11質量%の量で使用してもよい。 The gum base may also include an emulsifier that helps to disperse the non-mixed ingredients in a single stable system. Emulsifiers useful in the present invention include glyceryl monostearate, lecithin, fatty acid monoglycerides, diglycerides, propylene glycol monostearic acid, and the like, and mixtures thereof. The emulsifier may be used in an amount of about 2 to about 15 weight percent, more specifically about 7 to about 11 weight percent, based on the gum base.
ガムベースはまた、種々の望ましいテクスチャ及び整合性特性を与えるために、可塑剤又は軟化剤を含んでもよい。可塑剤及び軟化剤は、成分の分子量が低いため、ガムベースの実質的な構造を透過できることから、可塑性を与えながら粘性を低くする。有用な可塑剤及び軟化剤としては、ラノリン、パルミチン酸、オレイン酸、ステアリン酸、ステアリン酸ナトリウム、ステアリン酸カリウム、グリセリルトリアセテート、グリセリルレシチン、モノステアリン酸グリセリン、プロピレングリコールモノステアリン酸、アセチル化モノグリセリド、グリセリン等、及びそれらの混合物が挙げられる。ロウと、例えば、天然及び合成ロウ、水素化植物油、石油ロウ、例えばポリウレタンロウ、ポリエチレンロウ、パラフィンロウ、微晶質ロウ、脂肪ロウ、モノステアリン酸ソルビタン、牛脂、プロピレングリコール、それらの混合物等を、ガムベースに混和してもよい。可塑剤と軟化剤は、一般にガムベースの約20質量%以下の量で、より詳しくは、ガムベースの質量の約9%〜約17%の量でガムベースに使用する。 The gum base may also include plasticizers or softeners to provide various desirable texture and consistency properties. Plasticizers and softeners have a low molecular weight and can penetrate the substantial structure of the gum base, thus reducing viscosity while imparting plasticity. Useful plasticizers and softeners include lanolin, palmitic acid, oleic acid, stearic acid, sodium stearate, potassium stearate, glyceryl triacetate, glyceryl lecithin, glyceryl monostearate, propylene glycol monostearic acid, acetylated monoglycerides, A glycerin etc. and those mixtures are mentioned. Waxes such as natural and synthetic waxes, hydrogenated vegetable oils, petroleum waxes such as polyurethane wax, polyethylene wax, paraffin wax, microcrystalline wax, fat wax, sorbitan monostearate, beef tallow, propylene glycol, mixtures thereof, etc. It may be mixed with the gum base. Plasticizers and softeners are generally used in the gum base in an amount up to about 20% by weight of the gum base, and more specifically in an amount from about 9% to about 17% of the weight of the gum base.
可塑剤は、水素化植物油も含み、大豆油及び綿実油が挙げられ、これらは単独で又は組み合わせて使用してもよい。これらの可塑剤は、ガムベースに良好なテクスチャ及び軟らかい噛み応えを与える。これら可塑剤及び軟化剤は、一般に、ガムベースの約5〜約14質量%で、より詳細には約5〜約13.5質量%の量で使用する。 Plasticizers also include hydrogenated vegetable oils, including soybean oil and cottonseed oil, which may be used alone or in combination. These plasticizers give the gum base a good texture and a soft chewing feel. These plasticizers and softeners are generally used in an amount of about 5 to about 14% by weight of the gum base, more specifically about 5 to about 13.5% by weight.
無水グリセリンを、柔軟剤(例えば市販の米国薬局方(USP)等級)として使用してもよい。グリセリンは、甘く暖かい味を備えたシロップ状の液体であって、ショ糖の約60%の甘味を有する。グリセリンは吸湿性を有するため、無水グリセリンは、チューインガム組成物の調製中ずっと、無水状態の下で維持される場合がある。 Anhydrous glycerin may be used as a softening agent (eg, commercially available United States Pharmacopeia (USP) grade). Glycerin is a syrupy liquid with a sweet and warm taste and has a sweetness of about 60% of sucrose. Because glycerin is hygroscopic, anhydrous glycerin may be maintained under anhydrous conditions throughout the preparation of the chewing gum composition.
ある実施形態において、本発明のガムベースは、有効量の増量剤(例えば充填剤及びテクスチャ剤としての役割を果たすことができるミネラル補助剤)も含んでもよい。有用なミネラル補助剤としては、炭酸カルシウム、炭酸マグネシウム、アルミナ、水酸化アルミニウム、ケイ酸アルミニウム、タルク、リン酸三カルシウム、リン酸二カルシウム、硫酸カルシウム等、及びそれらの混合物が挙げられる。これらの充填剤又はアジュバントは、種々の量でガムベース組成物に使用してもよい。充填剤の量は、ガムベースに対して、約0質量%〜約40質量%、より詳細には約0質量%〜約30質量%であってよい。ある実施形態では、充填剤の量は、約0〜約15%、更に詳細には約3%〜約11%とされることになる。 In certain embodiments, the gum base of the present invention may also include an effective amount of a bulking agent (eg, a mineral adjuvant that can serve as a filler and texture agent). Useful mineral adjuvants include calcium carbonate, magnesium carbonate, alumina, aluminum hydroxide, aluminum silicate, talc, tricalcium phosphate, dicalcium phosphate, calcium sulfate, and the like, and mixtures thereof. These fillers or adjuvants may be used in the gum base composition in various amounts. The amount of filler may be from about 0% to about 40% by weight, more specifically from about 0% to about 30% by weight, based on the gum base. In certain embodiments, the amount of filler will be from about 0 to about 15%, more particularly from about 3% to about 11%.
着色剤、酸化防止剤、防腐剤、着香剤等のような各種の伝統的な配合成分を、ガムベースの中に有効量で含んでもよい。例えば、二酸化チタン並びにF.D.&C.染料として知られている食品、薬品、及び化粧品の用途に好適な他の染料を利用してもよい。ブチル化ヒドロキシトルエン(BHT)、ブチル化ヒドロキシアニソール(BHA)、没食子酸プロピル、及びそれらの混合物などの酸化防止剤も、含んでもよい。チューインガム技術における当業者に公知の他の従来のチューインガム添加物も、ガムベースに用いてもよい。ガム領域に、或いは液体充填領域又はコーティングに添加してもよい種々の成分は、後述する「追加の成分」という名称の項に更に詳細に記載する。 Various traditional ingredients such as colorants, antioxidants, preservatives, flavoring agents and the like may be included in the gum base in effective amounts. For example, titanium dioxide and F.I. D. & C. Other dyes known as dyes suitable for food, drug and cosmetic applications may be utilized. Antioxidants such as butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), propyl gallate, and mixtures thereof may also be included. Other conventional chewing gum additives known to those skilled in the chewing gum art may also be used in the gum base. The various ingredients that may be added to the gum area or to the liquid-filled area or coating are described in more detail in the section entitled “Additional ingredients” below.
ある実施形態は、中央充填ガム組成物の製造方法に及ぶ。ガムベース成分を混合する仕方は決定的なものではなく、当業者に公知の標準的な技術及び装置を用いて行う。代表的な方法では、エラストマーをエラストマー溶媒及び/又は可塑剤及び/又は乳化剤と混合し、1〜30分間撹拌する。次いで、ガムベース混合物を再び1〜30分間にわたって混合しながら、低融点ロウなどの残りの成分を、まとめて又は漸増的のいずれかで添加する。 Certain embodiments extend to methods of making a center-filled gum composition. The manner in which the gum base components are mixed is not critical and is performed using standard techniques and equipment known to those skilled in the art. In a typical method, the elastomer is mixed with an elastomer solvent and / or a plasticizer and / or an emulsifier and stirred for 1 to 30 minutes. The remaining ingredients, such as a low melting wax, are then added either together or incrementally while the gum base mixture is mixed again for 1 to 30 minutes.
ガム組成物は、甘味剤(甘味料)、可塑剤、軟化剤、乳化剤、ロウ、充填剤、増量剤(担体、増量化剤、バルク甘味料)、ミネラル補助剤、着香剤(香味料、着香料)、着色作用物(着色料、着色剤)、抗酸化剤、酸味料、増粘剤、薬物等、及びそれらの混合物からなる群より選択される所要量の従来の添加物を含んでもよい。これらの添加物のいくつかは、1以上の目的を果たすものであってもよい。例えば、無糖ガム組成物では、マルチトール又は他の糖アルコールなどの甘味料は、増量剤としても機能し得る。 Gum compositions are sweeteners (sweeteners), plasticizers, softeners, emulsifiers, waxes, fillers, bulking agents (carriers, bulking agents, bulk sweeteners), mineral supplements, flavoring agents (flavorants, Flavoring agents), coloring agents (coloring agents, coloring agents), antioxidants, acidulants, thickeners, drugs and the like, and including the required amount of conventional additives selected from the group consisting of mixtures thereof. Good. Some of these additives may serve more than one purpose. For example, in sugar-free gum compositions, sweeteners such as maltitol or other sugar alcohols can also function as bulking agents.
ガムベースでの使用に好適なものとして前記した可塑剤、軟化剤、ミネラル補助剤、ロウ及び抗酸化剤を、チューインガム組成物で使用してもよい。使用してもよい他の従来の添加物の例として、レシチン及びモノステアリン酸グリセリンなどの乳化剤、単独で又は他の軟化剤と組み合わせて使用する増粘剤、例えばメチルセルロース、アルギン酸塩、カラギーナン、キサンタンガム、ゼラチン、イナゴマメ、トラガント、ローカストビーンガム、ペクチン、アルギン酸塩、グアーガム、イナゴマメガムなどのガラクトマンナン類、グルコマンナン、ゼラチン、デンプン、デンプン誘導体、デキストリン及びカルボキシメチルセルロースなどのセルロース誘導体、リンゴ酸、アジピン酸、クエン酸、酒石酸、フマル酸、及びそれらの混合物などの酸味料、並びにミネラル補助剤の分類で前記したものなどの充填剤が挙げられる。 The plasticizers, softeners, mineral adjuvants, waxes and antioxidants described above as suitable for use in the gum base may be used in the chewing gum composition. Examples of other conventional additives that may be used include emulsifiers such as lecithin and glyceryl monostearate, thickeners used alone or in combination with other softeners, such as methylcellulose, alginate, carrageenan, xanthan gum Galactmannans such as gelatin, locust bean, tragacanth, locust bean gum, pectin, alginate, guar gum, locust bean gum, glucomannan, gelatin, starch, starch derivatives, cellulose derivatives such as dextrin and carboxymethylcellulose, malic acid, adipic acid And sour agents such as citric acid, tartaric acid, fumaric acid, and mixtures thereof, and fillers such as those described above in the classification of mineral adjuvants.
ある実施形態では、ガム領域は、増量剤も含有してもよい。好適な増量剤は、水溶性であってもよく、また、限定しないが単糖、二糖、多糖、糖アルコール類、及びそれらの混合物から選択される甘味剤;Danisco Sweeteners,Ltd.(41−51 Brighton Road,Redhill,Surrey,RH1 6YS、連合王国)製造のポリデキストロースに対する商品名である、Litesse(商標)の商標名で販売されているポリマーなどの、ランダムに結合したグルコースポリマー;イソマルト(商標名PALATINITでPalatinit Sussungsmittel GmbH(Gotlieb−Daimler−Strause 12a、68165 Mannheim、ドイツ)が製造するアルファ−D−グルコピラノシル−1,6−マンニトールとアルファ−D−グルコピラノシル−1,6−ソルビトールとのラセミ混合物);マルトデキストリン;水素化デンプン加水分解物;水素化ヘキソース;水素化二糖;炭酸カルシウム、タルク、二酸化チタン、リン酸二カルシウムなどの無機物;セルロース;及びそれらの混合物を含んでもよい。
In certain embodiments, the gum region may also contain a bulking agent. Suitable bulking agents may be water-soluble and are sweeteners selected from, but not limited to, monosaccharides, disaccharides, polysaccharides, sugar alcohols, and mixtures thereof; Danisco Sweeteners, Ltd. (41-51 Brighton Road, Redhill, Surrey, RH1 6YS, United Kingdom), a randomly linked glucose polymer, such as the polymer sold under the trade name Litesse ™, which is the trade name for polydextrose manufactured by Alpha-D-glucopyranosyl-1,6-mannitol and alpha-D-glucopyranitol of isomalt (Palatinit Sussunsmittel GmbH (Gotlieb-Daimler-
好適な糖増量剤として、キシロース、リブロース、グルコース(デキストロース)、マンノース、ガラクトース、フルクトース(果糖)、サッカロース(砂糖)、マルトース、転化糖、部分的に加水分解したデンプン及びコーンシロップ固体、並びにそれらの混合物などの単糖類、二糖類及び多糖類が挙げられる。 Suitable sugar extenders include xylose, ribulose, glucose (dextrose), mannose, galactose, fructose (fructose), saccharose (sugar), maltose, invert sugar, partially hydrolyzed starch and corn syrup solids and their Examples include monosaccharides, disaccharides and polysaccharides such as mixtures.
好適な糖アルコール増量剤として、ソルビトール、キシリトール、マンニトール、ガラクチトール、マルチトール、ラクチトール、エリスリトール、イソマルト及びそれらの混合物が挙げられる。 Suitable sugar alcohol bulking agents include sorbitol, xylitol, mannitol, galactitol, maltitol, lactitol, erythritol, isomalt and mixtures thereof.
好適な水素化デンプン加水分解物としては、米国特許第4279931号明細書に開示されたもの、及び種々の水素化グルコースシロップ及び/又はソルビトール、マルチトール、水素化二糖、三糖以上の水素化多糖、若しくはそれらの混合物を含有する粉体が挙げられる。水素化デンプン加水分解物は、主に、コーンシロップの制御された接触水素化によって調製される。得られる水素化デンプン加水分解物は、モノマー、ダイマー、及びポリマー多糖の混合物である。これらの糖類の比が異なることによって、異なる性質の異なる水素化デンプン加水分解物が得られる。フランスのRoquette Freres製造の市販品LYCASIN(登録商標)、及びNew Castle,DelawareのSPI Polyols,Inc.製造の市販品HYSTAR(登録商標)等の、水素化デンプン加水分解物の混合物も有用である。 Suitable hydrogenated starch hydrolysates include those disclosed in US Pat. No. 4,279,931, and various hydrogenated glucose syrups and / or sorbitol, maltitol, hydrogenated disaccharide, trisaccharide or more hydrogenated Examples thereof include powders containing polysaccharides or mixtures thereof. Hydrogenated starch hydrolysates are prepared primarily by controlled catalytic hydrogenation of corn syrup. The resulting hydrogenated starch hydrolyzate is a mixture of monomers, dimers, and polymer polysaccharides. Different ratios of these sugars result in different hydrogenated starch hydrolysates with different properties. Commercially available LYCASIN® manufactured by Roquette Freres, France, and SPI Polyols, Inc. of New Castle, Delaware. Mixtures of hydrogenated starch hydrolysates such as the commercial product HYSTAR (R) manufactured are also useful.
ある実施形態の組成物に配合してもよい甘味剤は、当該技術分野で公知の種々の甘味料の任意のものであってもよい。これらは、本願明細書で後記する「追加の成分」の項に更に詳細に記載されており、当該技術分野で周知の多くの異なる物理的形態で用いて、甘味の初期噴出及び/又は甘味の持続的な知覚を与えてもよい。限定されるものではないが、こうした物理的形態としては、噴霧乾燥、粉末化、ビーズ形態、カプセル化形態、及びこれらの混合物のような自由な形態が挙げられる。 The sweetener that may be included in the composition of an embodiment may be any of a variety of sweeteners known in the art. These are described in more detail in the “Additional Ingredients” section later in this application and are used in many different physical forms well known in the art to provide an initial ejection of sweetness and / or sweetness. It may give sustained perception. Such physical forms include, but are not limited to, free forms such as spray dried, powdered, beaded forms, encapsulated forms, and mixtures thereof.
好ましくは、甘味料はアスパルテーム、ネオテーム、スクラロース、及びアセスルフェームカリウム(Ace−K)などの高甘味度甘味料である。 Preferably, the sweetener is a high intensity sweetener such as aspartame, neotame, sucralose, and acesulfame potassium (Ace-K).
一般に、有効量の甘味料を利用して所望の甘味レベルとしてもよく、この量は選択した甘味料によって異なり得る。ある実施形態では、甘味料の量は、用いる甘味料又は甘味料の組み合わせに応じて、ガム組成物の約0.001〜約3質量%の量で存在してもよい。各種甘味料の量の正確な範囲は、当業者が選択してもよい。 In general, an effective amount of sweetener may be utilized to achieve the desired sweetness level, which may vary depending on the sweetener selected. In certain embodiments, the amount of sweetener may be present in an amount from about 0.001 to about 3% by weight of the gum composition, depending on the sweetener or combination of sweeteners used. The exact range of amounts of the various sweeteners may be selected by those skilled in the art.
着色剤を、所望の色を生成するのに有効な量で使用してもよい。着色剤には顔料が挙げられ、ガム組成物の約6質量%以下の量で混和してもよい。例えば、二酸化チタンを、ガム組成物の質量で約2%以下、好ましくは約1%未満の量で混和してもよい。また、着色剤には、食品、薬品、及び化粧品の用途に好適な自然食品の色材や染料が挙げられる。これらの着色剤は、F.D.&C.染料・レーキとして知られる。上記の使用に受け入れられる材料は、好ましくは水溶性である。例えば限定されない例としては、F.D.&C.ブルーNo.2として知られる5,5−インジゴ錫ジスルホン酸のジナトリウム塩であるインジゴイド染料が挙げられる。同様に、F.D.&C.グリーンNo.1として知られる染料は、トリフェニルメタン染料を含み、4−[4−(N−エチル−p−スルホニウムベンジルアミノ)ジフェニルメチレン]−[1−(N−エチル−N−p−スルホニウムベンジル)−デルタ−2,5−シクロヘキサジエンイミン]のモノナトリウム塩である。全てのF.D.&C.着色剤とそれらの対応する化学構造の十分な詳述は「Kirk−Othmer Encyclopedia of Chemical Technology、第3版、5巻、857〜884頁」に示されており、この文献を、本願で引用して援用する。追加の着色成分は、後述する「追加の成分」の項に記載している。 The colorant may be used in an amount effective to produce the desired color. Colorants include pigments and may be incorporated in amounts up to about 6% by weight of the gum composition. For example, titanium dioxide may be incorporated in an amount of about 2% or less, preferably less than about 1% by weight of the gum composition. Examples of the colorant include natural food coloring materials and dyes suitable for food, medicine, and cosmetic applications. These colorants are F.I. D. & C. Known as dye rake. Acceptable materials for the above uses are preferably water soluble. For example, non-limiting examples include F.I. D. & C. Blue No. 2, an indigoid dye known as 2, which is a disodium salt of 5,5-indigotin disulfonic acid. Similarly, F.M. D. & C. Green No. Dyes known as 1 include triphenylmethane dyes and include 4- [4- (N-ethyl-p-sulfoniumbenzylamino) diphenylmethylene]-[1- (N-ethyl-Np-sulfoniumbenzyl)- Delta-2,5-cyclohexadienimine] monosodium salt. All F.C. D. & C. Full details of the colorants and their corresponding chemical structures are given in “Kirk-Othmer Encyclopedia of Chemical Technology, 3rd edition, Volume 5, pages 857-884”, which is incorporated herein by reference. To use. The additional coloring component is described in the section “Additional component” described later.
ガム組成物で使用できる好適な油及び脂肪として、部分的に硬化した植物または動物脂肪、特にココナツ油、パーム核油、牛脂、及びラードが挙げられる。使用する場合、これらの配合成分は一般的に、ガム組成物の約7質量%まで、好ましくは約3.5質量%までの量で存在する。 Suitable oils and fats that can be used in the gum composition include partially hardened vegetable or animal fats, especially coconut oil, palm kernel oil, beef tallow, and lard. When used, these ingredients are generally present in an amount up to about 7%, preferably up to about 3.5% by weight of the gum composition.
ある実施形態は、チューインガム及び風船ガム組成物の双方を含め、ガム領域のための改良したチューインガム組成物を調製する方法を含んでもよい。チューインガム組成物は、当業者に公知の標準技術及び装置を使用して調製してもよい。ある実施態様にかかる有用な装置は、チューインガム製造技術分野で周知の混合及び加熱装置を含み、従って、具体的な装置の選択は当業者にとって明らかであろう。 Certain embodiments may include methods of preparing improved chewing gum compositions for the gum region, including both chewing gum and bubble gum compositions. Chewing gum compositions may be prepared using standard techniques and equipment known to those skilled in the art. Useful devices according to certain embodiments include mixing and heating devices well known in the chewing gum manufacturing art, and thus the selection of specific devices will be apparent to those skilled in the art.
中央充填層に関し、ガム領域は中央充填組成物の水分活性以上の水分活性を有してもよい。しかし、より高い水分活性が中央又は液体充填に望まれる組成物では、中央充填組成物の水分活性はガム領域のものより高くてもよい。中央充填で高含水量であることは、キサンタンガム及びセルロースのような増粘剤の水和に役立つであろう。 With respect to the center fill layer, the gum region may have a water activity that is greater than or equal to the water activity of the center fill composition. However, in compositions where higher water activity is desired for center or liquid filling, the water activity of the center filling composition may be higher than that of the gum region. High water content in the center fill will help hydrate thickeners such as xanthan gum and cellulose.
ガム領域は、ガム領域の約14質量%の総含水量を有してもよく、更に詳細には約9〜約14質量%の総含水量で、約5%未満の遊離含水量を有してもよい。中央充填は更に、前記中央充填の約0〜約35質量%まで、詳細には約22%の遊離及び結合水分を含む総含水量を有してもよい。 The gum region may have a total water content of about 14% by weight of the gum region, and more specifically, a total water content of about 9 to about 14% by weight and a free water content of less than about 5%. May be. The center fill may further have a total water content comprising about 0 to about 35% by weight of the center fill, specifically about 22% free and bound moisture.
(液体充填組成物)
中央充填又は液体充填組成物は、中央充填組成物に混和されることが当該技術分野で公知となっている任意の成分を含んでもよい。液体充填は、ガム組成物全体の0質量%より多く約20質量%まで、更に詳細には、チューインガム組成物全体(即ち、中央充填組成物、ガム領域及びコーティングを含む)の約10質量%までの量で存在してもよい。ガム組成物に含められる液体充填の量は、ガム片全体のサイズと形状に応じて変更してもよい。ある実施形態では、例えば、ガム片全体が3グラム未満であれば、中央充填はチューインガム組成物全体のおよそ8質量%であってもよい。
(Liquid filling composition)
The center-filled or liquid-filled composition may include any ingredient known in the art to be incorporated into the center-filled composition. The liquid fill is greater than 0% to about 20% by weight of the total gum composition, and more specifically, up to about 10% by weight of the total chewing gum composition (ie, including the center fill composition, gum region and coating). May be present in an amount of. The amount of liquid filling included in the gum composition may vary depending on the size and shape of the entire gum piece. In certain embodiments, for example, if the entire gum piece is less than 3 grams, the center fill may be approximately 8% by weight of the total chewing gum composition.
ある実施形態では、中央充填組成物は、結晶性ソルビトールと、任意に水素化デンプン加水分解物を含んでもよい。グリセリンも、液体充填組成物の0質量%から約5質量%までの量で存在してもよい。 In certain embodiments, the center-fill composition may comprise crystalline sorbitol and optionally hydrogenated starch hydrolysate. Glycerin may also be present in an amount from 0% to about 5% by weight of the liquid fill composition.
ある実施形態では、水素化デンプン加水分解物(HSH)が、液体充填組成物の約58〜約83質量%、詳細には液体充填組成物の約65〜約75質量%の量で存在してもよい。ある実施形態では、HSHは、2質量%〜約6質量%のソルビトール、50質量%〜約55質量%のマルチトール、約20〜約25質量%の3〜5モノマー単位の水素化グルコースポリマー、及び約20〜約25質量%の5以上のモノマー単位の水素化グルコースポリマーを含んでもよい。 In certain embodiments, the hydrogenated starch hydrolyzate (HSH) is present in an amount of about 58 to about 83% by weight of the liquid fill composition, specifically about 65 to about 75% by weight of the liquid fill composition. Also good. In certain embodiments, the HSH is 2% to about 6% by weight sorbitol, 50% to about 55% maltitol, about 20 to about 25% by weight 3-5 monomer unit hydrogenated glucose polymer, And about 20 to about 25% by weight of hydrogenated glucose polymer of 5 or more monomer units.
前記のとおり、ガム領域の項では、水素化デンプン加水分解物は、商標名Lycasin(登録商標)及びHystar(登録商標)で市販されている。好適な市販のHSH製品の例は、85%の固形分を含むLycasin(登録商標)80/55HDSである。その成分の重合度(DP)によって記されるように、Lycasin(登録商標)80/55 HDSはおよそ、ソルビトール(DPI)=4%、マルチトール(DP2)=53%、DP3〜DP5=22%、及び>DP5=21%を含む。 As described above, in the gum region section, hydrogenated starch hydrolysates are commercially available under the trade names Lycasin® and Hystar®. An example of a suitable commercial HSH product is Lycasin® 80/55 HDS containing 85% solids. Lycasin® 80/55 HDS is approximately sorbitol (DPI) = 4%, maltitol (DP2) = 53%, DP3-DP5 = 22% as noted by the degree of polymerization (DP) of the component. And> DP5 = 21%.
ある実施形態では、結晶性ソルビトールは液体充填組成物中にも存在する。結晶性ソルビトールの量は、液体充填組成物の望ましい粘度によって選択してもよい。例えば、結晶性ソルビトールは、液体充填組成物の約10〜約35質量%の量で存在してもよい。ガンマ多形を含め、結晶性ソルビトールの任意の好適な形態を用いてもよい。 In certain embodiments, crystalline sorbitol is also present in the liquid fill composition. The amount of crystalline sorbitol may be selected depending on the desired viscosity of the liquid fill composition. For example, crystalline sorbitol may be present in an amount from about 10 to about 35% by weight of the liquid fill composition. Any suitable form of crystalline sorbitol may be used, including the gamma polymorph.
ある実施形態では、中央充填領域は、実質的又は完全に、液体中央充填組成物で充填されていてもよい。ある他の実施形態では、中央充填領域は、一部分のみ液体中央充填組成物で充填されてもよい。 In certain embodiments, the center-fill region may be substantially or completely filled with a liquid center-fill composition. In certain other embodiments, the center fill region may be only partially filled with the liquid center fill composition.
ある実施形態では、中央充填領域は、2種以上の中央充填組成物を含んでもよい。この2種以上の中央充填組成物は、同じ形態でも、又は異なる形態であってもよい。例えば、ある実施形態では、2種以上の別の液体の混合物を含んでもよく、これらは混和性でも、又は非混和性であってもよい。同様に、ある実施形態では、2種以上の別の固体、半固体又は気体を中央充填領域に含んでもよい。異なる中央充填形態の混合物も、ある実施形態に含まれてもよい。例えば、液体及び固体を中央充填領域に含ませてもよい。2種以上の液体が中央充填領域で用いられるある実施形態では、これらは同量又は異なる量で配合してもよく、またその特性が類似していても異なっていてもよい。更に具体的には、ある実施形態では、2種以上の中央充填組成物は、粘度、色、香味、呈味、知覚、配合成分、機能性成分、甘味料等の種々の特性が異なっていてもよい。 In certain embodiments, the center-fill region may include two or more center-fill compositions. The two or more centerfill compositions may be in the same form or in different forms. For example, in certain embodiments, it may include a mixture of two or more other liquids, which may be miscible or immiscible. Similarly, in certain embodiments, two or more other solids, semi-solids or gases may be included in the central fill region. Mixtures of different center fill forms may also be included in certain embodiments. For example, liquids and solids may be included in the central filling area. In some embodiments where two or more liquids are used in the central fill region, they may be blended in the same or different amounts, and the properties may be similar or different. More specifically, in some embodiments, the two or more center-fill compositions differ in various properties such as viscosity, color, flavor, taste, perception, compounding ingredients, functional ingredients, sweeteners, and the like. Also good.
ある実施形態では、中央充填組成物は、例えば、香味料ビーズ、フルーツ粒子、ナッツ粒子、香味料粒子、ゼラチン部分等の非液体成分も含んでもよい。 In certain embodiments, the center-fill composition may also include non-liquid ingredients such as, for example, flavor beads, fruit particles, nut particles, flavor particles, gelatin portions, and the like.
ある実施形態では、中央充填組成物は水性であっても又は非水性であってもよい。更に、中央充填組成物は、溶液、懸濁液、エマルション又は半固体であってもよい。 In certain embodiments, the center-fill composition may be aqueous or non-aqueous. Furthermore, the center-fill composition may be a solution, suspension, emulsion or semi-solid.
液体中央は、前記のとおり、着香剤、甘味剤等、及びそれらの混合物などといった、チューインガム及び菓子の技術分野で周知の伝統的な配合成分を含有してもよい。菓子添加物に加えて、液体中央は、薬物、呼気清涼化剤、ビタミン、ミネラル、カフェイン、フルーツジュース等、及びそれらの混合物などの医薬添加物も含有してもよい。菓子及び医薬製剤は、当該技術分野で周知の多くの別の物理的形態で使用して、甘味並びに香味及び/若しくは治療活性の初期噴出、又は甘味並びに香味及び/若しくは治療活性の持続的な知覚をもたらしてもよい。限定されるものではないが、こうした物理的形態として、噴霧乾燥、粉末化、ビーズ形態、カプセル化形態、及びこれらの混合物のような自由な形態が挙げられる。ある実施形態での使用に好適な液体中央の例として、限定しないが、米国特許第3894154号明細書、第4156740号明細書、第4157402号明細書、第4316915号明細書、及び第4466983号に開示のもののような中央が例示でき、これらの開示を本願に引用して援用する。好適な追加の成分の具体例として、タウリン、ガラナ、ビタミン、Actizol(商標)、クロロフィル、Recaldent(商標)、歯の再ミネラル強化技術、及びRetsyn(商標)が挙げられる。 The liquid center may contain traditional ingredients well known in the chewing gum and confectionery arts, such as flavors, sweeteners, and the like, as described above. In addition to confectionery additives, the liquid center may also contain pharmaceutical additives such as drugs, breath fresheners, vitamins, minerals, caffeine, fruit juices, and the like, and mixtures thereof. Confectionery and pharmaceutical formulations are used in many different physical forms well known in the art to provide an initial squirt of sweetness and flavor and / or therapeutic activity, or sustained perception of sweetness and flavor and / or therapeutic activity. May bring about. Such physical forms include, but are not limited to, free forms such as spray dried, powdered, beaded forms, encapsulated forms, and mixtures thereof. Examples of liquid centers suitable for use in certain embodiments include, but are not limited to, U.S. Pat. Nos. 3,894,154, 4,156,740, 4,157,402, 4,316,915, and 4,466,983. Centers such as those of the disclosure can be exemplified and these disclosures are incorporated herein by reference. Specific examples of suitable additional ingredients include taurine, guarana, vitamins, Actizol ™, chlorophyll, Recaldent ™, dental remineralization technology, and Retsyn ™.
中央充填組成物はまた、カルボキシメチルセルロース、ペクチン、プロピレングリコールアギネート(aginate)、寒天及びガムトラガントなどの天然又は合成ガムも含んでもよい。これらの組成物は、組成物中の遊離水の量を低減することによって粘度を高めるのに役立つ。中央充填の粘度は、25℃で約300cpから約6000cpまでの範囲であってもよい。周りのガム領域よりも高い水分活性を有する液体充填組成物で、粘度は25℃で約3000cpから約6000cpまでの範囲であってもよい。 The center-fill composition may also include natural or synthetic gums such as carboxymethylcellulose, pectin, propylene glycol aginate, agar and gum tragacanth. These compositions help to increase viscosity by reducing the amount of free water in the composition. The center-fill viscosity may range from about 300 cp to about 6000 cp at 25 ° C. With liquid fill compositions having higher water activity than the surrounding gum region, the viscosity may range from about 3000 cp to about 6000 cp at 25 ° C.
キサンタンガムも、中央充填組成物の粘度を高めるのに使用してもよい。液体の粘度を高めることは、ガム片を通して液体が漏出するのを防ぐ助けにもなる。キサンタンガムは、Atlanta、GeorgiaのCP Kelcoから、商標名Keltrol(登録商標)として入手可能である。 Xanthan gum may also be used to increase the viscosity of the center-fill composition. Increasing the viscosity of the liquid also helps prevent liquid from leaking through the gum pieces. Xanthan gum is available from CP Kelco, Atlanta, Georgia under the trade name Keltrol®.
ある実施形態は、改良した中央充填チューインガム組成物の製造方法に及ぶ。改良した組成物は、当業者に公知の標準技術及び装置を使用して調製してもよい。本願明細書に記載の実施形態にかかる有用な装置は、チューインガム製造技術で周知の混合及び加熱装置を含み、従って、特定の装置の選択は当業者にとって明らかであろう。このような方法及び装置は、例えば、米国特許第3806290号明細書及び第3857963号明細書に開示されており、これらの開示を本願に引用して援用する。 Certain embodiments extend to methods of making improved center-filled chewing gum compositions. Improved compositions may be prepared using standard techniques and equipment known to those skilled in the art. Useful devices according to the embodiments described herein include mixing and heating devices well known in the chewing gum manufacturing art, and therefore the selection of a particular device will be apparent to those skilled in the art. Such methods and apparatus are disclosed, for example, in US Pat. Nos. 3,806,290 and 3,857,963, the disclosures of which are incorporated herein by reference.
(コーティング組成物)
コーティング組成物は、中央充填組成物中に含められる場合、前記した方法などの、当該技術分野で公知の任意の方法を含む種々の方法によって塗布してもよい。コーティング組成物は、中央充填ガム片全体の約2〜約80質量%、より詳しくは、約25〜約35質量%、より一層詳しくは、ガム片の約30質量%の量で存在してもよい。
(Coating composition)
When included in the center-fill composition, the coating composition may be applied by a variety of methods, including any method known in the art, such as those described above. The coating composition may also be present in an amount from about 2 to about 80% by weight of the total center-filled gum piece, more specifically from about 25 to about 35% by weight, and even more specifically from about 30% by weight of the gum piece. Good.
外側コーティングは、硬質でも、歯ごたえがあっても、又は軟質であってもよい。典型的に、外側コーティングは、ソルビトール、マルチトール、キシリトール、エリスリトール、イソマルト、及び他の結晶性ポリオールを含んでもよく、サッカロースもまた使用してもよい。更に、前記コーティングは、チューインガム組成物がコーティングそのものを通して見ることができないように、いくつかの不透明な層を含んでもよく、このコーティングは更に、場合により、美観、組織、及び保護の目的で、1つ又は複数の透明な層で被覆することができる。外側コーティングは、少量の水とアラビアゴムも含んでもよい。このコーティングは、更にワックスで被覆することができる。このコーティングは、各塗布の間に乾燥させながらコーティング溶液を継続して適用することによる従来の方法で施してもよい。コーティングが乾燥すると、通常は不透明になり、通常は白色であるが、他の着色剤を添加してもよい。ポリオールのコーティングを更にワックスで被覆することができる。このコーティングは、着色したフレーク又は斑点を更に含むことができる。組成物がコーティングを含む場合、1つ以上の口腔ケア用活性物質をコーティングの全体に分散させることができる。このことは、1つ以上の口腔ケア用活性物質が、別の活性物質を有する単一相組成物中で非適合性である場合に、特に好ましい。香味料を更に添加し、ユニークな製品特性を生じさせてもよい。 The outer coating may be hard, crunchy, or soft. Typically, the outer coating may include sorbitol, maltitol, xylitol, erythritol, isomalt, and other crystalline polyols, and saccharose may also be used. In addition, the coating may include several opaque layers so that the chewing gum composition cannot be seen through the coating itself, and this coating may optionally further include 1 for aesthetic, tissue, and protective purposes. It can be coated with one or more transparent layers. The outer coating may also contain a small amount of water and gum arabic. This coating can be further coated with wax. This coating may be applied in a conventional manner by continuously applying the coating solution while drying between each application. When the coating dries, it usually becomes opaque and is usually white, but other colorants may be added. The polyol coating can be further coated with wax. The coating can further include colored flakes or spots. Where the composition includes a coating, one or more oral care actives can be dispersed throughout the coating. This is particularly preferred when one or more oral care actives are incompatible in a single phase composition with another active substance. Additional flavors may be added to produce unique product characteristics.
前記コーティングは、ガム片の熱安定性を高め、液体充填の漏れを防ぐのを支援するように処方してもよい。ある実施態様では、前記コーティングは、ゼラチン組成物を含んでもよい。ゼラチン組成物は、40質量%の溶液として添加してもよく、コーティング組成物の約5〜約10質量%、より詳細には約7%〜約8%で、コーティング組成物中に存在してもよい。ゼラチンのゲル強度は、約130ブルーム(bloom)から約250ブルームまでであってもよい。 The coating may be formulated to help increase the thermal stability of the gum pieces and prevent liquid fill leaks. In certain embodiments, the coating may comprise a gelatin composition. The gelatin composition may be added as a 40% by weight solution and is present in the coating composition from about 5 to about 10% by weight of the coating composition, more particularly from about 7% to about 8%. Also good. The gel strength of the gelatin may be from about 130 bloom to about 250 bloom.
所望の特性を得るため、その他の材料をコーティングに添加してもよい。これらの材料としては、限定されるものではないが、カルボキシメチルセルロースのようなセルロース、ゼラチン、プルラン、アルギン酸塩、デンプン、カラギーナン、キサンタンガム、アラビアゴム、及びポリ酢酸ビニル(PVA)が挙げられる。 Other materials may be added to the coating to obtain the desired properties. These materials include, but are not limited to, cellulose such as carboxymethylcellulose, gelatin, pullulan, alginate, starch, carrageenan, xanthan gum, gum arabic, and polyvinyl acetate (PVA).
コーティング組成物は、任意の硬質コーティングの前に個々のガム片に添加されるプレコーティングも含んでもよい。前記プレコーティングには、ポリ酢酸ビニル(PVA)を適用してもよい。これは、エチルアルコールのような溶媒中のPVAの溶液として施してもよい。外側の硬質コーティングが望まれる場合、PVAの適用は、全コーティングの約3〜4質量%、又はガム片の総質量(液体充填、ガム領域、及び硬質コーティングを含む)の約1%であってもよい。 The coating composition may also include a pre-coating that is added to the individual gum pieces prior to any hard coating. Polyvinyl acetate (PVA) may be applied to the pre-coating. This may be applied as a solution of PVA in a solvent such as ethyl alcohol. If an outer hard coating is desired, the PVA application is about 3-4% by weight of the total coating, or about 1% of the total weight of the gum pieces (including liquid fill, gum area, and hard coating). Also good.
他の種々のコーティング組成物及び製造方法で考えられるものとして、限定しないが、軟質パニング、二軸又は多軸押出し、積層等が挙げられる。よって、ある実施形態では、コーティングは無定形又は結晶性であることができ、得られるテクスチャは、硬質、歯ごたえのある、サクサクした、軟質、又は噛み応えのあるものとすることができる。 Other various coating compositions and manufacturing methods that may be considered include, but are not limited to, soft panning, biaxial or multiaxial extrusion, lamination, and the like. Thus, in certain embodiments, the coating can be amorphous or crystalline, and the resulting texture can be hard, crunchy, crisp, soft, or chewy.
(追加の成分)
温感剤、冷感剤、刺激剤、香味料、甘味料、酸味剤、苦味剤、塩味剤、界面活性剤、呼気清涼剤、抗微生物剤、抗菌剤、歯石防止剤、歯垢防止剤、フッ素化合物、再ミネラル強化剤、医薬品、微量栄養素、喉のケア用活性物、歯漂白剤、エネルギー亢進剤、集中力亢進剤、食欲抑制剤、着色料及び他の活性物などの追加の添加物も、チューインガム組成物の任意若しくは全ての部分又は領域に配合してもよい。かかる成分を、それらの意図する効果を達成するのに十分な量で使用してもよい。
(Additional ingredients)
Warming agent, cooling agent, stimulant, flavoring agent, sweetener, sour agent, bitter agent, salting agent, surfactant, breath freshener, antimicrobial agent, antibacterial agent, anticalculus agent, anti-plaque agent, Additional additives such as fluorine compounds, remineral enhancers, pharmaceuticals, micronutrients, throat care actives, tooth bleaches, energy enhancers, concentration enhancers, appetite suppressants, colorants and other actives Alternatively, it may be incorporated into any or all parts or regions of the chewing gum composition. Such ingredients may be used in an amount sufficient to achieve their intended effect.
チューインガム組成物からの管理した随意放出が望まれ得る個々の配合成分のタイプとしては、限定しないが、甘味料、香味料、活性物、発泡性配合成分、食欲抑制剤、呼気清涼化剤、歯科ケア用配合成分、乳化剤、香味増強物質、苦味遮蔽又は遮断配合成分、食品用酸類、微量栄養素、知覚物質、口腔保湿配合成分、喉のケア用配合成分、着色料、酸味剤、苦味剤、塩味剤、医薬品、エネルギー亢進剤、集中力亢進剤及びこれらの組み合わせが挙げられる。配合成分は、例えば、液状形態、噴霧乾燥形態、又は結晶性形態などの異なる形態にて入手可能であり得る。ある実施形態では、送達システム又はチューインガム組成物は、異なる形態の同タイプの配合成分を含んでもよい。例えば、チューインガム組成物は、液体香味料、及び同じ香味料の噴霧乾燥品を含んでもよい。ある実施形態では、配合成分は、その自由形態又は封入形態であってもよく、また中央充填、ガム領域、又はコーティング中などのガム組成物の任意の領域に存在してもよい。更に、同じ成分が、その自由な形態だけでなく、その封入形態で存在してもよい。 The types of individual ingredients that a controlled voluntary release from a chewing gum composition may be desired include, but are not limited to, sweeteners, flavorings, actives, effervescent ingredients, appetite suppressants, breath fresheners, dental Care ingredients, emulsifiers, flavor enhancers, bitterness masking or blocking ingredients, food acids, micronutrients, sensory substances, oral moisturizer ingredients, throat care ingredients, colorants, sour agents, bitter agents, salty taste Agents, pharmaceuticals, energy enhancers, concentration enhancers, and combinations thereof. Formulation ingredients may be available in different forms such as, for example, liquid form, spray dried form, or crystalline form. In certain embodiments, the delivery system or chewing gum composition may include the same type of ingredients in different forms. For example, the chewing gum composition may include a liquid flavor and a spray-dried product of the same flavor. In certain embodiments, the compounding ingredients may be in their free or encapsulated form and may be present in any region of the gum composition, such as in the center fill, gum region, or coating. Furthermore, the same component may be present not only in its free form but also in its encapsulated form.
ある実施形態では、消費者がチューインガムを噛む場合に、香味料若しくは甘味を知覚する期間が長期化していると感じ得るように、及び/又は配合成分が長期間に亘って放出、或いは利用可能とされるように、配合成分の放出を改質する。放出の改質は、封入によるものなど、当該技術分野で公知の任意の方法で成し遂げてもよい。放出の改質が封入によるものである場合、これはスプレーコーティング又は押出しによるなどの種々の手段によって成し遂げてもよい。 In some embodiments, when a chewing gum is chewed by a consumer, it can be felt that the period of perception of flavoring or sweetness is prolonged and / or the ingredients are released or available over time. To modify the release of formulation ingredients. The modification of release may be accomplished by any method known in the art, such as by encapsulation. If the release modification is by encapsulation, this may be accomplished by various means such as by spray coating or extrusion.
また、配合成分の初期及び長期放出が望ましいのであれば、チューインガム組成物は、放出を改質していない配合成分(場合により、「自由な」配合成分と称される)と、更には放出を改質した配合成分を含んでもよい。ある実施形態では、配合成分(例えば、香味料、冷感剤)の初期量若しくは「ヒット(hit)」、又は配合成分により引き起こされる初期知覚又は利点(例えば、香味、鼻への作用、冷却、加温、刺激、唾液産生、呼気清涼化、歯漂白、喉の無痛化、口腔保湿等)を送達するために、自由な配合成分を使用してもよい。ある実施形態では、同じ配合成分に放出特性の改質をもたらし、同じ知覚又は利点を付加的に又は遅延させて提供できる。自由な配合成分、及び改質した放出特性を備えた配合成分の双方を使用することによって、その配合成分による知覚又は利点を長期間に亘ってもたらし得、且つ/又は消費者による知覚若しくは利点の知覚が改善され得る。また、ある実施形態では、初期量又は配合成分の「ヒット」は、消費者の口、即ちチューインガム組成物の知覚を指向化若しくは予備調整し得る。 Also, if initial and long term release of the compounding ingredients is desired, the chewing gum composition may contain a compounding ingredient that has not modified the release (sometimes referred to as a “free” compounding ingredient) and even release. A modified compounding component may be included. In certain embodiments, the initial amount or “hit” of a formulation component (eg, flavor, cooling agent), or initial perception or benefit caused by the formulation component (eg, flavor, nasal effect, cooling, Free ingredients may be used to deliver warming, stimulation, saliva production, exhalation refreshment, tooth bleaching, sore throat, oral moisturizing, etc.). In certain embodiments, the same formulation ingredients can provide modified release characteristics, providing the same perception or benefit in addition or delayed. By using both a free formulation component and a formulation component with modified release characteristics, the perception or benefit of the formulation component can be brought on for a long time and / or the perception or benefit of the consumer Perception can be improved. Also, in certain embodiments, the initial amount or “hit” of the compounding ingredients may direct or precondition the consumer's mouth, ie, chewing gum composition perception.
別の例として、ある実施形態では、チューインガム組成物中の配合成分の徐放を長期間もたらすのが望ましいことがある。徐放を成し遂げるために、低濃度の配合成分を長期間に亘って放出させ、これに対して高濃度の配合成分を短期間で放出させることを可能とするように、配合成分を改質してもよい。徐放は、送達システムが約6500psiの引張強度を有する封入などの送達システムの使用によって成し遂げてもよい。他の好適な送達システムは、米国特許公開第2005/0112236A1号明細書に更に十分に開示されており、これは本願に引用して援用する。配合成分の徐放は、配合成分が高濃度で苦み又はその多の悪い味を有する状況で有利であり得る。高濃度の配合成分の短期間での放出によって、少量の配合成分が消費者へ至適に送達される結果をもたらし得る場合にも、配合成分の徐放は有利であり得る。例えば、歯漂白又は呼気清涼化配合成分の場合、配合成分を過量に過度な早さで提供することで、配合成分が消費者の歯、粘膜、及び/又は歯科充填物と相互作用する機会を得る前に消費者が配合成分の大部分を嚥下してしまうという結果をもたらすことがあり、これにより配合成分の無駄、又は少なくともチューインガム組成物中の配合成分が有する利点が低減すことになり得る。 As another example, in certain embodiments, it may be desirable to provide sustained release of the ingredients in the chewing gum composition for an extended period of time. In order to achieve sustained release, the compounding ingredients are modified so that the low concentration compounding ingredients can be released over a long period of time, while the high concentration compounding ingredients can be released in a short period of time. May be. Sustained release may be accomplished through the use of a delivery system such as an encapsulation where the delivery system has a tensile strength of about 6500 psi. Other suitable delivery systems are more fully disclosed in US 2005/0112236 A1, which is incorporated herein by reference. Sustained release of the ingredients can be advantageous in situations where the ingredients are bitter at high concentrations or have many bad tastes. The sustained release of the formulation component can also be advantageous when a short period of release of the high concentration formulation can result in a small amount of formulation being optimally delivered to the consumer. For example, in the case of a tooth bleaching or exhalation refreshing compounding ingredient, providing the compounding ingredient in an excessively high rate provides an opportunity for the compounding ingredient to interact with the consumer's teeth, mucous membranes and / or dental fillings. May result in the consumer swallowing most of the ingredients before obtaining, which may reduce the waste of the ingredients or at least the benefits of the ingredients in the chewing gum composition .
ある実施形態で、封入を用いて、成分の放出を改質するというのでなく、成分に対する又は成分からのバリア保護を提供してもよい。例えば、多くの場合、チューインガム組成物中の他の成分への酸の曝露を限定することが望ましい。このような酸を、他の成分への曝露を限定するために封入してもよいし、或いは、チューインガム組成物中の他の成分を、酸への曝露を限定するために封入してもよい。 In certain embodiments, encapsulation may be used to provide barrier protection to or from the component rather than modifying the release of the component. For example, in many cases it is desirable to limit the exposure of acids to other ingredients in the chewing gum composition. Such acids may be encapsulated to limit exposure to other ingredients, or other ingredients in the chewing gum composition may be encapsulated to limit exposure to acids. .
本願明細書に記載の追加の成分の任意のものを、放出が改質された形態で、及び/又は放出を改質せずに(場合によって「自由な」成分と称する)中央充填チューインガム組成物の任意の領域に添加してもよい。ある実施形態では、例えば、単一成分を、その放出が改質された形態及び自由な形態にて中央充填チューインガムに添加してもよい。放出が改質された成分及び自由な成分を、中央充填チューインガムの同じ領域に一緒に含ませてもよく、又は、ある実施形態では、2種の成分をガムの異なる領域に含ませてもよい。 A center-filled chewing gum composition with any of the additional ingredients described herein in a modified release form and / or without modified release (sometimes referred to as a “free” ingredient) It may be added to any region. In certain embodiments, for example, a single component may be added to the center-filled chewing gum in a modified and free form of its release. The release-modified component and the free component may be included together in the same region of the center-filled chewing gum, or in one embodiment the two components may be included in different regions of the gum. .
他のある実施形態で、例えば、同じ機能性をもたらす2種の異なる成分、例えば、2種の異なる香味料、甘味料、食味料、知覚料等を、中央充填チューインガムに含ませてもよい。ある実施形態では、両成分ともが、改質した放出性を有してもよい。或いは、ある実施形態では、成分の1つは放出が改質され、他の成分は自由なものであってもよい。2種の成分が、中央充填チューインガムの同じか又は異なる領域に含まれてもよい。 In certain other embodiments, for example, two different ingredients that provide the same functionality may be included in the center-filled chewing gum, such as two different flavors, sweeteners, flavorings, perceptives, and the like. In certain embodiments, both components may have a modified release. Alternatively, in some embodiments, one of the components may be modified in release and the other components may be free. The two components may be included in the same or different regions of the center-filled chewing gum.
(香味料)
ある実施形態では、風味剤は、天然及び人工香味料など、当業者にそれらの風味が既知であるものを含んでもよい。これら香味料は、合成香味料油及び香味性の芳香族化合物及び/又は芳香族油、植物、葉、花、果実等から誘導されるオレオレジン及び抽出物、並びにそれらの組合せから選択してもよい。非限定的な代表的な香味料油としては、スペアミント油、ケイ皮油、ウィンターグリーン油(サリチル酸メチル)、ペパーミント油、和種ハッカ油、チョウジ油、ベイ油、アニス油、ユーカリ油、タイム油、ニオイヒバ油、ナツメグ油、オールスパイス、セージ油、メース、苦扁桃油及びカッシア油が挙げられる。また、有用な香味料としては、バニラや、柑橘類油(レモン、オレンジ、ライム、グレープフルーツ、ユズ、スダチを含む)及び果物エッセンス(リンゴ、西洋ナシ、モモ、ブドウ、ブルーベリー、イチゴ、キイチゴ、サクランボ、プラム、パイナップル、アンズ、バナナ、メロン、アンズ、ウメ、サクランボ、キイチゴ、ブラックベリー、熱帯果実、マンゴー、マンゴスチン、ザクロ、パパイア、スイカを含む)等の人工、天然及び合成の果物香味料が挙げられる。放出プロファイルを管理できる、潜在性のある他の香味料としては、牛乳香味料、バター香味料、チーズ香味料、クリーム香味料及びヨーグルト香味料、バニラ香味料、茶葉又はコーヒー香味料(例えば緑茶香味料、ウーロン茶香味料、茶葉香味料、カカオ香味料、チョコレート香味料及びコーヒー香味料)、ミント香味料(例えばペパーミント香味料、スペアミント香味料及び和種ハッカ香味料)、香辛香味料(例えばアギ香味料、アジョワン香味料、アニス香味料、アンゼリカ香味料、ウイキョウ香味料、オールスパイス香味料、シナモン香味料、カミツレ香味料、マスタード香味料、カルダモン香味料、キャラウェー香味料、クミン香味料、チョウジ香味料、コショウ香味料、コリアンダ香味料、サッサフラス香味料、風味香味料、サンショウ香味料、シソ香味料、ビャクシン液果香味料、ジンジャー香味料、スターアニス香味料、セイヨウワサビ香味料、タイム香味料、タラゴン香味料、イノンド香味料、トウガラシ香味料、ナツメグ香味料、バジル香味料、マヨラナ香味料、ローズマリ香味料、ローリエ香味料及びワサビ(日本のセイヨウワサビ)香味料)、アルコール香味料(例えばワイン香味料、ウイスキー香味料、ブランデー香味料、ラム香味料、ジン香味料及びリキュール香味料)、花の香味料及び野菜香味料(例えばタマネギ香味料、ニンニク香味料、キャベツ香味料、ニンジン香味料、セロリ香味料、キノコ香味料及びトマト香味料)が挙げられる。これらの着香剤は、液体又は固体形状で用いてもよく、また単独又は混合して用いてもよい。通常使用される香味料は、ペパーミント、メントール、スペアミント等のミント類、人工バニラ、シナモン誘導体及び様々なフルーツ香味料を含み、単独又は混合して用いられる。香味料は、本願明細書で後述する冷感剤と組み合わせて用いた場合に、特にミント香料は、呼気清涼化特性ももたらすと考えられる。
(Flavoring)
In certain embodiments, flavoring agents may include those whose flavors are known to those skilled in the art, such as natural and artificial flavors. These flavors may be selected from synthetic flavor oils and flavored aromatic compounds and / or aromatic oils, oleoresin and extracts derived from plants, leaves, flowers, fruits, etc., and combinations thereof. Good. Non-limiting representative flavoring oils include spearmint oil, cinnamon oil, wintergreen oil (methyl salicylate), peppermint oil, Japanese mint oil, clove oil, bay oil, anise oil, eucalyptus oil, thyme oil , Scented oil, nutmeg oil, allspice, sage oil, mace, bitter tonsil oil and cassia oil. Useful flavors include vanilla, citrus oil (including lemon, orange, lime, grapefruit, yuzu, sudachi) and fruit essence (apple, pear, peach, grape, blueberry, strawberry, raspberry, cherry, Artificial, natural and synthetic fruit flavors such as plums, pineapples, apricots, bananas, melons, apricots, ume, cherries, raspberries, blackberries, tropical fruits, mango, mangosteen, pomegranate, papaya, watermelon) . Other potential flavors that can control the release profile include milk flavors, butter flavors, cheese flavors, cream flavors and yogurt flavors, vanilla flavors, tea leaves or coffee flavors (eg green tea flavors). , Oolong tea flavor, tea leaf flavor, cacao flavor, chocolate flavor and coffee flavor), mint flavor (eg peppermint flavor, spearmint flavor and Japanese mint flavor), spicy flavor (eg agi flavor) , Ajowan Flavor, Anise Flavor, Angelica Flavor, Fennel Flavor, Allspice Flavor, Cinnamon Flavor, Chamomile Flavor, Mustard Flavor, Cardamom Flavor, Caraway Flavor, Cumin Flavor, Clove Flavor , Pepper flavor, coriander flavor, sassafras flavor, flavor flavor, Shaw flavoring, perilla flavoring, juniper berry flavoring, ginger flavoring, star anise flavoring, horseradish flavoring, thyme flavoring, tarragon flavoring, inondo flavoring, capsicum flavoring, nutmeg flavoring, basil flavoring , Majorana Flavor, Rosemary Flavor, Laurier Flavor and Wasabi (Japanese Wasabi) Flavor), Alcohol Flavor (eg Wine Flavor, Whiskey Flavor, Brandy Flavor, Lamb Flavor, Gin Flavor, and Gin Flavor) Liqueur flavor), floral flavors and vegetable flavors (eg, onion flavor, garlic flavor, cabbage flavor, carrot flavor, celery flavor, mushroom flavor and tomato flavor). These flavoring agents may be used in liquid or solid form, or may be used alone or in combination. Commonly used flavors include mint such as peppermint, menthol and spearmint, artificial vanilla, cinnamon derivatives and various fruit flavors, and are used alone or in combination. When used in combination with the cooling sensation agent described later in the present specification, the mint flavor is considered to bring breath refreshing properties in particular.
ある実施形態では、他の香味料には、アルデヒド及びエステルが含まれ、酢酸シンナミル、シンナムアルデヒド、シトラールジエチルアセタール、酢酸ジヒドロカルビル、ギ酸オイゲニル、p−メチルアミソール等を用いてもよい。一般的に、「Chemicals Used in Food Processing,publication1274」(63〜258頁、National Academy of Sciences)に記載されるような任意の香味料又は食品添加物を使用してもよい。この出版物は、本願に引用して援用する。天然香料や合成香料も含んでもよい。 In certain embodiments, other flavoring agents include aldehydes and esters, and cinnamyl acetate, cinnamaldehyde, citral diethyl acetal, dihydrocarbyl acetate, eugenyl formate, p-methylamisol, and the like may be used. In general, any flavoring or food additive as described in “Chemicals Used in Food Processing, publication 1274” (pages 63-258, National Academy of Sciences) may be used. This publication is incorporated herein by reference. Natural fragrances and synthetic fragrances may also be included.
アルデヒド香味料の更なる例としては、限定されるものではないが、アセトアルデヒド(リンゴ)、ベンズアルデヒド(サクランボ、アーモンド)、アニスアルデヒド(甘草、アニス)、ケイ皮アルデヒド(シナモン)、シトラール(即ちアルファ−シトラール(レモン、ライム))、ネラール(即ちβ−シトラール(レモン、ライム))、デカナール(オレンジ、レモン)、エチルバニリン(バニラ、クリーム)、ヘリオトロープ(即ちピペロナール(バニラ、クリーム))、バニリン(バニラ、クリーム)、アルファ−アミルシンナムアルデヒド(スパイシーな果実風味)、ブチルアルデヒド(バター、チーズ)、バレルアルデヒド(バター、チーズ)、シトロネラール(多くの種類に修飾)、デカナール(柑橘類果実)、アルデヒドC−8(柑橘類果実)、アルデヒドC−9(柑橘類果実)、アルデヒドC−12(柑橘類果実)、2−エチルブチルアルデヒド(液果類)、ヘキセナール(即ちトランス−2(液果類))、トリルアルデヒド(サクランボ、アーモンド)、ベラトルムアルデヒド(バニラ)、2,6−ジメチル−5−ヘプテナール(即ちメロナール(メロン))、2,6−ジメチルオクタナール(熟していない緑色の果物)及び2−ドデセナール(柑橘類、マンダリン)、サクランボ、ブドウ、ブルーベリー、ブラックベリー、イチゴのショートケーキ及びそれらの混合物が挙げられる。 Further examples of aldehyde flavorants include, but are not limited to, acetaldehyde (apple), benzaldehyde (cherry, almond), anisaldehyde (licorice, anise), cinnamic aldehyde (cinnamon), citral (ie alpha- Citral (lemon, lime)), neral (ie β-citral (lemon, lime)), decanal (orange, lemon), ethyl vanillin (vanilla, cream), heliotrope (ie piperonal (vanilla, cream)), vanillin (vanilla) , Cream), alpha-amylcinnamaldehyde (spicy fruit flavor), butyraldehyde (butter, cheese), valeraldehyde (butter, cheese), citronellal (modified to many types), decanal (citrus fruit), aldehyde C 8 (citrus fruit), aldehyde C-9 (citrus fruit), aldehyde C-12 (citrus fruit), 2-ethylbutyraldehyde (berries), hexenal (ie trans-2 (berries)), tolylaldehyde (Cherry, almond), veratrum aldehyde (vanilla), 2,6-dimethyl-5-heptenal (ie melonal (melon)), 2,6-dimethyloctanal (unripe green fruit) and 2-dodecenal ( Citrus, mandarin), cherries, grapes, blueberries, blackberries, strawberry shortcakes and mixtures thereof.
ある実施形態では、着香剤は、液体形態及び/又は乾燥形態のいずれにおいても使用することができる。後者では、液体をスプレードライする等の好適な乾燥手段を用いてもよい。或いは、着香剤を、水溶性材料(例えばセルロース、デンプン、糖、マルトデキストリン、アラビアゴム等)に吸収してもよいし、又は封入してもよい。更に他の実施形態では、着香剤はシリカ、ゼオライト等に吸着されてもよい。 In certain embodiments, flavoring agents can be used in either liquid and / or dry form. In the latter case, a suitable drying means such as spray drying of the liquid may be used. Alternatively, the flavoring agent may be absorbed into a water soluble material (eg cellulose, starch, sugar, maltodextrin, gum arabic, etc.) or encapsulated. In yet other embodiments, the flavoring agent may be adsorbed on silica, zeolite, and the like.
ある実施形態で、着香剤を多くの別異の物理的形態で使用してもよい。限定されるものではないが、こうした物理的形態としては、噴霧乾燥、粉末化、ビーズ形態、カプセル化形態、及びこれらの混合物のような自由な形態が挙げられる。 In certain embodiments, the flavoring agent may be used in many different physical forms. Such physical forms include, but are not limited to, free forms such as spray dried, powdered, beaded forms, encapsulated forms, and mixtures thereof.
香味料や他の追加の成分の封入の例示は、本願明細書に記載の実施例に見出すことができる。典型的には、成分の封入は、封入成分を(例えば、チューインガム組成物への配合成分として添加する送達システムの一部として)含むチューインガム組成物の消費の間に、成分の過半量の放出を遅延させる結果をもたらすことになる。ある実施形態では、配合成分(例えば、香味料、甘味料等)の放出プロファイルは、配合成分の種々の特性、配合成分を含有する送達システム、及び/又は送達システムを含有するチューインガム組成物及び/又はどのように送達システムを製造するかを管理することによって管理できる。例えば、特性には、以下の1種以上が含まれるかもしれない:送達システムの引張強度、配合成分の水溶性、封入材料の水溶性、送達システムの水溶性、送達システム中の封入材料に対する配合成分の割合、配合成分の平均又は最高粒子径、粉砕した送達システムの平均又は最高粒子径、チューインガム組成物中の配合成分又は送達システムの量、1以上の配合成分を封入するのに用いる異なるポリマーの割合、1以上の配合成分を封入するのに用いる1以上のポリマーの疎水性、送達システムの疎水性、送達システムのコーティングのタイプ又は量、配合成分が封入される前の配合成分のコーティングのタイプ又は量等。 An illustration of the inclusion of flavors and other additional ingredients can be found in the examples described herein. Typically, the encapsulation of the component results in a release of a majority of the component during consumption of the chewing gum composition including the encapsulated component (eg, as part of a delivery system that is added as a compounding component to the chewing gum composition). Will result in delays. In certain embodiments, the release profile of a compounding ingredient (eg, flavoring agent, sweetener, etc.) is determined by the various properties of the compounding ingredient, the delivery system containing the compounding ingredient, and / or the chewing gum composition containing the delivery system and / or Or it can be managed by managing how the delivery system is manufactured. For example, the properties may include one or more of the following: tensile strength of the delivery system, water solubility of the formulation components, water solubility of the encapsulating material, water solubility of the delivery system, formulation for the encapsulating material in the delivery system. Proportion of ingredients, average or maximum particle size of compounding ingredients, average or maximum particle size of milled delivery system, amount of compounding ingredients or delivery system in chewing gum composition, different polymers used to encapsulate one or more compounding ingredients The ratio of the hydrophobicity of the one or more polymers used to encapsulate the one or more ingredients, the hydrophobicity of the delivery system, the type or amount of coating of the delivery system, the coating of the ingredient before the ingredients are encapsulated Type or quantity etc.
(甘味配合成分)配合する甘味料は、水溶性甘味料、水溶性人工甘味料、天然素材の水溶性甘味料から誘導された水溶性甘味料、ジペプチド系甘味料、蛋白質系甘味料、及びこれらの混合物等の広範囲の材料から選択してもよい。特定の甘味料に限定することなく、代表的な分類及び例を以下に挙げる:(a)ジヒドロカルコン、モネリン、ステビオシド、グリチルリチン、ジヒドロフラベノール、及びソルビトール、マンニトール、マルチトール、キシリトール、エリスリトール等の糖アルコール、及び米国特許第4619834号明細書(この開示は本願に引用して援用する)に開示されたもの等のL−アミノジカルボン酸アミノアルケン酸エステルアミド、並びにこれらの混合物等の水溶性甘味料;(b)可溶性サッカリン塩(サッカリンナトリウム塩又はカルシウム塩)、シクラミン酸塩、3,4−ジヒドロ−6−メチル−1,2,3−オキサチアジン−4−オン−2,2−ジオキシドのナトリウム塩、アンモニウム塩、又はカルシウム塩、3,4−ジヒドロ−6−メチル−1,2,3−オキサチアジン−4−オン−2,2−ジオキシドのカリウム塩(アセスルファム−K)、遊離酸型のサッカリン、及びこれらの混合物等の水溶性人工甘味料;(c)L−アスパルチル−L−フェニルアラニンメチルエステル(アスパルテーム)、N−[N−(3,3−ジメチルブチル)−L−α−アスパルチル]−L−フェニルアラニン1−メチルエステル(ネオテーム)、及び米国特許第3492131号明細書に記載の物質、L−アルファアスパルチル−N−(2,2,4,4−テトラメチル−3−チエタニル)−D−アラニンアミド水和物(アリテーム)、L−アスパルチル−L−フェニルグリセリン及びL−アスパルチル−L−2,5−ジヒドロフェニル−グリシンのメチルエステル、L−アスパルチル−2,5−ジヒドロ−L−フェニルアラニン;L−アスパルチル−L−(1−シクロヘキセン)−アラニン、及びこれらの混合物等のL−アスパラギン酸由来甘味料等のジペプチド系甘味料;(d)普通の砂糖(サッカロース)の塩素化誘導体等の水可溶性甘味料を生じる天然由来の水可溶性甘味料、例えば、スクラロースの品名で知られている、例えばクロロデオキシサッカロース又はクロロデオキシガラクトサッカロースの誘導体等といったクロロデオキシ糖誘導体;クロロデオキシサッカロース及びクロロデオキシガラクトサッカロース誘導体の例として、限定しないが、以下のものが挙げられる:1−クロロ−1’−デオキシサッカロース;4−クロロ−4−デオキシ−アルファ−D−ガラクトピラノシル−アルファ−D−フラクトフラノシド、又は4−クロロ−4−デオキシガラクトサッカロース;4−クロロ−4−デオキシ−アルファ−D−ガラクトピラノシル−1−クロロ−1−デオキシ−ベータ−D−フラクトフラノシド、又は4,1’−ジクロロ−4,1’−ジデオキシガラクトサッカロース;1’,6’−ジクロロ−1’,6’−ジデオキシサッカロース;4−クロロ−4−デオキシ−アルファ−D−ガラクトピラノシル−1,6−ジクロロ−1,6−ジデオキシ−ベータ−D−フラクトフラノシド、又は4,1’,6’−トリクロロ−4,1’,6’−トリデオキシガラクトサッカロース、4,6−ジクロロ−4,6−ジデオキシ−アルファ−D−ガラクトピラノシル−6−クロロ−6−デオキシ−ベータ−D−フラクトフラノシド、又は4,6,6’−トリクロロ−4,6,6’−トリデオキシガラクトサッカロース;6,1’,6’−トリクロロ−6,1’,6’−トリデオキシサッカロース;4,6−ジクロロ−4,6−ジデオキシ−アルファ−D−ガラクト−ピラノシル−1,6−ジクロロ−1,6−ジデオキシ−ベータ−D−フラクトフラノシド、又は4,6,1’,6’−テトラクロロ−4,6,1’,6’−テトラデオキシガラクト−サッカロース;及び4,6,1’,6’−テトラデオキシ−サッカロース、及びこれらの混合物;並びに(e)タウマッコスダニエリ(タウマチンI及びII)及びタリン等の蛋白質系甘味料、及び(f)甘味料モナチン(2−ヒドロキシ−2−(インドール−3−イルメチル)−4−アミノグルタル酸)及びその誘導体;並びに(g)甘味料Lo han guo(羅漢果「Lo han kuo」又は「Lo han quo」と称されることもある)。 (Sweet blending component) Sweeteners to be blended include water-soluble sweeteners, water-soluble artificial sweeteners, water-soluble sweeteners derived from natural water-soluble sweeteners, dipeptide sweeteners, protein sweeteners, and these A wide range of materials such as a mixture of Without limiting to specific sweeteners, typical classifications and examples are listed below: (a) Dihydrochalcone, monelin, stevioside, glycyrrhizin, dihydroflavenol, and sorbitol, mannitol, maltitol, xylitol, erythritol, etc. Water-soluble sweetness such as sugar alcohols and L-aminodicarboxylic acid aminoalkenoic acid ester amides such as those disclosed in US Pat. No. 4,619,934, the disclosure of which is incorporated herein by reference, and mixtures thereof (B) Soluble saccharin salt (saccharin sodium salt or calcium salt), cyclamate, sodium salt of 3,4-dihydro-6-methyl-1,2,3-oxathiazin-4-one-2,2-dioxide , Ammonium salt or calcium salt, 3,4-dihydro- Water soluble artificial sweeteners such as methyl-1,2,3-oxathiazin-4-one-2,2-dioxide potassium salt (acesulfame-K), free acid form of saccharin, and mixtures thereof; (c) L-aspartyl-L-phenylalanine methyl ester (aspartame), N- [N- (3,3-dimethylbutyl) -L-α-aspartyl] -L-phenylalanine 1-methyl ester (neotame), and US Pat. No. 3,492,131 L-alpha aspartyl-N- (2,2,4,4-tetramethyl-3-thietanyl) -D-alanine amide hydrate (Aritame), L-aspartyl-L- Methyl ester of phenylglycerin and L-aspartyl-L-2,5-dihydrophenyl-glycine, L-aspartyl-2 Dipeptide sweeteners such as L-aspartic acid-derived sweeteners such as L-aspartyl-L- (1-cyclohexene) -alanine and mixtures thereof; (d) ordinary sugar ( Naturally derived water-soluble sweeteners that produce water-soluble sweeteners such as chlorinated derivatives of saccharose, for example, chlorodeoxysugar derivatives known under the trade name of sucralose, such as derivatives of chlorodeoxysaccharose or chlorodeoxygalactosaccharose Examples of chlorodeoxysaccharose and chlorodeoxygalactosaccharose derivatives include, but are not limited to: 1-chloro-1′-deoxysaccharose; 4-chloro-4-deoxy-alpha-D-galactopyrano Sil-alpha-D-fractula Or 4-chloro-4-deoxygalactosaccharose; 4-chloro-4-deoxy-alpha-D-galactopyranosyl-1-chloro-1-deoxy-beta-D-fructofuranoside, or 4,1 '-Dichloro-4,1'-dideoxygalactosaccharose; 1', 6'-dichloro-1 ', 6'-dideoxysaccharose; 4-chloro-4-deoxy-alpha-D-galactopyranosyl-1,6 -Dichloro-1,6-dideoxy-beta-D-fructofuranoside, or 4,1 ', 6'-trichloro-4,1', 6'-trideoxygalactosaccharose, 4,6-dichloro-4,6 Dideoxy-alpha-D-galactopyranosyl-6-chloro-6-deoxy-beta-D-fructofuranoside, or 4,6,6′-trick B-4,6,6′-trideoxygalactosaccharose; 6,1 ′, 6′-trichloro-6,1 ′, 6′-trideoxysaccharose; 4,6-dichloro-4,6-dideoxy-alpha- D-galacto-pyranosyl-1,6-dichloro-1,6-dideoxy-beta-D-fructofuranoside, or 4,6,1 ′, 6′-tetrachloro-4,6,1 ′, 6′- Tetradeoxygalacto-saccharose; and 4,6,1 ', 6'-tetradeoxy-saccharose, and mixtures thereof; and (e) protein-based sweeteners such as Taumaccos danieri (Taumatins I and II) and talin; And (f) sweetener monatin (2-hydroxy-2- (indol-3-ylmethyl) -4-aminoglutaric acid) and derivatives thereof; and (g) sweetener Lo ha guo (sometimes referred to as Luo Han Guo "Lo han kuo" or "Lo han quo").
高甘味度甘味剤は、当該技術分野で周知の多くの異なる物理的形態で用いることで、甘味の初期噴出及び/又は甘味の持続的な知覚を与えることができる。限定されるものではないが、こうした物理的形態としては、自由な形態、噴霧乾燥形態、粉末形態、ビーズ形態、カプセル化形態、及びこれらの混合形態が挙げられる。一実施形態で、甘味料はアスパルテーム、スクラロース、及びアセスルフェームカリウム(例えば、Ace−K)などの高甘味度甘味料である。 High intensity sweeteners can be used in many different physical forms well known in the art to provide an initial ejection of sweetness and / or a sustained perception of sweetness. Such physical forms include, but are not limited to, free forms, spray-dried forms, powder forms, bead forms, encapsulated forms, and mixed forms thereof. In one embodiment, the sweetener is a high intensity sweetener such as aspartame, sucralose, and acesulfame potassium (eg, Ace-K).
ある実施形態では、甘味料はポリオールであってもよい。ポリオールとしては、限定しないが、グリセロール、ソルビトール、マリチトール(malititol)、マルチトールシロップ、マンニトール、イソマルト、エリスリトール、キシリトール、水素化デンプン加水分解物、ポリグリシトールシロップ、ポリグリシトール粉末、ラクチトール、及びこれらの組み合わせを含むことができる。 In certain embodiments, the sweetener may be a polyol. Polyols include, but are not limited to, glycerol, sorbitol, malititol, maltitol syrup, mannitol, isomalt, erythritol, xylitol, hydrogenated starch hydrolysate, polyglycitol syrup, polyglycitol powder, lactitol, and these Can be included.
送達システムの一部をなす有効成分(例えば、甘味料)は、有効成分の使用に伴う所望の効果(例えば、甘味)を与えるのに必要な量にて用いてもよい。一般に、有効量の高甘味度甘味料を利用して、所望のレベルの甘味をもたらしてもよく、この量は選択した甘味料によって変動し得る。高甘味度甘味料は、使用する甘味料又は甘味料の組み合わせによって、組成物の約0.001質量%〜約3質量%の量で存在してもよい。各種甘味料の量の正確な範囲は、当業者が選択できる。 The active ingredient (eg, sweetener) that forms part of the delivery system may be used in an amount necessary to provide the desired effect (eg, sweetness) associated with the use of the active ingredient. In general, an effective amount of a high intensity sweetener may be utilized to provide the desired level of sweetness, and this amount may vary depending on the selected sweetener. High intensity sweeteners may be present in an amount from about 0.001% to about 3% by weight of the composition, depending on the sweetener or combination of sweeteners used. The exact range of amounts of the various sweeteners can be selected by those skilled in the art.
(知覚物質配合成分)
知覚物質化合物としては、冷感剤、温感剤、刺激剤、発泡剤、及びこれらの組み合わせを挙げることができる。様々な周知の冷感剤を用いてもよい。例えば、とりわけ有用な冷感剤としては、キシリトール、エリスリトール、デキストロース、ソルビトール、メンタン、メントン、ケタール、メントンケタール、メントングリセロールケタール、被置換p−メンタン、非環状カルボキサミド、モノメンチルグルタレート、被置換シクロヘキサミド、被置換シクロヘキサンカルボキサミド、被置換ウレア及びスルホンアミド、被置換メンタノール、p−メンタンのヒドロキシメチル及びヒドロキシメチル誘導体、2−メルカプト−シクロ−デカノン、炭素数2〜6のヒドロキシカルボン酸、シクロヘキサンアミド、酢酸メンチル、サリチル酸メンチル、N,2,3−トリメチル−2−イソプロピルブタンアミド(WS−23)、N−エチル−p−メンタン−3−カルボキサミド(WS−3)、イソプレゴール、3−(1−メントキシ)プロパン−1,2−ジオール、3−(1−メントキシ)−2−メチルプロパン−1,2−ジオール、p−メンタン−2,3−ジオール、p−メンタン−3,8−ジオール、6−イソプロピル−9−メチル−1,4−ジオキサスピロ[4,5]デカン−2−メタノール、コハク酸メチル及びそのアルカリ金属塩類、トリメチルシクロヘキサノール、N−エチル−2−イソプロピル−5−メチルシクロヘキサンカルボキサミド、和種ハッカ油、ペパーミント油、3−(1−メントキシ)エタン−1−オール、3−(1−メントキシ)プロパン−1−オール、3−(1−メントキシ)ブタン−1−オール、1−メンチル酢酸N−エチルアミド、1−メンチル−4−ヒドロキシペンタノエート、1−メンチル−3−ヒドロキシブチレート、N,2,3−トリメチル−2−(1−メチルエチル)−ブタンアミド、n−エチル−t−2−c−6ノナジエンアミド、N,N−ジメチルメンチルスクシンアミド、被置換p−メンタン、被置換p−メンタン−カルボキサミド、2−イソプロパニル−5−メチルシクロヘキサノール(久光製薬社製、本明細書にて「イソプレゴール」と後述)メントングリセロールケタール類(FEMA3807、商品名FRESCOLAT(登録商標)MGAタイプ)、3−1−メントキシプロパン−1,2−ジオール(タカサゴ社製、FEMA3784)、乳酸メンチル、(Haarman&Reimer製、FEMA3748、商品名FRESCOLAT(登録商標)MLタイプ)、WS−30、WS−14、ユーカリエキス(p−メンタ−3,8ジオール)、メントール(その天然又は合成誘導体)、メントールPGカーボネート、メントールEGカーボネート、メントールグリセリルエーテル、N−tertブチル−p−メンタン−3−カルボキサミド、P−メンタン−3−カルボン酸グリセロールエステル、メチル−2−イソプリル−ビシクロ(2.2.1)、ヘプタン−2−カルボキサミド、並びにメントールメチルエーテル及びメンチルピロリドンカルボキシレートが挙げられる。以上及び他の好適な冷感剤は、米国特許第4230688号明細書、米国特許第4032661号明細書、米国特許第4459425号明細書、米国特許第4136163号明細書、米国特許第5266592号明細書、米国特許第6627233号明細書に更に記載されており、これらすべては本願に引用して全体を援用する。
(Sensitive substance compounding ingredients)
Sensory substance compounds can include cooling agents, warming agents, stimulants, foaming agents, and combinations thereof. Various well-known cooling agents may be used. For example, particularly useful cooling sensates include xylitol, erythritol, dextrose, sorbitol, menthane, menthone, ketal, menthone ketal, menthone glycerol ketal, substituted p-menthane, acyclic carboxamide, monomenthyl glutarate, substituted cyclohexyl. Samide, substituted cyclohexanecarboxamide, substituted urea and sulfonamide, substituted mentanol, hydroxymethyl and hydroxymethyl derivatives of p-menthane, 2-mercapto-cyclo-decanone, C2-C6 hydroxycarboxylic acid, cyclohexaneamide , Menthyl acetate, menthyl salicylate, N, 2,3-trimethyl-2-isopropylbutanamide (WS-23), N-ethyl-p-menthane-3-carboxamide (WS-3), Sopulegol, 3- (1-Mentoxy) propane-1,2-diol, 3- (1-Mentoxy) -2-methylpropane-1,2-diol, p-menthan-2,3-diol, p-menthane- 3,8-diol, 6-isopropyl-9-methyl-1,4-dioxaspiro [4,5] decane-2-methanol, methyl succinate and its alkali metal salts, trimethylcyclohexanol, N-ethyl-2-isopropyl -5-methylcyclohexanecarboxamide, Japanese mint oil, peppermint oil, 3- (1-menthoxy) ethane-1-ol, 3- (1-menthoxy) propan-1-ol, 3- (1-menthoxy) butane 1-ol, 1-menthyl acetic acid N-ethylamide, 1-menthyl-4-hydroxypentanoate, 1-menthyl 3-hydroxybutyrate, N, 2,3-trimethyl-2- (1-methylethyl) -butanamide, n-ethyl-t-2-c-6nonadienamide, N, N-dimethylmenthyl succinamide, substituted p-menthane, substituted p-menthane-carboxamide, 2-isopropanyl-5-methylcyclohexanol (manufactured by Hisamitsu Pharmaceutical Co., Ltd., hereinafter referred to as “isopulegol”) Menton glycerol ketals (FEMA3807, trade name FRESCOLAT (registered) (Trademark) MGA type), 3-1-menthoxypropane-1,2-diol (manufactured by Takasago Co., Ltd., FEMA3784), menthyl lactate (manufactured by Haarman & Reimer, FEMA3748, trade name FRESCOLAT (registered trademark) ML type), WS-30 , WS-14, Eucalyptus (P-menta-3,8diol), menthol (natural or synthetic derivatives thereof), menthol PG carbonate, menthol EG carbonate, menthol glyceryl ether, N-tertbutyl-p-menthane-3-carboxamide, P-menthane- Examples include 3-carboxylic acid glycerol ester, methyl-2-isopril-bicyclo (2.2.1), heptane-2-carboxamide, and menthol methyl ether and menthyl pyrrolidone carboxylate. These and other suitable cooling agents are disclosed in U.S. Pat. No. 4,230,688, U.S. Pat. No. 4,032,661, U.S. Pat. No. 4,459,425, U.S. Pat. No. 4,136,163, U.S. Pat. No. 5,266,592. U.S. Pat. No. 6,627,233, all of which are hereby incorporated by reference in their entirety.
ある実施形態では、温感成分は、使用者に暖かい知覚信号をもたらすことが知られている多岐にわたる化合物から選択してもよい。これらの化合物は、特に口腔内で温かみを認知する感覚を与え、香味料、甘味料、及びその他の知覚刺激性成分の知覚を増強する場合が多い。ある実施形態では、有用な温感化合物として、高砂香料(Takasago Perfumary Company Limited)、東京、日本により供給されるバニリルアルコールn−ブチルエーテル(TK−1000)、バニリルアルコールn−プロピルエーテル、バニリルアルコールイソプロピルエーテル、バニリルアルコールイソブチルエーテル、バニリルアルコールn−アミノエーテル、バニリルアルコールイソアミルエーテル、バニリルアルコールn−ヘキシルエーテル、バニリルアルコールメチルエーテル、バニリルアルコールエチルエーテル、ジンゲロール、ショウガオール、パラドール、ジンゲロン、カプサイシン、ジヒドロカプサイシン、ノルジヒドロカプサイシン、ホモカプサイシン、ホモジヒドロカプサイシン、エタノール、イソプロピルアルコール、イソ−アミルアルコール、ベンジルアルコール、グリセリン、及びこれらの組合せを挙げることができる。 In certain embodiments, the warming component may be selected from a wide variety of compounds known to provide a warm sensory signal to the user. These compounds provide a sense of warmth, particularly in the oral cavity, and often enhance the perception of flavors, sweeteners, and other sensory stimulating ingredients. In some embodiments, useful warming compounds include Takasago Perfume Company Limited, Tokyo, Japan, vanillyl alcohol n-butyl ether (TK-1000), vanillyl alcohol n-propyl ether, vanillyl. Alcohol isopropyl ether, vanillyl alcohol isobutyl ether, vanillyl alcohol n-amino ether, vanillyl alcohol isoamyl ether, vanillyl alcohol n-hexyl ether, vanillyl alcohol methyl ether, vanillyl alcohol ethyl ether, gingerol, gingerol, paradol , Zingerone, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, Ethanol, isopropyl alcohol, iso - amyl alcohol, benzyl alcohol, glycerine, and can be combinations thereof.
ある実施形態では、刺激知覚をもたらすことができる。このような刺激知覚の1つは、ジャンブー、オレオレジン、又はスピラントールをある例に添加することによってもたらされる。ある実施態様では、ジャンブー又はサンショール等の物質から抽出したアルキルアミドを含むことができる。更に、ある実施態様において、知覚は発泡によって引き出される。かかる発泡性は、塩基性物質を酸性物質と合わせることによって生み出される。ある実施態様において、塩基性物質は、アルカリ金属炭酸塩、アルカリ金属炭酸水素塩、アルカリ土類金属炭酸塩、アルカリ土類金属炭酸水素塩及びそれらの混合物を含むことができる。ある実施形態で、酸性物質は、酢酸、アジピン酸、アスコルビン酸、酪酸、クエン酸、ギ酸、フマル酸、グリコン酸、乳酸、リン酸、リンゴ酸、シュウ酸、コハク酸、酒石酸及びこれらの組み合わせを含むことができる。「刺激」型知覚物質の例は、米国特許第6780443号明細書に見出すことができ、その内容全体を、あらゆる目的で本願に引用して援用する。 In some embodiments, stimulus perception can be provided. One such stimulus perception is brought about by adding jambu, oleoresin, or spiranthol to certain examples. In certain embodiments, alkylamides extracted from materials such as jambu or sansholes can be included. Furthermore, in certain embodiments, perception is drawn by foaming. Such effervescence is created by combining a basic material with an acidic material. In certain embodiments, the basic material can include alkali metal carbonates, alkali metal bicarbonates, alkaline earth metal carbonates, alkaline earth metal bicarbonates, and mixtures thereof. In certain embodiments, the acidic substance comprises acetic acid, adipic acid, ascorbic acid, butyric acid, citric acid, formic acid, fumaric acid, glyconic acid, lactic acid, phosphoric acid, malic acid, oxalic acid, succinic acid, tartaric acid and combinations thereof. Can be included. Examples of “stimulus” type sensory substances can be found in US Pat. No. 6,780,443, the entire contents of which are incorporated herein by reference for all purposes.
知覚物質成分は、本願に引用して援用する、米国特許出願第205/0202118号明細書に開示のもののような「三叉神経刺激薬」とも称してもよい。三叉神経刺激薬は、経口摂取品又は三叉神経を刺激する作用物として定義される。三叉神経刺激薬である冷感剤の例として、メントール、WS−3、N−被置換p−メンタンカルボキサミド、WS−23を含む非環状カルボキサミド、コハク酸メチル、メントングリセロールケタール、キシリトール、エリスリトール、デキストロース、及びソルビトールなどのバルク甘味料、並びにこれらの組み合わせが挙げられる。三叉神経刺激薬として、香味料、刺激剤、ジャンブー抽出物、バニリルn−ブチルエーテルなどのバニリルアルキルエーテル、スピラントール、エキナセア出物、キタサンショウ(Northern Prickly Ash)抽出物、カプサイシン、トウガラシオレオレジン、赤コショウオレオレジン、黒コショウオレオレジン、ピペリン、ジンジャーオレオレジン、ジンゲロール、ショウガオール、シナモンオレオレジン、カッシアオレオレジン、ケイ皮アルデヒド、オイゲノール、バニリンの環状アセタール及びメントールグリセリンエーテル、不飽和アミド、及びこれらの組み合わせも挙げることができる。 The sensory substance component may also be referred to as a “trigeminal nerve stimulant”, such as that disclosed in US patent application Ser. No. 205/0202118, incorporated herein by reference. A trigeminal stimulant is defined as an orally ingested product or an agent that stimulates the trigeminal nerve. Examples of cooling agents that are trigeminal stimulants include menthol, WS-3, N-substituted p-menthane carboxamide, acyclic carboxamide including WS-23, methyl succinate, menthone glycerol ketal, xylitol, erythritol, dextrose And bulk sweeteners such as sorbitol, and combinations thereof. As trigeminal nerve stimulant, flavoring agent, stimulant, jambu extract, vanillyl alkyl ether such as vanillyl n-butyl ether, spirantol, echinacea extract, northern salmon extract, capsaicin, red pepper oleoresin, red Pepper oleoresin, black pepper oleoresin, piperine, ginger oleoresin, gingerol, gingerol, cinnamon oleoresin, cassia oleoresin, cinnamic aldehyde, eugenol, vanillin cyclic acetal and menthol glycerin ether, unsaturated amide, and these Combinations can also be mentioned.
(呼気清涼化配合成分)
呼気清涼化剤として、精油や、種々のアルデヒド類、アルコール類、及び類似の物質を含むことができる。ある実施形態では、精油として、スペアミント、ペパーミント、ウィンターグリーン、サッサフラス、クロロフィル、シトラール、ゲラニオール、カルダモン、チョウジ、セージ、カルバクロール、ユーカリ、カルダモン、コウボク抽出物、マージョラム、シナモン、レモン、ライム、グレープフルーツ、及びオレンジの油を挙げることができる。ある実施形態では、ケイ皮アルデヒド及びサリチルアルデヒドなどのアルデヒド類を使用できる。更に、メントール、カルボン、イソ−ガリゴール、及びアネトールなどの化学物質が呼気清涼化剤として機能できる。これらのうち、最も一般に用いられるのは、ペパーミント、スペアミント及びクロロフィルの油である。
(Exhalation refreshing ingredients)
The breath freshener can include essential oils, various aldehydes, alcohols, and similar substances. In some embodiments, the essential oils include spearmint, peppermint, winter green, sassafras, chlorophyll, citral, geraniol, cardamom, clove, sage, carvacrol, eucalyptus, cardamom, koboku extract, marjoram, cinnamon, lemon, lime, grapefruit, And orange oil. In some embodiments, aldehydes such as cinnamic aldehyde and salicylaldehyde can be used. In addition, chemicals such as menthol, carvone, iso-galligol, and anethole can function as breath fresheners. Of these, the most commonly used are peppermint, spearmint and chlorophyll oils.
それらから由来する精油及び化学物質に加えて、ある実施形態では呼気清涼化剤は、限定しないが、クエン酸亜鉛、酢酸亜鉛、フッ化亜鉛、硫酸アンモニウム亜鉛、臭化亜鉛、ヨウ化亜鉛、塩化亜鉛、硝酸亜鉛、フルオロケイ酸亜鉛、グルコン酸亜鉛、酒石酸亜鉛、コハク酸亜鉛、ギ酸亜鉛、クロム酸亜鉛、フェノールスルホン酸亜鉛、ジチオン酸亜鉛、硫酸亜鉛、硝酸銀、サリチル酸亜鉛、グリセロリン酸亜鉛、硝酸銅、クロロフィル、銅クロロフィル、クロロフィリン、硬化綿実油、二酸化塩素、ベータシクロデキストリン、ゼオライト、シリカ系物質、炭素系物質、ラッカーゼなどの酵素、及びこれらの組み合わせを含むことができる。ある実施形態では、限定しないが、Bacillus coagulans、Bacillus subtilis、Bacillus laterosporus、Bacillus laevolacticus、Sporolactobacillus inulinus、Lactobacillus acidophilus、Lactobacillus curvatus、Lactobacillus plantarum、Lactobacillus jenseni、Lactobacillus casei、Lactobacillus fermentum、Lactococcus lactis、Pedioccocus acidilacti、Pedioccocus pentosaceus、Pedioccocus urinae、Leuconostoc mesenteroides、Bacillus coagulans、Bacillus subtilis、Bacillus laterosporus、Bacillus laevolacticus、Sporolactobacillus inulinus及びそれらの混合物などの乳酸生産微生物を含むガムについて、プロバイオティクスの放出プロファイルが管理できる。呼気清涼化剤は、以下の商標名:Retsyn,(商標)Actizol,(商標)及びNutrazin(商標)でも知られている。悪臭をコントロールする組成物の例は、Staplerらの米国特許第5300305号明細書、並びに米国特許公開公報第2003/0215417号及び同第2004/0081713号明細書に記載されており、その内容全体を、あらゆる目的で本願に引用して援用する。 In addition to the essential oils and chemicals derived from them, in some embodiments, the breath refresher includes, but is not limited to, zinc citrate, zinc acetate, zinc fluoride, zinc ammonium sulfate, zinc bromide, zinc iodide, zinc chloride , Zinc nitrate, Zinc fluorosilicate, Zinc gluconate, Zinc tartrate, Zinc succinate, Zinc formate, Zinc chromate, Zinc phenolsulfonate, Zinc dithionate, Zinc sulfate, Silver nitrate, Zinc salicylate, Zinc glycerophosphate, Copper nitrate , Chlorophyll, copper chlorophyll, chlorophyllin, hydrogenated cottonseed oil, chlorine dioxide, betacyclodextrin, zeolite, silica-based materials, carbon-based materials, enzymes such as laccase, and combinations thereof. In some embodiments, without limitation, Bacillus coagulans, Bacillus subtilis, Bacillus laterosporus, Bacillus laevolacticus, Sporolactobacillus inulinus, Lactobacillus acidophilus, Lactobacillus curvatus, Lactobacillus plantarum, Lactobacillus jenseni, Lactobacillus casei, Lactobacillus fermentum, Lactococcus lactis, Pedioccocus acidilacti, Pedioccocus pentosaceus , Pediocc Ous urinae, Leuconostoc mesenteroides, Bacillus coagulans, Bacillus subtilis, Bacillus laterosporus, bio-produced microbials such as Bacillus laevolusticus, Sprolactoinulus Breath refreshers are also known under the following trade names: Retsyn, (trademark) Actizol, (trademark) and Nutrazin (TM). Examples of malodor control compositions are described in Stapler et al., US Pat. No. 5,300,305, and US Patent Publication Nos. 2003/0215417 and 2004/0081713. Which is incorporated herein by reference for all purposes.
(歯科ケア用配合成分)
歯科ケア用配合成分(口腔ケア配合成分としても知られる)としては、限定しないが、歯漂白剤、汚れ除去剤、口腔洗浄、漂白剤、減感剤、歯の再ミネラル強化剤、抗菌剤、抗齲蝕剤、歯垢の酸緩衝剤、界面活性剤及び歯石防止剤を挙げてもよい。このような成分の非限定的な例として、蛋白質分解酵素等の加水分解性物質、水和シリカ、炭酸カルシウム、重炭酸ナトリウム、及びアルミナ等の研磨剤、ステアリン酸ナトリウム、パルミチン酸ナトリウム、スルフェート化オレイン酸ブチル、オレイン酸ナトリウム、フマル酸塩、グリセロール、ヒドロキシル化レシチン、及びラウリル硫酸ナトリウムのようなアニオン界面活性剤を含むがこれに限定しない界面活性剤、及びポリリン酸塩のようなキレート化剤等のその他の活性汚れ除去成分を挙げることができ、これらは典型的に、歯石除去成分として使用される。ある実施形態では、歯科ケア用配合成分は、ピロリン酸四ナトリウム及びトリポリリン酸ナトリウム、炭酸水素ナトリウム、酸性ピロリン酸ナトリウム、トリポリリン酸ナトリウム、キシリトール、ヘキサメタリン酸ナトリウムも含むことができる。
(Dental care ingredients)
Dental care ingredients (also known as oral care ingredients) include, but are not limited to, tooth bleach, stain remover, mouth rinse, bleach, desensitizer, tooth remineral enhancer, antibacterial agent, Mention may also be made of anti-caries agents, plaque acid buffers, surfactants and calculus inhibitors. Non-limiting examples of such components include hydrolysable substances such as proteolytic enzymes, abrasives such as hydrated silica, calcium carbonate, sodium bicarbonate, and alumina, sodium stearate, sodium palmitate, sulfated Surfactants including but not limited to anionic surfactants such as butyl oleate, sodium oleate, fumarate, glycerol, hydroxylated lecithin, and sodium lauryl sulfate, and chelating agents such as polyphosphate And other active soil removal ingredients such as these are typically used as tartar removal ingredients. In certain embodiments, the dental care ingredients can also include tetrasodium pyrophosphate and sodium tripolyphosphate, sodium bicarbonate, sodium acid pyrophosphate, sodium tripolyphosphate, xylitol, sodium hexametaphosphate.
ある実施形態で、過酸化カルバミド、過酸化カルシウム、過酸化マグネシウム、過酸化ナトリウム、過酸化水素、及びペルオキシ二リン酸塩などの過酸化物が含まれる。ある実施形態では、硝酸カリウム及びクエン酸カリウムが含まれる。他の例として、カゼイングリコマクロペプチド、カルシウムカゼインペプトン−リン酸カルシウム、カゼインホスホペプチド、カゼインホスホペプチド−無定形リン酸カルシウム(CPP−ACP)、及び無定形リン酸カルシウムを挙げることができる。更に他の例として、パパイン、クリラーゼ、ペプシン、トリプシン、リゾチーム、デキストラナーゼ、ミュータナーゼ、グリコアミラーゼ、アミラーゼ、グルコースオキシダーゼ、及びこれらの組み合わせを挙げることができる。 In certain embodiments, peroxides such as carbamide peroxide, calcium peroxide, magnesium peroxide, sodium peroxide, hydrogen peroxide, and peroxydiphosphate are included. In certain embodiments, potassium nitrate and potassium citrate are included. Other examples include casein glycomacropeptide, calcium casein peptone-calcium phosphate, casein phosphopeptide, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), and amorphous calcium phosphate. Still other examples include papain, clarase, pepsin, trypsin, lysozyme, dextranase, mutanase, glycoamylase, amylase, glucose oxidase, and combinations thereof.
予防作用を高めて、歯科ケア用配合成分を化粧品上より許容し得るようにすべく、ある実施形態で使用するために更なる例として、ステアリン酸ナトリウム、リシノール酸ナトリウム、及びラウリル硫酸ナトリウム界面活性剤などの界面活性剤を挙げることができる。界面活性剤は、組成物に洗浄性及び起泡性を付与する、洗浄性物質であり得る。界面活性剤の好適な例は、硬化ヤシ油脂肪酸の一硫酸化モノグリセリドのナトリウム塩などの高級脂肪酸モノグリセリド一硫酸の水溶性塩、ラウリル硫酸ナトリウムなどの高級アルキル硫酸塩、ドデシルベンゼンスルホン酸ナトリウムなどのアルキルアリールスルホン酸塩、高級アルキルスルホ酢酸、ラウリルスルホ酢酸ナトリウム、1,2−ジヒドロキシプロパンスルホン酸の高級脂肪酸エステル、及び低級脂肪族アミノカルボン酸化合物の実質的に飽和した高級脂肪族アシルアミド(脂肪酸に12〜16の炭素数を有するものなど)、アルキル又はアシルラジカル等である。最後に述べるアミドの例は、N−ラウロイルサルコシン、及びN−ラウロイル、N−ミリストイル、又はN−パルミトイルサルコシンのナトリウム、カリウム、及びエタノールアミン塩である。 Sodium stearate, sodium ricinoleate, and sodium lauryl sulfate surfactants are further examples for use in certain embodiments to enhance preventive action and make dental care ingredients more cosmetically acceptable. Surfactants such as agents can be mentioned. The surfactant can be a detersive substance that imparts detergency and foaming properties to the composition. Suitable examples of surfactants include water-soluble salts of higher fatty acid monoglyceride monosulfate such as monosulfated monoglyceride sodium salt of hydrogenated coconut oil fatty acid, higher alkyl sulfates such as sodium lauryl sulfate, sodium dodecylbenzenesulfonate, etc. Alkyl aryl sulfonates, higher alkyl sulfoacetic acid, sodium lauryl sulfoacetate, higher fatty acid esters of 1,2-dihydroxypropane sulfonic acid, and substantially saturated higher aliphatic acylamides of lower aliphatic aminocarboxylic acid compounds Those having 12 to 16 carbon atoms), alkyl or acyl radicals, and the like. Examples of amides to be mentioned last are N-lauroyl sarcosine and the sodium, potassium and ethanolamine salts of N-lauroyl, N-myristoyl or N-palmitoyl sarcosine.
界面活性剤に加えて、歯科ケア用配合成分として、限定しないが、トリクロサン、クロルヘキシジン、クエン酸亜鉛、硝酸銀、銅、リモネン、及びセチルピリジニウムクロライドなどの抗菌剤を挙げることができる。ある実施形態で、追加の抗齲蝕剤として、無機フッ化物塩などの、フッ素イオン又はフッ素供給成分を挙げることができる。ある実施形態で、可溶性アルカリ金属塩、例えば、フッ化ナトリウム、フッ化カリウム、フルオロケイ酸ナトリウム、フルオロケイ酸アンモニウム、モノフルオロリン酸ナトリウム、更にはフッ化スタナスなどのフッ化スズ、及び塩化スタナスを挙げることができる。ある実施形態で、例えば、酸でのエナメル溶解性の減少、及び歯の崩壊に対する保護などの、口腔のケア及び衛生に有益な効果を有するフッ素含有化合物も、配合成分として配合してもよい。その例として、フッ化ナトリウム、フッ化スタナス、フッ化カリウム、フッ化スタナスカリウム(SnF2−KF)、ヘキサフルオロスズ酸ナトリウム、塩化フッ化スタナス、フルオロジルコン酸ナトリウム、及びモノフルオロリン酸ナトリウムが挙げられる。ある実施形態では、尿素が含まれる。 In addition to surfactants, the dental care ingredients include, but are not limited to, antibacterial agents such as triclosan, chlorhexidine, zinc citrate, silver nitrate, copper, limonene, and cetylpyridinium chloride. In certain embodiments, the additional anti-cariogenic agent can include fluorine ions or fluorine supply components, such as inorganic fluoride salts. In certain embodiments, soluble alkali metal salts such as sodium fluoride, potassium fluoride, sodium fluorosilicate, ammonium fluorosilicate, sodium monofluorophosphate, and also stannous chloride such as stannous fluoride, and stannous chloride Can be mentioned. In certain embodiments, fluorine-containing compounds that have beneficial effects on oral care and hygiene, such as, for example, reduced enamel solubility with acids and protection against tooth decay, may also be formulated as a formulation component. As an example, sodium fluoride, fluoride Sutanasu, potassium fluoride, sodium fluoride stannous potassium (SnF 2 -KF), hexafluoro stannate, chloride fluoride Sutanasu, sodium fluorozirconate, and sodium monofluorophosphate, Is mentioned. In certain embodiments, urea is included.
更なる例は、以下の米国特許及び米国特許出願公開に挙げられ、これらすべての内容はその全体を、あらゆる目的で本願に引用して援用する:Reynoldsの米国特許第5227154号明細書、Greenbergの第5378131号明細書、Luoらの第6846500号明細書、Luoらの第6733818号明細書、Luoらの第6696044号明細書、Holmeらの第6685916号明細書、Luoらの第6485739号明細書、Holmeらの第6479071号明細書、Luoらの第6471945号明細書、Holmeらの米国特許公開第20050025721号明細書、Gebreselassieらの同第2005008732号明細書、及びHolmeらの同第20040136928号明細書。 Further examples can be found in the following U.S. Patents and U.S. Patent Application Publications, the entire contents of which are hereby incorporated by reference in their entirety for all purposes: Reynolds U.S. Pat. No. 5,227,154, Greenberg No. 5,378,131, Luo et al. 6,846,500, Luo et al., 6,733,818, Luo et al., 6,669,044, Holme et al., 6,685,916, Luo et al., 6,485,739. Holme et al., 6,479,071, Luo et al., 6,471,945, Holme et al., US 20050025721, Gebreslasie et al., 2005008732, and Holme, et al., 20040136928. book.
(有効成分)
活性物は一般的に、それらが使用者に提供する所望の最終的な利点のために、送達システム及び/又はチューインガム組成物に配合される配合成分を言う。ある実施形態では、活性物として、薬物、栄養素、栄養補給品、薬草、栄養補給剤、医薬品、薬物等、及びこれらの組み合わせを挙げることができる。
(Active ingredient)
Actives generally refer to compounding ingredients that are incorporated into the delivery system and / or chewing gum composition for the desired ultimate benefit they provide to the user. In certain embodiments, actives can include drugs, nutrients, nutritional supplements, herbs, nutritional supplements, pharmaceuticals, drugs, and the like, and combinations thereof.
有用な薬物の例としては、アンギオテンシン変換酵素阻害薬、抗狭心症薬、抗不整脈薬、抗喘息薬、抗高コレステロール血症薬、鎮痛薬、麻酔薬、抗痙攣薬、抗うつ薬、抗糖尿病薬、止瀉薬調剤、解毒薬、抗ヒスタミン薬、降圧薬、抗炎症薬、抗脂質薬、抗躁薬、制吐薬、抗卒中薬、抗甲状腺薬製剤、抗腫瘍薬、抗ウイルス薬、挫創薬、アルカロイド、アミノ酸調剤、鎮咳薬、抗尿酸血症薬、抗ウイルス薬、アナボリック調剤、全身及び非全身抗感染薬、抗移植的新組織形成薬、抗パーキンソン病薬、抗リウマチ薬、食欲刺激剤、生物学的応答修飾剤、血液修飾薬、骨代謝調節剤、心血管薬、中枢神経系刺激剤、コリンエステラーゼ阻害薬、避妊薬、鬱血除去薬、栄養補助食品、ドーパミンレセプター作用薬、子宮内膜症管理薬、酵素、シルデナフィルクエン酸塩等の勃起機能障害治療薬(現在、Viagra(商標)として流通)、不妊治療薬、胃腸薬、ホメオパシー治療薬、ホルモン、高カルシウム血症及び低カルシウム血症管理薬、免疫変調薬、免疫抑制薬、片頭痛薬調剤、動揺病治療薬、筋肉弛緩薬、肥満管理薬、骨粗鬆症薬調剤、子宮収縮薬、副交感神経遮断薬、副交感神経作動薬、プロスタグランジン、精神治療薬、呼吸器作用薬、鎮静薬、ブロモクリプチン又はニコチン等の禁煙補助薬、交感神経遮断薬、振戦薬調剤、尿管作用薬、血管拡張薬、緩下薬、制酸薬、イオン交換樹脂、抗発熱薬、食欲抑制薬、去痰薬、抗不安薬、抗潰瘍薬、抗炎症性物質、冠動脈拡張薬、脳拡張薬、末梢血管拡張薬、向精神薬、刺激薬、抗高血圧薬、血管収縮薬、片頭痛治療薬、抗生物質、精神安定薬、抗精神病薬、抗腫瘍薬、抗凝固薬、抗血栓薬、睡眠薬、鎮吐薬、抗嘔吐薬、抗痙攣薬、神経筋肉作用薬、高糖血症及び低糖血症薬、甲状腺及び抗甲状腺薬調剤、利尿薬、鎮痙薬、子宮弛緩薬、肥満抑制薬、赤血球生成薬、抗喘息薬、鎮咳剤、粘液溶解薬、DNA及び遺伝的修飾薬、及びそれらの組合せが挙げられる。 Examples of useful drugs include angiotensin converting enzyme inhibitors, antianginal drugs, antiarrhythmic drugs, antiasthma drugs, antihypercholesterolemia drugs, analgesics, anesthetics, anticonvulsants, antidepressants, anti Diabetes, antidiarrheal preparation, antidote, antihistamine, antihypertensive, anti-inflammatory, antilipid, anti-epileptic, antiemetic, anti-stroke, anti-thyroid, anti-tumor, anti-viral, wound wound Drugs, alkaloids, amino acid preparations, antitussives, antiuricemia drugs, antiviral drugs, anabolic preparations, systemic and non-systemic antiinfectives, antigraft new tissue formation drugs, antiparkinsonian drugs, antirheumatic drugs, appetite stimuli Agents, biological response modifiers, blood modifiers, bone metabolism regulators, cardiovascular agents, central nervous system stimulants, cholinesterase inhibitors, contraceptives, decongestants, dietary supplements, dopamine receptor agonists, intrauterine Membrane control drug, enzyme, sill Drugs for erectile dysfunction such as nafil citrate (currently distributed as Viagra ™), fertility drugs, gastrointestinal drugs, homeopathic drugs, hormones, hypercalcemia and hypocalcemia management drugs, immunomodulators , Immunosuppressant, migraine medication, motion sickness treatment, muscle relaxant, obesity management agent, osteoporosis medication, uterine contractor, parasympathomimetic, parasympathomimetic, prostaglandin, psychotherapeutic, respiratory Vasoactive drugs, sedatives, smoking cessation aids such as bromocriptine or nicotine, sympatholytic drugs, tremor drug preparations, ureteric drugs, vasodilators, laxatives, antacids, ion exchange resins, antipyretic drugs , Appetite suppressant, expectorant, anxiolytic, anti-ulcer, anti-inflammatory, coronary dilator, brain dilator, peripheral vasodilator, psychotropic, stimulant, antihypertensive, vasoconstrictor, fragment Headache remedies, antibiotics , Tranquilizers, antipsychotics, antitumor agents, anticoagulants, antithrombotics, sleeping pills, antiemetics, antiemetics, anticonvulsants, neuromuscular agents, hyperglycemic and hypoglycemic agents, thyroid And antithyroid drugs, diuretics, antispasmodics, uterine relaxants, anti-obesity drugs, erythropoiesis drugs, anti-asthma drugs, antitussives, mucolytic agents, DNA and genetic modifiers, and combinations thereof.
本発明での使用が考えられる有効成分の例としては、制酸剤、H2アンタゴニスト及び鎮痛薬を挙げることができる。例えば、制酸剤は、成分として炭酸カルシウムを単独で、或いは、水酸化マグネシウム及び/又は水酸化アルミニウムとの組み合わせを用いて調製することができる。更に、制酸剤は、H2アンタゴニストと組み合わせて使用することができる。 Examples of active ingredients contemplated for use in the present invention include antacids, H2 antagonists and analgesics. For example, an antacid can be prepared using calcium carbonate alone or in combination with magnesium hydroxide and / or aluminum hydroxide as a component. Furthermore, antacids can be used in combination with H2 antagonists.
鎮痛薬として、オピエート、及びOXYCONTIN(登録商標)などのオピエート誘導体、イブプロフェン、アスピリン、アセトアミノフェン、及び任意にカフェインを含んでもよいこれらの組み合わせが挙げられる。 Analgesics include opiates and opiate derivatives such as OXYCONTIN®, ibuprofen, aspirin, acetaminophen, and combinations thereof that may optionally include caffeine.
実施形態で用いられる他の薬剤有効成分としては、下痢止め薬(例えばImmodium(商標)AD、抗ヒスタミン剤、鎮咳剤、充血除去薬、ビタミン及び口中清涼剤)を挙げることができる。また、本明細書において使用が考えられるものは、抗不安剤(例えばXanax(商標))、抗精神病剤(例えばClozaril(商標))及びHaldol(商標))、非ステロイド性の抗炎症剤(NSAID)(例えばイブプロフェン、ナプロキセンナトリウム、Voltaren(商標)及びLodine(商標))、抗ヒスタミン剤(例えばClaritin(商標)、Hismanal(商標)、Relafen(商標)及びTavist(商標))、抗嘔吐剤(例えばKytril(商標)及びCesamet(商標))、気管支拡張剤(例えばBentolin(商標)及びProventil(商標))、抗うつ剤(例えばProzac(商標)、Zoloft(商標)及びPaxil(商標))、抗片頭痛薬(例えばImigra(商標))、ACE抑制剤(例えばVasotec(商標)、Capoten(商標)及びZestril(商標))、アルツハイマー治療剤(例えばNicergoline(商標))及びCaHアンタゴニスト(例えばProcardia(商標)、Adalat(商標)及びCalan(商標))である。 Examples of other active pharmaceutical ingredients used in the embodiment include antidiarrheal drugs (eg, Immodium ™ AD, antihistamines, antitussives, decongestants, vitamins and mouth refreshing agents). Also contemplated herein are anti-anxiety agents (eg, Xanax ™), antipsychotic agents (eg, Clozaril ™) and Haldol ™), non-steroidal anti-inflammatory agents (NSAIDs). ) (Eg ibuprofen, naproxen sodium, Voltaren ™ and Lodine ™), antihistamines (eg Claritin ™, Hismanal ™, Relafen ™ and Tabist ™), antiemetics (eg Kytril ( Trademark) and Cesame ™, bronchodilators (eg Bentolin ™ and Proventil ™), antidepressants (eg Prozac ™, Zoloft ™ and Paxil ™), anti-migraine drugs (Eg I igra (TM), ACE inhibitors (e.g. Vasotec (TM), Capoten (TM) and Zestril (TM)), Alzheimer's therapeutics (e.g. Nigergoline (TM)) and CaH antagonists (e.g. Procardia (TM), Adalat (TM) ) And Calan (TM)).
本発明での使用が考えられる、普及しているH2アンタゴニストとしては、シメチジン、塩酸ラニチジン、ファモチジン、ニザチジエン、エブロチジン、ミフェンチジン、ロキサチジン、ピサチジン及びアセロクサチジンが挙げられる。 Popular H2 antagonists contemplated for use in the present invention include cimetidine, ranitidine hydrochloride, famotidine, nizadiene, ebrotidine, mifentidine, roxatidine, pisatidine and aceloxatidine.
活性制酸剤成分としては、限定しないが、水酸化アルミニウム、アミノ酢酸ジヒドロキシアルミニウム、アミノ酢酸、リン酸アルミニウム、炭酸ジヒドロキシアルミニウムナトリウム、重炭酸塩、アルミン酸ビスマス、炭酸ビスマス、次炭酸ビスマス、次没食子酸ビスマス、次硝酸ビスマス、次珪酸ビスマス、炭酸カルシウム、リン酸カルシウム、クエン酸イオン(酸又は塩)、アミノ酢酸、水和硫酸アルミン酸マグネシウム、マガルドレート、アルミノケイ酸マグネシウム、炭酸マグネシウム、グリシン酸マグネシウム、水酸化マグネシウム、酸化マグネシウム、三ケイ酸マグネシウム、乳固形分、リン酸アルミニウムモノ−又はジ塩基性カルシウム、リン酸三カルシウム、炭酸水素カリウム、酒石酸ナトリウム、炭酸水素ナトリウム、アルミノケイ酸マグネシウム、酒石酸及び塩が挙げられる。 Active antacid components include, but are not limited to, aluminum hydroxide, dihydroxyaluminum aminoacetate, aminoacetic acid, aluminum phosphate, sodium dihydroxyaluminum carbonate, bicarbonate, bismuth aluminate, bismuth carbonate, bismuth subcarbonate, subgallium Bismuth acid, bismuth hyponitrate, bismuth hyposilicate, calcium carbonate, calcium phosphate, citrate ion (acid or salt), aminoacetic acid, hydrated magnesium aluminate sulfate, magaldrate, magnesium aluminosilicate, magnesium carbonate, magnesium glycinate, hydroxylated Magnesium, magnesium oxide, magnesium trisilicate, milk solids, aluminum mono- or dibasic calcium phosphate, tricalcium phosphate, potassium bicarbonate, sodium tartrate, sodium bicarbonate, aluminum Magnesium Minokei acid, tartaric acid and salts.
事実上任意のビタミン又はミネラルを含め、種々の栄養補給剤も、有効成分として使用してもよい。例えば、ビタミンA、ビタミンC、ビタミンD、ビタミンE、ビタミンK、ビタミンB6、ビタミンB12、チアミン、リボフラビン、ビオチン、葉酸、ナイアシン、パントテン酸、ナトリウム、カリウム、カルシウム、マグネシウム、リン、硫黄、塩素、鉄、銅、ヨード、亜鉛、セレン、マンガン、コリン、クロム、モリブデン、フッ素、コバルト、及びこれらの組み合わせを使用することができる。 Various nutritional supplements, including virtually any vitamin or mineral, may also be used as active ingredients. For example, vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B 6 , vitamin B 12 , thiamine, riboflavin, biotin, folic acid, niacin, pantothenic acid, sodium, potassium, calcium, magnesium, phosphorus, sulfur, Chlorine, iron, copper, iodine, zinc, selenium, manganese, choline, chromium, molybdenum, fluorine, cobalt, and combinations thereof can be used.
有効成分として使用できる栄養補給剤の例は、米国特許出願公開第2003/0157213号明細書、米国特許出願公開第2003/0206993号明細書及び米国特許出願公開第2003/0099741号明細書に記載されており、この内容全体を、あらゆる目的で本願明細書に参照して援用する。 Examples of nutritional supplements that can be used as active ingredients are described in U.S. Patent Application Publication No. 2003/0157213, U.S. Patent Application Publication No. 2003/0206993 and U.S. Patent Application Publication No. 2003/0099741. The entire contents of which are incorporated herein by reference for all purposes.
様々な医薬的、或いは、栄養補助特性を有する種々の薬草も、有効成分として使用してもよい。薬草は通常、医薬的に或いは香味料として使用できる、芳香植物若しくは芳香植物の部分、及び/又はその抽出物である。好適な薬草は、単独又は様々に混合して使用することができる。広く使用されるハーブとしては、エキナシア、ヒドラスチス、キンセンカ、ローズマリー、タイム、カバカバ、アロエ、アカネグサ、グレープフルーツ種子抽出物、ブラックコホッシュ、ニンジン、ガラナ、クランベリー、イチョウの葉、セイヨウオトギリソウ、マツヨイグサ油、ヨヒンビ樹皮、緑茶、マオウ、マカ、コケモモ、ルテイン及びそれらの組み合わせが挙げられる。 Various medicinal herbs with various medicinal or nutritional support properties may also be used as active ingredients. Herbs are usually aromatic plants or parts of aromatic plants and / or extracts thereof that can be used pharmaceutically or as a flavor. Suitable herbs can be used alone or in various mixtures. Commonly used herbs include Echinasia, Hydratis, Calendula, Rosemary, Thyme, Hippopotamus, Aloe, Anegusa, Grapefruit Seed Extract, Black Cohosh, Carrot, Guarana, Cranberry, Ginkgo biloba, Hypericum perforatum, Oenothera oil, Yohimbi Examples include bark, green tea, mao, maca, cowberry, lutein and combinations thereof.
(発泡性システム配合成分)
発泡システムは、1以上の食用酸及び1以上の食用アルカリ性物質を含んでもよい。食用酸及び食用アルカリ性物質は、共に反応して発泡を生じる。
(Foaming system compounding ingredients)
The foaming system may include one or more edible acids and one or more edible alkaline substances. The edible acid and the edible alkaline substance react together to produce foam.
ある実施形態では、アルカリ性物質は、限定しないが、アルカリ金属炭酸塩、アルカリ金属炭酸水素塩、アルカリ土類金属炭酸塩、アルカリ土類金属炭酸水素塩、及びこれらの組み合わせから選択してもよい。食用酸は、限定しないがクエン酸、リン酸、酒石酸、リンゴ酸、アスコルビン酸、及びこれらの組み合わせから選択してもよい。ある実施形態では、発泡性システムは、例えば、二酸化炭素、口腔ケア配合成分、風味剤等の1種以上の他の配合成分を含んでもよい。 In certain embodiments, the alkaline material may be selected from, but not limited to, alkali metal carbonates, alkali metal bicarbonates, alkaline earth metal carbonates, alkaline earth metal bicarbonates, and combinations thereof. The edible acid may be selected from, but not limited to, citric acid, phosphoric acid, tartaric acid, malic acid, ascorbic acid, and combinations thereof. In certain embodiments, the effervescent system may include one or more other ingredients such as, for example, carbon dioxide, oral care ingredients, flavoring agents, and the like.
チューインガムでの発泡性システムの使用の例については、2004年10月13日出願の「Effervescent Pressed Gum Tablet Compositions」という名称の米国仮特許第60/618222号明細書を参照されたく、その内容はあらゆる目的で本願に引用して援用する。他の例は、米国特許第6235318号明細書に認めることができ、その内容をあらゆる目的で本願に引用して援用する。 For an example of the use of an effervescent system in chewing gum, see US Provisional Patent No. 60/618222, entitled “Efficient Pressed Gum Table Compositions” filed Oct. 13, 2004, the contents of which Incorporated herein by reference for purposes. Other examples can be found in US Pat. No. 6,235,318, the contents of which are incorporated herein by reference for all purposes.
(食欲抑制配合成分)
食欲抑制剤は、食品を摂取する欲求を抑圧するように機能する繊維及び蛋白質などの配合成分であることができる。食欲抑制剤は、ベンズフェタミン、ジエチルプロピオン、マジンドール、フェンジメトラジン、フェンテルミン、フーディア(P57)、Olibra,(商標)エフェドラ、カフェイン及びこれらの組み合わせも含むことができる。食欲抑制剤は、以下の商標名:Adipex(商標)、Adipost(商標)、Bontril(商標)PDM、Bontril(商標)Slow Release,Didrex(商標)、Fastin(商標)、Ionamin(商標)、Mazanor(商標)、Melfiat(商標)、Obenix(商標)、Phendiet(商標)、Phendiet−105(商標)、Phentercot(商標)、Phentride(商標)、Plegine(商標)、Prelu−2(商標)、Pro−Fast(商標)、PT 105(商標)、Sanorex(商標)、Tenuate(商標)、Sanorex(商標)、Tenuate(商標)、Tenuate Dospan(商標)、Tepanil Ten−Tab(商標)、Teramine(商標)、及びZantryl(商標)でも知られている。これらの、及び他の好適な食欲抑制剤は、以下の米国特許に更に記載されており、これらはすべて、引用してその全体を本願に援用する:Portmanの米国特許第6838431号明細書、Portmanの米国特許第6716815号明細書、Portmanの米国特許第6558690号明細書、Portmanの米国特許第6468962号明細書、Portmanの米国特許第6436899号明細書。
(Appetite suppression ingredients)
An appetite suppressant can be a compounding ingredient such as fiber and protein that functions to suppress the desire to consume food. Appetite suppressants can also include benzphetamine, diethylpropion, mazindol, phendimetrazine, phentermine, hoodia (P57), Olibra, ™ ephedra, caffeine and combinations thereof. An appetite suppressant has the following trade names: Adipex ™, Adipost ™, Bontril ™ PDM, Bontril ™ Slow Release, Didrex ™, Fastin ™, Ionamin ™, Mazanor ( Trademark), Melfiat (TM), Obenix (TM), Phendiet (TM), Phendiet-105 (TM), Phencott (TM), Phentride (TM), Plegine (TM), Prelu-2 (TM), Pro-Fast (TM), PT 105 (TM), Sanorex (TM), Tenuate (TM), Sanorex (TM), Tenuate (TM), Tenuate Dospan (TM), Tepanil Ten-Tab (trade) Mark), Teramine (TM), and Zantryl (TM). These and other suitable appetite suppressants are further described in the following US patents, all of which are incorporated herein by reference in their entirety: Portman US Pat. No. 6,838,431, Portman. U.S. Pat. No. 6,716,815, Portman U.S. Pat. No. 6,558,690, Portman U.S. Pat. No. 6,468,962, and Portman U.S. Pat. No. 6,436,899.
(増強物質配合成分)
増強物質は、元の物質の味及び/又は芳香の知覚を、それら自体の特徴的な味及び/又は芳香の知覚を導入することなく強化、補充、改質又は増強し得る物質から成ることができる。ある実施形態では、香味、甘味、酸味、旨味、コク味、塩味及びこれらの組み合わせの知覚を強化、補充、改質、又は増強するように設計された増強物質を挙げることができる。
(Enhanced substance combination component)
The enhancing substance may consist of a substance that can enhance, supplement, modify or enhance the taste and / or aroma perception of the original substance without introducing its own characteristic taste and / or aroma perception. it can. In certain embodiments, mention may be made of enhancers designed to enhance, supplement, modify, or enhance the perception of flavor, sweetness, sourness, umami, richness, saltiness and combinations thereof.
ある実施形態では、呈味増強物質としても知られる好適な増強物質の例として、限定しないが、ネオヘスペリジンジヒドロカルコン、クロロゲン酸、アラピリダイン、シナリン、ミラクリン、グルピリダイン、ピリジニウム−ベタイン化合物、グルタミン酸1ナトリウム及びグルタミン酸1カリウムなどのグルタミン酸塩、ネオテーム、タウマチン、タガトース、トレハロース、塩化ナトリウムなどの塩、グリチルリジン酸1アンモニウム、バニラ抽出物(エチルアルコール抽出)、糖酸類、塩化カリウム、硫酸水素ナトリウム、加水分解した植物性蛋白質、加水分解した動物性蛋白質、酵母エキス、アデノシン一リン酸(AMP)、グルタチオン、イノシン一リン酸などのヌクレオチド、イノシン酸二ナトリウム、キサントシン一リン酸、グアニル酸一リン酸、アラピリダイン(N−(1−カルボキシエチル)−6−(ヒドロキシメチル)ピリジニウム−3−オール分子内塩、サトウダイコン抽出物(アルコール抽出物)、サトウキビ葉エッセンス(アルコール抽出物)、クルクリン、ストロジン、マビンリン、ギムネマ酸、3−ヒドロ安息香酸、2,4−ジヒドロ安息香酸、ダイダイ、バニラオレオレジン、サトウキビ葉エッセンス、マルトール、エチルマルトール、バニリン、甘草グリチルリジン酸塩、G−蛋白質結合受容体(T2R及びT1R)に応答する化合物、及びコク味を付与する呈味増強物質組成物(Kurodaらの米国特許第5679397号明細書に開示、引用してその全体を本願に援用する)が挙げられる。「コク味」とは、「味わい(mouthfulness)」及び「こく(good body)」を付与する物質を言う。 In certain embodiments, examples of suitable enhancers, also known as taste enhancers include, but are not limited to, neohesperidin dihydrochalcone, chlorogenic acid, alapyridine, cinalin, miraculin, gulpyridine, pyridinium-betaine compounds, monosodium glutamate and Glutamates such as monopotassium glutamate, salts such as neotame, thaumatin, tagatose, trehalose, sodium chloride, monoammonium glycyrrhizinate, vanilla extract (ethyl alcohol extraction), sugar acids, potassium chloride, sodium hydrogen sulfate, hydrolyzed plants Protein, hydrolyzed animal protein, yeast extract, adenosine monophosphate (AMP), glutathione, inosine monophosphate and other nucleotides, disodium inosinate, xanthosine monophosphate, Anilyl monophosphate, alapyridine (N- (1-carboxyethyl) -6- (hydroxymethyl) pyridinium-3-ol inner salt, sugar beet extract (alcohol extract), sugar cane leaf essence (alcohol extract) , Curculin, strodine, mabinlin, gymnemaic acid, 3-hydrobenzoic acid, 2,4-dihydrobenzoic acid, Daidai, vanilla oleoresin, sugarcane leaf essence, maltol, ethylmaltol, vanillin, licorice glycyrrhizinate, G-protein binding A compound that responds to receptors (T2R and T1R), and a taste enhancer composition that imparts a rich taste (disclosed in Kuroda et al., US Pat. No. 5,679,397, incorporated herein by reference in its entirety). “Body taste” means “taste (moutful). ess) "and it refers to a substance that imparts a" rich (good body) ".
呈味増強物質の1種である甘味料増強物質は、甘味の呈味を増強する。ある実施形態では、甘味料増強物質の例として、限定しないが、グリチルリジン酸1アンモニウム、甘草グリチルリジン酸塩、ダイダイ、アラピリダイン、アラピリダイン(N−(1−カルボキシエチル)−6−(ヒドロキシメチル)ピリジニウム−3−オール)分子内塩、ミラクリン、クルクリン、ストロジン、マビンリン、ギムネマ酸、シナリン、グルピリダイン、ピリジニウム−ベタイン化合物、サトウダイコン抽出物、ネオテーム、タウマチン、ネオヘスペリジンジヒドロカルコン、タガトース、トレハロース、マルトール、エチルマルトール、バニラ抽出物、バニラオレオレジン、バニリン、サトウダイコン抽出物(アルコール抽出物)、サトウキビ葉エッセンス(アルコール抽出物)、G−蛋白質結合受容体(T2R及びT1R)に応答する化合物及びこれらの組み合わせが挙げられる。 A sweetener-enhancing substance that is one of the taste-enhancing substances enhances the taste of sweetness. In certain embodiments, examples of sweetener enhancers include, but are not limited to, monoammonium glycyrrhizinate, licorice glycyrrhizinate, Daidai, alapyridine, alapyridine (N- (1-carboxyethyl) -6- (hydroxymethyl) pyridinium- 3-ol) inner salt, miraculin, curculin, strodine, mabinline, gymnemaic acid, cinalin, gulpyridine, pyridinium-betaine compound, sugar beet extract, neotame, thaumatin, neohesperidin dihydrochalcone, tagatose, trehalose, maltol, ethylmaltol , Vanilla extract, vanilla oleoresin, vanillin, sugar beet extract (alcohol extract), sugar cane leaf essence (alcohol extract), G-protein coupled receptors (T2R and T1R) They include compounds, and combinations thereof in response to.
塩味の増強のための増強物質の更なる例として、酸性ペプチド(米国特許第6974597号明細書(引用して本願に援用する)に開示のものなど)が挙げられる。酸性ペプチドとして、塩基性アミノ酸(リジン、アルギニン及びヒスチジンなど)よりも多数の酸性アミノ酸(アスパラギン酸及びグルタミン酸など)を有するペプチドが挙げられる。酸性ペプチドは、ペプチド合成によって、又は蛋白質をエンドペプチダーゼを用いた加水分解に付し、必要に応じ、脱アミド化に付すことによって得られる。酸性ペプチド、又は蛋白質を加水分解及び脱アミド化に付すことによって得られるペプチドの生産のための使用に好適な蛋白質として、植物蛋白質(例えば、コムギグルテン、トウモロコシ蛋白質(例えば、ゼイン及びグルテンミール)、大豆蛋白質単離物)、動物性蛋白質(例えば、ミルクカゼイン及び乳清蛋白質などの乳蛋白質、食肉蛋白質及び魚肉蛋白質などの筋蛋白質、卵白蛋白質及びコラーゲン)、及び微生物蛋白質(例えば、微生物によって産生される微生物細胞蛋白質及びポリペプチド)が挙げられる。 Further examples of enhancers for enhancing salty taste include acidic peptides such as those disclosed in US Pat. No. 6,974,597 (incorporated herein by reference). Examples of acidic peptides include peptides having a larger number of acidic amino acids (such as aspartic acid and glutamic acid) than basic amino acids (such as lysine, arginine and histidine). The acidic peptide can be obtained by peptide synthesis or by subjecting the protein to hydrolysis using an endopeptidase and, if necessary, deamidation. As proteins suitable for use for the production of acidic peptides or peptides obtained by subjecting proteins to hydrolysis and deamidation, plant proteins (eg wheat gluten, corn proteins (eg zein and gluten meal)), Soy protein isolate), animal protein (eg milk protein such as milk casein and whey protein, muscle protein such as meat protein and fish protein, egg white protein and collagen), and microbial protein (eg produced by microorganisms) Microbial cell proteins and polypeptides).
温感又は冷感の知覚の効果は、米国特許出願公開第2003/0072842A1号明細書に記載(本願に引用して全体を援用する)のように、疎水性甘味料の使用によって長期化させてもよい。例えば、こうした疎水性甘味料として、以下に示す式I〜XIのものが挙げられる。
米国特許第6159509号明細書に記載のようなペリラルチンもまた添加されてもよく、この特許も、本願に引用してその全体を援用する。 Perilartin as described in US Pat. No. 6,159,509 may also be added, which patent is also incorporated by reference in its entirety.
(食品用酸配合成分)
酸として、限定しないが、酢酸、アジピン酸、アスコルビン酸、酪酸、クエン酸、ギ酸、フマル酸、グリコン酸、乳酸、リン酸、リンゴ酸、シュウ酸、コハク酸、酒石酸及びこれらの組み合わせを挙げることができる。
(Food acid ingredients)
Acids include, but are not limited to, acetic acid, adipic acid, ascorbic acid, butyric acid, citric acid, formic acid, fumaric acid, glyconic acid, lactic acid, phosphoric acid, malic acid, oxalic acid, succinic acid, tartaric acid and combinations thereof Can do.
(微量栄養素配合成分)
微量栄養素は、所望の効果を生物が得るのに必要な量が、蛋白質、炭水化物、及び脂肪などの多量養素に対して少なくても、生物の栄養学的な健康に影響を及ぼす物質を含むことができる。微量栄養素としては、限定しないが、ビタミン、ミネラル、酵素、植生化学物質、抗酸化剤、及びこれらの組み合わせを挙げることができる。
(Contains micronutrients)
Micronutrients contain substances that affect the nutritional health of an organism, even if the amount necessary for the organism to achieve the desired effect is less than for macronutrients such as proteins, carbohydrates, and fats. be able to. Micronutrients can include, but are not limited to, vitamins, minerals, enzymes, vegetation chemicals, antioxidants, and combinations thereof.
ある実施形態では、ビタミンとして、ビタミンA、ビタミンD、ビタミンE、及びビタミンK及びこれらの組み合わせなどの脂溶性ビタミンを挙げることができる。ある実施形態では、ビタミンとして、ビタミンC(アスコルビン酸)、Bビタミン類(チアミン即ちB1、リボフラビン即ちB2、ナイアシン即ちB3、ピリドキシン即ちB6、葉酸即ちB9、シアノコバラミン即ちB12、パントテン酸、ビオチン)、及びこれらの組み合わせなどの水溶性ビタミンを挙げることができる。 In some embodiments, vitamins can include fat-soluble vitamins such as vitamin A, vitamin D, vitamin E, and vitamin K and combinations thereof. In one embodiment, the vitamins include vitamin C (ascorbic acid), B vitamins (thiamine or B 1 , riboflavin or B 2 , niacin or B 3 , pyridoxine or B 6 , folic acid or B 9 , cyanocobalamin or B 12 , pantothene And water-soluble vitamins such as acid, biotin), and combinations thereof.
ある実施形態では、ミネラルとして、限定しないが、ナトリウム、マグネシウム、クロム、ヨウ素、鉄、マンガン、カルシウム、銅、フッ化物、カリウム、リン、モリブデン、セレン、亜鉛、及びこれらの組み合わせを挙げることができる。 In some embodiments, minerals can include, but are not limited to, sodium, magnesium, chromium, iodine, iron, manganese, calcium, copper, fluoride, potassium, phosphorus, molybdenum, selenium, zinc, and combinations thereof. .
ある実施形態では、微量栄養素として、限定しないが、L−カルニチン、コリン、コエンザイムQ10、アルファ−リポ酸、オメガ−3−脂肪酸、ペプシン、フィターゼ、トリプシン、リパーゼ、プロテアーゼ、セルラーゼ、及びこれらの組み合わせを挙げることができる。 In certain embodiments, micronutrients include, but are not limited to, L-carnitine, choline, coenzyme Q10, alpha-lipoic acid, omega-3-fatty acid, pepsin, phytase, trypsin, lipase, protease, cellulase, and combinations thereof. Can be mentioned.
抗酸化剤としては、フリーラジカルを排除する物質を挙げることができる。ある実施形態では、抗酸化剤として、限定しないが、アスコルビン酸、クエン酸、ローズマリー油、ビタミンA、ビタミンE、ビタミンEホスフェート、トコフェロール、ジ−アルファ−トコフェリルホスフェート、トコトリエノール、アルファリポ酸、ジヒドロリポ酸、キサントフィル、ベータクリプトキサンチン、リコピン、ルテイン、ゼアキサンチン、アスタキサンチン、ベータ−カロテン、カロテン、混合カロテノイド、ポリフェノール、フラボノイド、及びこれらの組み合わせを挙げることができる。 Antioxidants can include substances that eliminate free radicals. In certain embodiments, antioxidants include but are not limited to ascorbic acid, citric acid, rosemary oil, vitamin A, vitamin E, vitamin E phosphate, tocopherol, di-alpha-tocopheryl phosphate, tocotrienol, alpha lipoic acid, Mention may be made of dihydrolipoic acid, xanthophyll, beta cryptoxanthine, lycopene, lutein, zeaxanthin, astaxanthin, beta-carotene, carotene, mixed carotenoids, polyphenols, flavonoids, and combinations thereof.
ある実施形態では、植生化学物質として、限定しないが、カロテノイド、クロロフィル、クロロフィリン、繊維、フラバノイド、アントシアニン、シアニジン(cyaniding)、デルフィニジン、マルビジン、ペラルゴニジン、ペオニジン、ペツニジン、フラバノール、カテキン、エピカテキン、エピガロカテキン、エピガロカテキンガレート、テアフラビン、テアルビジン、プロアントシアニン、フラボノール、ケルセチン、ケンペロール、ミリセチン、イソラムネチン、フラボノンシェスペレチン(flavononeshesperetin)、ナリンゲニン、エリオジクチオール、タンゲレチン、フラボン、アピゲニン、ルテオリン、リグナン、フィトエストロゲン、レスベラトロール、イソフラボン、ダイゼイン、ゲニステイン、グリシテイン、大豆イソフラボン、及びこれらの組み合わせを挙げることができる。 In certain embodiments, vegetation chemicals include, but are not limited to, carotenoids, chlorophylls, chlorophyllins, fibers, flavanoids, anthocyanins, cyaniding, delphinidin, malvidin, pelargonidin, peonidin, petunidin, flavanols, catechins, epicatechins, epigallo Catechin, epigallocatechin gallate, theaflavin, thealvidin, proanthocyanin, flavonol, quercetin, kaempferol, myricetin, isorhamnetin, flavonone shesperetin, naringenin, eriodictyol, tangeretin, flavone, apigenin, luteolin Estrogen, resveratrol, isoflavone, daidzein, geniste Emissions, may be mentioned glycitein, soy isoflavones, and combinations thereof.
(口腔保湿配合成分)
口腔保湿剤として、限定しないが、酸及び塩並びにこれらの組み合わせなどの唾液刺激剤を挙げることができる。ある実施形態では、酸として、酢酸、アジピン酸、アスコルビン酸、酪酸、クエン酸、ギ酸、フマル酸、グリコン酸、乳酸、リン酸、リンゴ酸、シュウ酸、コハク酸、酒石酸及びこれらの組み合わせを挙げることができる。
(Oral moisturizing ingredients)
Oral moisturizers include, but are not limited to, saliva stimulants such as acids and salts and combinations thereof. In some embodiments, the acid includes acetic acid, adipic acid, ascorbic acid, butyric acid, citric acid, formic acid, fumaric acid, glyconic acid, lactic acid, phosphoric acid, malic acid, oxalic acid, succinic acid, tartaric acid, and combinations thereof. be able to.
口腔保湿剤として、水和して経口表面に付着し口腔保湿の知覚をもたらし得る親水コロイド材料も挙げることができる。親水コロイド材料として、植物浸出物、種子ガム、及び海藻抽出物などの天然物質を挙げることができ、又はセルロース、デンプン、若しくは天然ガム誘導体などの化学的に修飾された物質であることができる。ある実施形態では、親水コロイド材料として、ペクチン、アラビアガム、アカシアガム、アルギン酸塩、寒天、カラギーナン、グアーガム、キサンタンガム、ローカストビーンガム、ゼラチン、ジェランガム、ガラクトマンナン、トラガントガム、カラヤガム、カードラン、コンニャク、キトサン、キシログルカン、ベータグルカン、フルセララン、ガティガム、タマリン、細菌ガム、及びこれらの組み合わせを挙げることができる。更に、ある実施形態では、アルギン酸プロピレングリコール、カルボキシメチルローカストビーンガム、低メトキシルペクチン、及びこれらの組み合わせなどの修飾した天然ガムを挙げることができる。ある実施形態では、結晶性セルロース、カルボキシメチルセルロース(CMC)、メチルセルロース(MC)、ヒドロキシプロピルメチルセルロース(HPCM)、及びヒドロキシプロピルセルロース(MPC)、並びにこれらの組み合わせなどの修飾したセルロースを含むことができる。 Oral moisturizers can also include hydrocolloid materials that can be hydrated to adhere to the oral surface and cause the perception of oral moisturization. Hydrocolloid materials can include natural substances such as plant exudates, seed gums, and seaweed extracts, or can be chemically modified substances such as cellulose, starch, or natural gum derivatives. In certain embodiments, the hydrocolloid material includes pectin, gum arabic, acacia gum, alginate, agar, carrageenan, guar gum, xanthan gum, locust bean gum, gelatin, gellan gum, galactomannan, tragacanth gum, caraya gum, curdlan, konjac, chitosan Xyloglucan, beta glucan, flucellaran, gati gum, tamarin, bacterial gum, and combinations thereof. In addition, certain embodiments may include modified natural gums such as propylene glycol alginate, carboxymethyl locust bean gum, low methoxyl pectin, and combinations thereof. In certain embodiments, modified cellulose, such as crystalline cellulose, carboxymethylcellulose (CMC), methylcellulose (MC), hydroxypropylmethylcellulose (HPCM), and hydroxypropylcellulose (MPC), and combinations thereof can be included.
同様に、口内水分補給の知覚をもたらすことができる湿潤剤を含むことができる。このような湿潤剤として、限定しないが、グリセロール、ソルビトール、ポリエチレングリコール、エリスリトール、及びキシリトールを挙げることができる。更に、ある実施形態では、脂肪が、口腔保湿の知覚をもたらすことができる。このような脂肪として、中鎖トリグリセリド、植物油、魚油、鉱油、及びこれらの組み合わせを挙げることができる。 Similarly, wetting agents that can provide a perception of mouth hydration can be included. Such wetting agents can include, but are not limited to, glycerol, sorbitol, polyethylene glycol, erythritol, and xylitol. Furthermore, in certain embodiments, fat can provide a perception of oral moisturization. Such fats can include medium chain triglycerides, vegetable oils, fish oils, mineral oils, and combinations thereof.
(喉のケア用配合成分)
喉の無痛化配合成分として、鎮痛薬、麻酔薬、緩和薬、防腐薬、及びこれらの組み合わせを挙げることができる。ある実施形態では、鎮痛薬/麻酔薬として、メントール、フェノール、ヘキシルレゾルシノール、ベンゾカイン、塩酸ジクロニン、ベンジルアルコール、サリチルアルコール、及びこれらの組み合わせを挙げることができる。ある実施形態では、緩和薬として、限定しないが、スリッペリーエルムバーク、ペクチン、ゼラチン、及びこれらの組み合わせを挙げることができる。ある実施形態では、防腐薬配合成分として、塩化セチルピリジニウム、臭化ドミフェン、塩化デカリニウム、及びこれらの組み合わせを挙げることができる。
(Ingredients for throat care)
Examples of the soothing throat component include analgesics, anesthetics, palliatives, preservatives, and combinations thereof. In certain embodiments, the analgesic / anesthetic can include menthol, phenol, hexyl resorcinol, benzocaine, dichronin hydrochloride, benzyl alcohol, salicyl alcohol, and combinations thereof. In certain embodiments, the alleviating agent can include, but is not limited to, slippery elm bark, pectin, gelatin, and combinations thereof. In some embodiments, the preservative ingredients can include cetylpyridinium chloride, domifene bromide, decalinium chloride, and combinations thereof.
ある実施形態では、塩酸クロフェジアノール、コデイン、リン酸コデイン、硫酸コデイン、デキストロメトルファン、臭化水素酸デキストロメトルファン、クエン酸ジフェンヒドラミン、及び塩酸ジフェンヒドラミン、並びにこれらの組み合わせなどの鎮咳配合成分を含むことができる。 In one embodiment, the composition comprises an antitussive formulation, such as clofedianol hydrochloride, codeine, codeine phosphate, codeine sulfate, dextromethorphan, dextromethorphan hydrobromide, diphenhydramine citrate, and diphenhydramine hydrochloride, and combinations thereof. be able to.
ある実施形態では、ハチミツ、プロポリス、アロエベラ、グリセリン、メントール及びこれらの組み合わせなどの喉の無痛化剤を含むことができる。更に他の実施形態で、鎮咳剤を含むことができる。このような鎮咳剤は、粘液溶解薬及び去痰薬などの、痰の粘度又は産生を変化させるもの;並びにコデイン(麻薬性鎮咳剤)、抗ヒスタミン薬、デキストロメトルファン及びイソプロテレノール(非麻薬性鎮咳剤)などの、咳反射を抑制するものの二群に分類できる。ある実施形態では、片方又は双方の群からの配合成分を含むことができる。 In certain embodiments, throat soothing agents such as honey, propolis, aloe vera, glycerin, menthol and combinations thereof may be included. In still other embodiments, an antitussive agent can be included. Such antitussives are those that alter the viscosity or production of sputum, such as mucolytics and expectorants; and codeine (narcotic antitussives), antihistamines, dextromethorphan and isoproterenol (non-narcotic antitussives) It can be classified into two groups that suppress the cough reflex. In certain embodiments, ingredients from one or both groups can be included.
更に他の実施形態で、鎮咳薬として、限定しないが、コデイン、デキストロメトルファン、デキストロルファン、ジフェンヒドラミン、ヒドロコドン、ノスカピン、オキシコドン、ペントキシベリン、及びこれらの組み合わせからなる群を挙げることができる。ある実施形態では、抗ヒスタミン薬として、限定しないが、アクリバスタチン、アザタジン、ブロムフェニルアミン、クロルフェニルアミン、クレマスチン、シプロヘプタジン、デクスブロムフェニルアミン、ジメンヒドリナート、ジフェンヒドラミン、ドキシラミン、ヒドロキシジン、メクリジン、フェニンダミン、フェニルトロキサミン、プロメタジン、ピリラミン、トリペレナミン、トリプロリジン及びこれらの組み合わせを挙げることができる。ある実施形態では、非鎮痛型抗ヒスタミン薬として、限定しないが、アステミゾール、セチリジン、エバスチン、フェキソフェナジン、ロラチジン、テルフェナジン、及びこれらの組み合わせを挙げることができる。 In still other embodiments, the antitussive agent can include, but is not limited to, the group consisting of codeine, dextromethorphan, dextrorphan, diphenhydramine, hydrocodone, noscapine, oxycodone, pentoxyberine, and combinations thereof. In certain embodiments, antihistamines include, but are not limited to, crivastatin, azatazine, bromophenylamine, chlorphenylamine, clemastine, cyproheptadine, dexbromphenylamine, dimenhydrinate, diphenhydramine, doxylamine, hydroxyzine, meclizine, Mention may be made of phenindamine, phenyltoloxamine, promethazine, pyrilamine, tripelenamine, triprolidine and combinations thereof. In certain embodiments, non-analgesic antihistamines can include, but are not limited to, astemizole, cetirizine, ebastine, fexofenadine, loratidine, terfenadine, and combinations thereof.
ある実施形態では、去痰薬として、限定しないが、塩化アンモニウム、グアイフェネシン、トコン流体抽出物、ヨウ化カリウム及びこれらの組み合わせを挙げることができる。ある実施形態では、粘液溶解薬として、限定しないが、アセチルシステイン、アンブロキソール、ブロムヘキシン及びこれらの組み合わせを挙げることができる。ある実施形態では、鎮痛、解熱及び抗炎症剤として、限定しないが、アセトアミノフェン、アスピリン、ジクロフェナク、ジフルニサル、エトドラク、フェノプロフェン、フルルビプロフェン、イブプロフェン、ケトプロフェン、ケトロラク、ナブメトン、ナプロキセン、ピロキシカム、カフェイン及びそれらの混合物を挙げることができる。ある実施形態では、局所麻酔薬として、限定しないが、リドカイン、ベンゾカイン、フェノール、ジクロニン、ベンゾノテート(benzonotate)及びそれらの混合物を挙げることができる。 In certain embodiments, expectorants can include, but are not limited to, ammonium chloride, guaifenesin, toconic fluid extract, potassium iodide, and combinations thereof. In certain embodiments, mucolytic agents can include, but are not limited to, acetylcysteine, ambroxol, bromohexine, and combinations thereof. In certain embodiments, analgesic, antipyretic and anti-inflammatory agents include, but are not limited to, acetaminophen, aspirin, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, ketoprofen, ketorolac, nabumetone, naproxen, piroxicam , Caffeine and mixtures thereof. In certain embodiments, local anesthetics can include, but are not limited to, lidocaine, benzocaine, phenol, dichronin, benzonotate, and mixtures thereof.
ある実施形態では、鼻鬱血除去薬、及び鼻清浄化の知覚をもたらす配合成分を含むことができる。ある実施形態では、鼻鬱血除去薬として、限定しないが、フェニルプロパノールアミン、プソイドエフェドリン、エフェドリン、フェニレフリン、オキシメタゾリン、及びこれらの組み合わせを挙げることができる。ある実施形態では、鼻清浄化の知覚をもたらす配合成分としては、限定しないが、メントール、カンファー、ボルネオール、エフェドリン、ユーカリ油、ペパーミント油、サリチル酸メチル、酢酸ボルニル、ラベンダー油、ワサビ抽出物、セイヨウワサビ抽出物、及びこれらの組み合わせを挙げることができる。ある実施形態では、鼻清浄化の知覚は、香気性精油、木材、ガム、花及び他の植物からの抽出物、樹脂、動物性分泌物、並びに合成芳香族物質によってもたらすことができる。 In certain embodiments, a nasal decongestant and a formulation component that provides a nasal cleansing sensation can be included. In certain embodiments, nasal decongestants can include, but are not limited to, phenylpropanolamine, pseudoephedrine, ephedrine, phenylephrine, oxymetazoline, and combinations thereof. In certain embodiments, ingredients that provide nasal cleansing perception include, but are not limited to, menthol, camphor, borneol, ephedrine, eucalyptus oil, peppermint oil, methyl salicylate, bornyl acetate, lavender oil, horseradish extract, horseradish. There may be mentioned extracts and combinations thereof. In some embodiments, the perception of nasal cleansing can be provided by aroma essential oils, wood, gums, flowers and other plant extracts, resins, animal secretions, and synthetic aromatic substances.
ある実施形態では、1種以上の着色料を含むことができる。米国食品医薬品化粧品法(United States Food, Drug, and Cosmetic Act)(21C.F.R.73)による分類のとおり、着色料として、認証免除着色料(合成により製造される可能性があるとしても「天然」と称する場合がある)、及び認証着色料(「人工」と称する場合がある)、又はこれらの組み合わせを挙げることができる。ある実施形態では、認証免除着色料又は天然着色料としては、限定しないが、アナトー抽出物、(E160b)、ビキシン、ノルビキシン、アスタキサンチン、脱水ビート(ビート粉末)、ビート根赤/ベタニン(E162)、群青、カンタキサンチン(E161g)、クリプトキサンチン(E161c)、ルビキサンチン(E161d)、ビオランキサンチン(E161e)、ロドキサンチン(E161f)、カラメル(E150(a−d))、β−アポ−8’−カロテナール(E160e)、β−カロテン(E160a)、アルファカロテン、ガンマカロテン、ベータ−アポ−8−カロテナール(E160f)のエチルエステル、フラボキサンチン(E161a)、ルテイン(E161b)、コチニール抽出物(E120);カルミン(E132)、カルモイシン/アゾルビン(E122)、銅クロロフィリンナトリウム(E141)、クロロフィル(E140)、焼いて部分的に脱脂加熱した綿実粉、グルコン酸第1鉄、乳酸第1鉄、ブドウ色抽出物、ブドウ果皮抽出物(エノシアニナ(enocianina))、アントシアニン(E163)、食用ヘマトコッカス藻、合成酸化鉄、鉄酸化物及び水酸化物(E172)、フルーツジュース、野菜ジュース、乾燥食用藻類、食用マンジュギク(アズテックマリーゴールド)及び抽出物、キャロット油、トウモロコシ胚乳油、パプリカ、パプリカオレオレジン、ファフィア酵母、リボフラビン(E101)、サフラン、二酸化チタン、ターメリック(E100)、ターメリックオレオレジン、アマランス(E123)、カプサンチン/カプソルビン(E160c)、リコピン(E160d)、及びこれらの組み合わせを挙げることができる。 In some embodiments, one or more colorants can be included. As classified by the United States Foods, Drugs and Cosmetics Act (United States Food, Drug, and Cosmetic Act) (21C.F.R.73), as a colorant, a certified exempt colorant (even if it may be manufactured by synthesis) May be referred to as “natural”), and certified colorants (sometimes referred to as “artificial”), or combinations thereof. In certain embodiments, authentication exempt colorants or natural colorants include, but are not limited to, Anato extract, (E160b), bixin, norbixin, astaxanthin, dehydrated beet (beat powder), beet root red / betanin (E162), Ultramarine, Canthaxanthin (E161g), Cryptoxanthine (E161c), Rubixanthin (E161d), Biolanxanthin (E161e), Rhodoxanthin (E161f), Caramel (E150 (ad)), β-Apo-8'- Carotenal (E160e), β-carotene (E160a), alpha-carotene, gamma-carotene, beta-apo-8-carotenal (E160f) ethyl ester, flavoxanthin (E161a), lutein (E161b), cochineal extract (E120); Carmine (E 132), calmoisine / azorubin (E122), copper chlorophyllin sodium (E141), chlorophyll (E140), baked and partially defatted and heated cottonseed powder, ferrous gluconate, ferrous lactate, grape color extract, Grape skin extract (Enocianina), anthocyanin (E163), edible hematococcus algae, synthetic iron oxide, iron oxide and hydroxide (E172), fruit juice, vegetable juice, dried edible algae, edible manjugiku (Aztec) Marigold) and extract, carrot oil, corn endosperm oil, paprika, paprika oleoresin, faffia yeast, riboflavin (E101), saffron, titanium dioxide, turmeric (E100), turmeric oleoresin, amaranth (E123), capsan On / capsorubin (E160c), lycopene (E160d), and can be combinations thereof.
ある実施形態では、認証着色料として、限定しないが、FD&Cブルー#1、FD&Cブルー#2、FD&Cグリーン#3、FD&Cレッド#3、FD&Cレッド#40、FD&Cイエロー#5及びFD&Cイエロー#6、テトラジン(E102)、キノリンイエロー(E104)、サンセットイエロー(E110)、ポンソー(E124)、エリスロシン(E127)、パテントブルーV(E131)、二酸化チタン(E171)、アルミニウム(E173)、銀(E174)、金(E175)、顔料ルビン/リソールルビンBK(E180)、炭酸カルシウム(E170)、カーボンブラック(E153)、ブラックPN/ブリリアントブラックBN(E151)、グリーンS/酸ブリリアントグリーンBS(E142)、及びこれらの組み合わせを挙げることができる。ある実施形態では、認証着色料として、FD&Cアルミニウムレーキを挙げることができる。これらは、アルミナ水和物の不溶性基質上に伸展するFD&C染料のアルミニウム塩からなる。更に、ある実施形態では、認証着色料は、カルシウム塩として配合できる。 In some embodiments, authentication colorants include, but are not limited to, FD & C Blue # 1, FD & C Blue # 2, FD & C Green # 3, FD & C Red # 3, FD & C Red # 40, FD & C Yellow # 5 and FD & C Yellow # 6, Tetrazine (E102), quinoline yellow (E104), sunset yellow (E110), ponceau (E124), erythrosin (E127), patent blue V (E131), titanium dioxide (E171), aluminum (E173), silver (E174), Gold (E175), pigment rubin / risol rubin BK (E180), calcium carbonate (E170), carbon black (E153), black PN / brilliant black BN (E151), green S / acid brilliant green BS (E142), and these Mention may be made of the combined viewing. In some embodiments, the certified colorant can include FD & C aluminum lakes. These consist of aluminum salts of FD & C dyes that extend on an insoluble substrate of alumina hydrate. Further, in certain embodiments, the certified colorant can be formulated as a calcium salt.
(複数配合成分)
ある実施形態では、送達システム又はチューインガムは、チューインガムの消費の間にチューインガムからの放出が管理されることが望ましい2種以上の配合成分を含んでもよい。ある実施形態では、配合成分が封入されてもよいし、さもなければ異なる送達システムに別々に含まれていてもよい。或いは、ある実施形態では配合成分が封入されてもよいし、さもなければ同じ送達システムに別々に含まれていてもよい。別の可能性として、配合成分の1種以上が自由(例えば、非封入)であってもよく、また、1種以上の他の配合成分が封入されていてもよい。
(Multiple ingredients)
In certain embodiments, the delivery system or chewing gum may include two or more compounding ingredients for which release from the chewing gum is desired during consumption of the chewing gum. In certain embodiments, the formulation components may be encapsulated or otherwise included separately in different delivery systems. Alternatively, in certain embodiments, the formulation components may be encapsulated or otherwise included separately in the same delivery system. As another possibility, one or more of the blending components may be free (eg, unencapsulated) and one or more other blending components may be encapsulated.
チューインガムは、チューインガムの消費の間にその群の放出が管理されることが望ましい、配合成分の群を含んでもよい。チューインガムの消費の間にチューインガムからの放出が管理されることが望ましいものであってもよい2種以上の配合成分の群として、限定しないが、以下のものが挙げられる:着色料と香味料、複数の香味料、複数の着色料、冷感剤と香味料、温感剤と香味料、冷感剤と温感剤、冷感剤と高甘味度甘味料、温感剤と高甘味度甘味料、複数の冷感剤(例えば、WS−3とWS−23、WS−3とコハク酸メンチル)、メントールと1種以上の冷感剤、メントールと1種以上の温感剤、複数の温感剤、高甘味度甘味料(1種又は複数種)と歯漂白活性物(1種又は複数種)、高甘味度甘味料(1種又は複数種)と呼気清涼化活性物(1種又は複数種)、ある程度の苦味を有する配合成分とその配合成分に対する苦味抑制剤、複数の高甘味度甘味料(例えば、ace−kとアスパルテーム)、複数の歯漂白活性物(例えば、研磨剤配合成分と抗微生物配合成分、パーオキサイドと硝酸塩、温感剤とポリオール、冷感剤とポリオール、複数のポリオール、温感剤と微量栄養素、冷感剤と微量栄養素、温感剤と口腔保湿剤、冷感剤と口腔保湿剤、温感剤と喉のケア剤、冷感剤と喉のケア剤、温感剤と食品用酸、冷感剤と食品用酸、温感剤と乳化剤/界面活性剤、冷感剤と乳化剤/界面活性剤、温感剤と着色料、冷感剤と着色料、温感剤と香味増強物質、冷感剤と香味増強物質、温感剤と甘味増強物質、冷感剤と甘味増強物質、温感剤と食欲抑制剤、冷感剤と食欲抑制剤、高甘味度甘味料と香味料、冷感剤と歯漂白剤、温感剤と歯漂白剤、温感剤と呼気清涼化剤、冷感剤と呼気清涼化剤、冷感剤と発泡性システム、温感剤と発泡性システム、温感剤と抗微生物剤、冷感剤と抗微生物剤、複数の歯石防止配合成分、複数の再ミネラル強化配合成分、複数の界面活性剤、再ミネラル強化配合成分(複数種)と脱塩配合成分(複数種)、酸性配合成分(複数種)と酸緩衝配合成分(複数種)、歯石防止配合成分(複数種)と抗菌配合成分(複数種)、再ミネラル強化配合成分(複数種)と歯石防止配合成分(複数種)、歯石防止配合成分(複数種)と再ミネラル強化配合成分(複数種)と抗菌配合成分(複数種)、界面活性剤配合成分(複数種)と歯石防止配合成分(複数種)、界面活性剤配合成分(複数種)と抗菌配合成分(複数種)、界面活性剤配合成分(複数種)と再ミネラル強化配合成分(複数種)、界面活性剤(複数種)と歯石防止配合成分(複数種)と抗菌配合成分(複数種)、複数のタイプのビタミン又はミネラル、複数の微量栄養素、複数の酸、複数の抗微生物配合成分、複数の呼気清涼化配合成分、呼気清涼化配合成分(複数種)と抗微生物配合成分、複数の食欲抑制剤、酸(複数種)とこれと反応して発泡する塩基(複数種)、苦味化合物と高甘味度甘味料、冷感剤と食欲抑制剤、温感剤と食欲抑制剤、高甘味度甘味料と食欲抑制剤、高甘味度甘味料と酸、プロバイオティクス配合成分とプレバイオティクス配合成分、ビタミンとミネラル、代謝増強配合成分と多量養素、代謝増強配合成分と微量栄養素、酵素と基質、高甘味度甘味料と甘味増強物質、冷感化合物と冷感増強物質、香味料と香味増強物質、温感化合物と温感増強物質、香味料と塩、高甘味度甘味料と塩、酸と塩、冷却化合物と塩、温感化合物と塩、香味料と界面活性剤、収斂化合物と、水和の知覚をもたらす配合成分等が挙げられる。ある実施形態では、複数の配合成分が同じ送達システムの一部であってもよく、又は異なる送達システムの一部であってもよい。異なる送達システムは、同じか又は異なる封入材料を使用してもよい。 The chewing gum may include a group of compounding ingredients where it is desirable to control the release of that group during consumption of the chewing gum. A group of two or more ingredients that may be desirable to control the release from the chewing gum during consumption of the chewing gum includes, but is not limited to, the following: colorants and flavors, Multiple flavors, Multiple colorants, Coolant and flavor, Warmth and flavor, Coolant and warmer, Cooler and high-intensity sweetener, Warmth and sweetness Materials, multiple cooling sensates (eg WS-3 and WS-23, WS-3 and menthyl succinate), menthol and one or more cooling agents, menthol and one or more warming agents, multiple temperatures Sensitizers, high-intensity sweeteners (one or more) and tooth bleaching actives (one or more), high-intensity sweeteners (one or more) and breath refreshing actives (one or Multiple types), blended ingredients with a certain bitterness, bitterness inhibitors for the blended ingredients, multiple sweetness sweetness (For example, ace-k and aspartame), multiple tooth bleaching actives (for example, abrasive compounding component and antimicrobial compounding component, peroxide and nitrate, warming agent and polyol, cooling agent and polyol, plural polyol , Warming sensation and micronutrient, cooling sensation and micronutrient, warming sensation and oral moisturizing agent, cooling sensation and oral moisturizing agent, warming sensation and throat care agent, cooling sensation agent and throat care agent, temperature Sensitizer and food acid, cooling agent and food acid, warming agent and emulsifier / surfactant, cooling agent and emulsifier / surfactant, warming agent and colorant, cooling agent and colorant, warm Sensitizer and flavor enhancer, cooling sensation and flavor enhancer, warm sensation and sweetness enhancer, cooling sensation and sweetness enhancer, warm sensation and appetite suppressant, cool sensation and appetite suppressant, high sweetness Sweeteners and flavors, cooling agents and tooth bleach, warming agents and tooth bleaching agents, warming agents and breath fresheners, cooling agents and breath fresheners, cold Agent and foaming system, warming agent and foaming system, warming agent and antimicrobial agent, cooling agent and antimicrobial agent, multiple anticalculus compounding ingredients, multiple remineral strengthening compounding ingredients, multiple surfactants , Remineral strengthening compounding ingredients (plural kinds) and desalting compounding ingredients (plural kinds), acidic compounding ingredients (plural kinds), acid buffer compounding ingredients (plural kinds), anticalculus compounding ingredients (plural kinds) and antibacterial compounding ingredients ( Multiple types), remineral strengthening compounding components (multiple types) and anticalculus compounding components (multiple types), anticalculus compounding components (multiple types), remineralizing compounding components (multiple types) and antibacterial compounding components (multiple types), Surfactant compounding component (plurality) and anticalculus compounding component (plurality), surfactant compounding component (plurality) and antibacterial compounding component (plurality), surfactant compounding component (plurality) and remineral strengthening Compounding ingredients (plural kinds), surfactant (plural kinds) and tartar Preventive ingredients (multiple) and antimicrobial ingredients (multiple), multiple types of vitamins or minerals, multiple micronutrients, multiple acids, multiple antimicrobial blended ingredients, multiple breath refreshing blends, breath refreshing Compounding ingredients (multiple types) and antimicrobial ingredients, multiple appetite suppressants, acids (multiple types) and bases that react with this (multiple types), bitter compounds and high-intensity sweeteners, cooling agents And appetite suppressant, warming agent and appetite suppressant, high sweetness sweetener and appetite suppressant, high sweetness sweetener and acid, probiotic compound and prebiotic compound, vitamin and mineral, metabolism enhancing compound Ingredients and macronutrients, metabolism enhancing ingredients and micronutrients, enzymes and substrates, high-intensity sweeteners and sweetness-enhancing substances, cooling compounds and cooling-enhancing substances, flavorings and flavor-enhancing substances, warming compounds and warming feelings Enhancement substances, flavors and salts, high sweetness Seasonings and salt, acid and salt, the cooling compounds and salts, warming compound with salt, flavors and surfactants, and astringent compounds, ingredients results in a perception of hydration, and the like. In some embodiments, multiple compounding components may be part of the same delivery system or may be part of different delivery systems. Different delivery systems may use the same or different encapsulating materials.
複数の配合成分の封入の例示は、本願明細書の実施例に見出すことができる。典型的には、複数の配合成分の封入で、封入した複数の配合成分を(例えば、チューインガムに配合成分として添加する送達システムの一部として)含むチューインガムの消費の間に、複数の配合成分の過半量の放出の遅延が引き起こされることになるであろう。これは、配合成分を別々に封入することで異なる放出プロファイルでの放出を引き起こしてもよい状況で、特に有益であり得る。例えば、異なる高甘味度甘味料は、水溶性が異なるか、又は他の特性が異なるために、異なる放出プロファイルを有し得る。それらを一緒に封入して、より同時期に放出を起こすようにしてもよい。 An illustration of the inclusion of multiple compounding ingredients can be found in the examples herein. Typically, the inclusion of a plurality of compounding ingredients during the consumption of the chewing gum including the plurality of encapsulated compounding ingredients (eg, as part of a delivery system that is added as a compounding ingredient to the chewing gum). A delay in the release of the majority will be caused. This can be particularly beneficial in situations where the formulation components may be encapsulated separately to cause release with different release profiles. For example, different high intensity sweeteners may have different release profiles due to different water solubility or other characteristics. They may be encapsulated together to release more at the same time.
ある実施形態では、複数の配合成分の放出プロファイルを、その複数の配合成分、その複数の配合成分を含む送達システム、及び/若しくはその送達システムを含むチューインガムの種々の特性を管理すること、並びに/又はその送達システムを前記の方法にてどのように製造するかを管理することによって、1つのガムに対して管理できる。 In certain embodiments, managing the release profile of the plurality of compounding ingredients, managing various properties of the plurality of compounding ingredients, the delivery system comprising the plurality of compounding ingredients, and / or the chewing gum comprising the delivery system, and / or Or it can be managed for one gum by managing how the delivery system is manufactured in the manner described above.
追加の成分を、前記のとおり、所望に応じて中央充填、ガム領域又はコーティングなどのガム組成物の1以上の領域又は層で使用してもよい。追加の成分の多くについての量を、下記の表1に示す。その成分に対して規定した量は、かかる成分が含まれてもよい特定領域に基づくものである。更に、表1に示す量は、ある成分を自由な形態、即ち非封入にてガム組成物に添加してもよいものとして、一般的に当てはめられるものである。ある実施形態で、ある成分が封入形態にて提供される場合、その追加の成分の放出プロファイルが改質されているため、表1に示す量よりも多くの量を使用してもよい。また、表1に示す成分の多くは任意成分であるので、それらの量は、組成物の層又は領域の1以上の中の組成物への配合に対してその成分が選択される場合に使用される量を表す。換言すると、たとえその成分が存在しなくてもよいとしても、0%の下限は含まれていない。 Additional ingredients may be used in one or more regions or layers of the gum composition, such as center fill, gum region or coating, as described above, as described above. The amounts for many of the additional ingredients are shown in Table 1 below. The amount specified for that component is based on the specific area in which such component may be included. Furthermore, the amounts shown in Table 1 are generally applied as certain ingredients may be added to the gum composition in free form, ie, unencapsulated. In certain embodiments, if an ingredient is provided in encapsulated form, an amount greater than that shown in Table 1 may be used because the release profile of the additional ingredient has been modified. Also, since many of the components shown in Table 1 are optional components, their amounts are used when that component is selected for incorporation into a composition in one or more of the layers or regions of the composition. Represents the amount to be played. In other words, the lower limit of 0% is not included even though the component may not be present.
下記の表1に列挙する成分は、中央充填ガムのの1以上の領域又は層に、それらの封入及び/又は非封入形態にて、更には他の任意の成分の何れと組み合わせて添加してもよい。例えば、単一の成分を、その封入及び非封入形態にて中央充填ガムに添加してもよい。2種の異なる形態の成分は、同量又は異なる量で中央充填ガムの同じ領域又は異なる領域に添加してもよい。 The ingredients listed in Table 1 below may be added to one or more regions or layers of the center-fill gum in their encapsulated and / or unencapsulated form and in combination with any other optional ingredient. Also good. For example, a single component may be added to the center-filled gum in its encapsulated and unencapsulated form. The two different forms of components may be added to the same or different regions of the central filling gum in the same or different amounts.
ある実施形態で、単一の成分を2種以上の異なる封入形態で添加してもよい。特に、2種以上の異なる封入材料(異なるポリマーなど)を使用して、その成分の2以上の別々の部分を封入してもよい。同じ成分の異なる封入形態を、同量又は異なる量で中央充填ガムの同じ領域又は異なる領域に添加してもよい。更に、ある実施形態では、同じ成分の非封入形態を、2以上の異なる封入形態と組み合わせて添加してもよい。その成分の非封入形態を、封入形態と同量又は異なる量にて、その中央充填ガムの任意の領域に添加してもよい。更に、ある実施形態では、2種以上の異なる封入形態と組み合わせて、類似の成分の非封入形態を添加してもよい。例えば、単一の甘味料の2種の封入形態を、異なる甘味料の非封入形態と組み合わせて使用してもよい。 In certain embodiments, a single component may be added in two or more different encapsulated forms. In particular, two or more different encapsulating materials (such as different polymers) may be used to encapsulate two or more separate parts of the component. Different encapsulated forms of the same component may be added to the same or different regions of the central filling gum in the same or different amounts. Further, in certain embodiments, unencapsulated forms of the same component may be added in combination with two or more different encapsulated forms. The non-encapsulated form of the component may be added to any region of the center-filled gum in the same or different amount as the encapsulated form. Further, in certain embodiments, non-encapsulated forms of similar components may be added in combination with two or more different encapsulated forms. For example, two encapsulated forms of a single sweetener may be used in combination with non-encapsulated forms of different sweeteners.
ある実施形態では、下記の表1から、又は前記の、2種以上の異なる成分の組み合わせを用いてもよい。ある実施形態では、成分の少なくとも1つを封入してもよく、一方で成分の少なくとも1つを非封入としてもよい。複数の成分は、同じタイプの成分、例えば、2種の異なる甘味料でであってもよく、又は明確に異なる範疇からの成分、例えば、甘味料と温感剤であってもよい。異なる成分を、同量又は異なる量で中央充填ガムの同じ領域又は異なる領域に添加してもよい。 In some embodiments, a combination of two or more different components from Table 1 below, or as described above, may be used. In certain embodiments, at least one of the components may be encapsulated, while at least one of the components may be unencapsulated. The plurality of ingredients may be the same type of ingredient, eg, two different sweeteners, or ingredients from distinctly different categories, eg, sweetener and warming agent. Different ingredients may be added to the same or different regions of the central filling gum in the same or different amounts.
ある実施形態では、下記の表1からの2種以上の異なる成分の組み合わせを用いてもよい。ある実施形態では、異なる成分の少なくとも1つを封入してもよく、一方でその組み合わせの他の成分の少なくとも1つを非封入としてもよい。複数の成分は、例えば2つの異なる甘味料など、同じタイプのものであってもよい。或いは、複数の成分は、明確に異なる範疇からの成分、例えば、甘味料と温感剤であってもよい。異なる成分は、同量又は異なる量で中央充填ガムの同じ領域又は異なる領域に添加してもよい。特定の一領域中の成分の量は、異なる領域でその成分が消費者によってどのように認知されてもよいか、消費者にもたらすのが望ましい官能の体感又は機能的な利点、任意の一領域で過量が使用されると悪い味が出る結果になる調整上の問題、等に応じて選択してもよい。 In certain embodiments, combinations of two or more different components from Table 1 below may be used. In certain embodiments, at least one of the different components may be encapsulated, while at least one other component of the combination may be unencapsulated. The plurality of ingredients may be of the same type, for example two different sweeteners. Alternatively, the plurality of ingredients may be ingredients from distinctly different categories, such as sweeteners and warming agents. Different components may be added to the same or different regions of the central filling gum in the same or different amounts. The amount of a component in a particular area is determined by how the component may be perceived by the consumer in different areas, the sensory experience or functional benefits that it is desirable to bring to the consumer, any one area May be selected depending on the adjustment problem that would result in a bad taste if overdose is used.
ある実施形態では、下記の表1からの複数の成分を含んでもよく、その各々は封入されている。複数の封入した成分は、同量又は異なる量でガムの同じ領域又は異なる領域に配合してもよい。複数の封入した成分は、同じタイプの成分であっても、又は明確に異なる範疇からの成分であってもよい。 In certain embodiments, it may include a plurality of components from Table 1 below, each of which is encapsulated. Multiple encapsulated components may be blended in the same or different regions of the gum in the same or different amounts. The plurality of encapsulated components may be the same type of components or components from distinctly different categories.
複数の封入した成分が中央充填ガム組成物に添加されるある実施形態では、その複数の成分は一緒に封入しても、別々に封入してもよい。複数の成分が一緒に封入される実施形態では、それらの成分を一緒に混合して、単一の封入材料によって封入してもよい。複数の成分が別々に封入される実施形態では、それらの成分を封入するのに使用する材料は、同じでも、又は異なっていてもよい。成分に対して規定する量は、その成分が含まれる特定の領域に基づく。 In certain embodiments where multiple encapsulated components are added to the center-filled gum composition, the multiple components may be encapsulated together or separately. In embodiments where multiple components are encapsulated together, the components may be mixed together and encapsulated by a single encapsulant. In embodiments where multiple components are encapsulated separately, the material used to encapsulate the components may be the same or different. The amount specified for a component is based on the particular region in which the component is included.
前記のとおり、表1はガム製品の1以上の領域に任意に存在してもよい成分のリストを提供する。コーティング、中央充填、又はガム領域に存在してもよい好適な量を、表に示す。表1での量は、ガム製品の領域又は層におけるppm又は質量%として示す。表1は代表例を示すに過ぎず、いかようにも、ガム領域に含ませることができる配合成分を限定するように解釈されるべきではない。 As noted above, Table 1 provides a list of ingredients that may optionally be present in one or more regions of the gum product. Suitable amounts that may be present in the coating, centerfill, or gum regions are shown in the table. The amounts in Table 1 are given as ppm or mass% in the gum product region or layer. Table 1 is merely representative and should not be construed as limiting the ingredients that can be included in the gum region in any way.
表1
本発明の特徴と効果は、例証の目的で提供され、本発明を制限するものと何ら解釈するべきでない以下の実施例によって、一層十分に示される。
Table 1
The features and advantages of the present invention are more fully shown by the following examples, which are provided for purposes of illustration and should not be construed as limiting the invention in any way.
(実施例)
表2〜4に示す以下の実施例A〜Hは、いくつかの実施形態の、本発明のガム組成物に関する。
(Example)
The following Examples AH shown in Tables 2-4 relate to some embodiments of the gum composition of the present invention.
実施例A〜H: Examples A to H:
表2−マルチトールガム領域組成物
ガムベースは、限定しないが、エラストマー、可塑剤及び充填剤を含んでもよい。
Table 2-Maltitol gum region composition
The gum base may include, without limitation, elastomers, plasticizers and fillers.
表3−液体充填組成物
表4−コーティング組成物
液体充填、ガム領域及びコーティングの3つの領域を含むガム片を、上記表2〜4の組成に従って調製する。各領域は、組成物A〜Hにつき対応する成分に従う。しかし、組成物は、所望に応じて可換性である。 Gum pieces comprising three areas of liquid filling, gum area and coating are prepared according to the compositions in Tables 2-4 above. Each region follows the corresponding component for compositions AH. However, the composition is commutative as desired.
ガム領域に対する組成物は、先ずタルクを(存在する場合は)ガムベースと、約85℃での加熱下に配合することによって調製する。この配合物は、次いでマルチトール又は増量剤、レシチン、及び他のポリオールと6分間混合する。香味料と冷感剤とのプレミックスを含む香味料のブレンドを添加して、1分間混合する。最後に、酸及び高甘味度甘味料を添加して、5分間混合する。 The composition for the gum region is prepared by first blending talc (if present) with the gum base under heating at about 85 ° C. This formulation is then mixed for 6 minutes with maltitol or a bulking agent, lecithin, and other polyols. Add a blend of flavors including a premix of flavor and cooling agent and mix for 1 minute. Finally, add acid and high intensity sweetener and mix for 5 minutes.
次いで、リカシン、結晶性ソルビトール、及びグリセリンのプレミックスを先ず調製することによって、液体充填組成物を調製する。このプレミックスは次いで、着色料、香味料、冷感剤、及び高甘味度甘味料と配合して、混合する。 A liquid fill composition is then prepared by first preparing a premix of lycasin, crystalline sorbitol, and glycerin. This premix is then blended with colorants, flavors, cooling agents, and high intensity sweeteners and mixed.
ガム領域と液体充填組成物とを、次いで一緒に押出し、第7〜8頁で前記したプロセスによってタブレットに成形する。ガム片は各々、約2.2gの総重量を有する。最終ガム片で、ガム領域は約62質量%であり、ここでガム領域全体の約50〜75質量%がマルチトールガム組成物の層であり、液体充填は約8質量%、そしてコーティングは約30質量%である。 The gum region and the liquid fill composition are then extruded together and formed into tablets by the process described above on pages 7-8. Each piece of gum has a total weight of about 2.2 grams. In the final gum piece, the gum area is about 62% by weight, where about 50-75% by weight of the total gum area is a layer of maltitol gum composition, the liquid fill is about 8% by weight, and the coating is about 30% by mass.
組成物A〜Hによって調製されるガム片は、37℃で3週間にわたり加速老化をさせた後に、液体充填の流動性の顕著な喪失を示さない。 The gum pieces prepared with compositions A to H do not show a significant loss of fluidity in liquid filling after accelerated aging at 37 ° C. for 3 weeks.
前記の液体充填、ガム領域及びコーティング組成物で使用する着色料、香味料、冷感剤、酸及び甘味料は、本願明細書の表1に示すような成分の何れからでも、具体的に選択してもよい。更に、これらの成分の何れも、それらの封入及び/又は非封入形態で使用してもよい。 The colorant, flavoring agent, cooling agent, acid and sweetener used in the liquid filling, gum region and coating composition are specifically selected from any of the components shown in Table 1 of this specification. May be. Furthermore, any of these components may be used in their encapsulated and / or unencapsulated form.
本発明の好ましい態様であると現状で考えられるものについて記載したが、当業者は、本発明の技術的思想から逸脱することなく、変化や変更がなされ得ることを理解しており、そうした変化や変更はいずれも、本発明の真の範囲内に含まれるものである。 Although what is presently considered to be a preferred embodiment of the present invention has been described, those skilled in the art understand that changes and modifications can be made without departing from the technical idea of the present invention, and All modifications are within the true scope of the present invention.
10 厚板
12 端部
12a 丸みを帯びたコーナー
12b 角張ったコーナー
100 液体充填組成物中央
200 ガム領域
10
Claims (11)
(b)前記液体充填組成物を囲むガム領域を含んでなる組成物であって、
前記ガム領域は、ポリオール組成物を含み、当該ポリオール組成物は、前記ガム領域の質量に対して40質量%〜60質量%のマルチトールを含み、
前記液体充填組成物は、当該液体充填組成物に対して58質量%〜83質量%の水素化デンプン加水分解物と、前記液体充填組成物に対して10質量%〜35質量%の結晶性ソルビトールとを含んでなる組成物。A composition comprising (a) a liquid filling composition, and (b) a gum region surrounding the liquid filling composition,
The gum region includes a polyol composition , and the polyol composition includes 40 mass% to 60 mass% maltitol with respect to the mass of the gum region;
The liquid filling composition comprises 58% to 83% by weight of hydrogenated starch hydrolyzate with respect to the liquid filling composition and 10% to 35% by weight of crystalline sorbitol with respect to the liquid filling composition. A composition comprising:
(a)前記ガム組成物の0より多く10質量%までの中央充填組成物、
(b)前記ガム組成物の55〜65質量%で含まれるガム領域、及び
(c)前記ガム組成物の25〜35質量%で含まれるコーティング、を含み、
前記ガム組成物は、3グラム以下のガム片であり、
前記ガム領域は、ポリオール組成物を含み、当該ポリオール組成物は、前記ガム領域の質量に対して40質量%〜60質量%のマルチトールを含み、
前記中央充填組成物は、当該中央充填組成物の質量に対して10質量%〜35質量%の結晶性ソルビトールと、前記中央充填組成物の質量に対して58質量%〜83質量%の水素化デンプン加水分解物を含んでなるガム組成物。A gum composition comprising:
(A) center-fill composition to Many 1 0 wt% than 0 of the gum composition,
(B) a gum region comprised between 55 and 65 % by weight of the gum composition , and (c) a coating comprised between 25 and 35 % by weight of the gum composition ,
The gum composition is a gum piece of 3 grams or less,
The gum region includes a polyol composition, and the polyol composition includes 40 mass% to 60 mass% maltitol with respect to the mass of the gum region;
The center filling composition comprises 10% to 35% by weight of crystalline sorbitol with respect to the weight of the center filling composition and 58% to 83% by weight of hydrogenation with respect to the weight of the center filling composition. A gum composition comprising a starch hydrolyzate.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77674806P | 2006-02-24 | 2006-02-24 | |
| US60/776,748 | 2006-02-24 | ||
| PCT/US2007/004832 WO2007100721A2 (en) | 2006-02-24 | 2007-02-26 | Liquid-filled chewing gum composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009527256A JP2009527256A (en) | 2009-07-30 |
| JP4840884B2 true JP4840884B2 (en) | 2011-12-21 |
Family
ID=38459593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008556455A Expired - Fee Related JP4840884B2 (en) | 2006-02-24 | 2007-02-26 | Liquid filled chewing gum composition |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1998630A4 (en) |
| JP (1) | JP4840884B2 (en) |
| CN (1) | CN101389224B (en) |
| AU (1) | AU2007221176B2 (en) |
| BR (1) | BRPI0708246A2 (en) |
| CA (1) | CA2643017C (en) |
| MX (1) | MX2008010795A (en) |
| RU (1) | RU2398442C2 (en) |
| WO (1) | WO2007100721A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080063748A1 (en) * | 2006-09-08 | 2008-03-13 | Cadbury Adams Usa Llc. | Center-fill confectionery and chewing gum compositions containing suspended saccharide particles |
| KR100848182B1 (en) * | 2007-02-06 | 2008-07-23 | 롯데제과주식회사 | Refreshing coated center peeling chewing gum and preparation method thereof |
| PL2219467T3 (en) * | 2007-11-29 | 2015-02-27 | Intercontinental Great Brands Llc | Multi-region chewing gum with actives |
| JP5285927B2 (en) * | 2008-02-25 | 2013-09-11 | 株式会社ロッテ | Chewing gum |
| ES2633338T3 (en) | 2011-03-31 | 2017-09-20 | Mondelez Japan Limited | Food composition in suspension and sweet |
| US10105320B2 (en) | 2013-10-03 | 2018-10-23 | Altria Client Services | Soluble fiber lozenge |
| US9351936B2 (en) * | 2013-10-03 | 2016-05-31 | Altria Client Services Llc | Nicotine lozenge |
| US9375033B2 (en) | 2014-02-14 | 2016-06-28 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
| MX392643B (en) * | 2014-06-30 | 2025-03-24 | Intercontinental Great Brands Llc | EDIBLE PRODUCT WITH COLOR COATING THAT CONTAINS A HIGH LEVEL OF LIQUID FLAVORS IN THE COATING AND METHODS FOR ITS PREPARATION. |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3973041A (en) * | 1976-03-03 | 1976-08-03 | Ici United States Inc. | Sugarless chewing gum having improved shelf life |
| US4250196A (en) * | 1979-10-09 | 1981-02-10 | Life Savers, Inc. | Center-filled chewing gums |
| JPS5668354A (en) * | 1979-11-09 | 1981-06-09 | Lotte Co Ltd | Method for retaining moisture in sugarless chewing gum containing center liquid |
| JPS57163445A (en) * | 1981-02-23 | 1982-10-07 | Nabisco Brands Inc | Simultaneously extruded chewing gum having soft gum core |
| US4466983A (en) * | 1983-02-04 | 1984-08-21 | Warner-Lambert Company | Substantially non-aqueous semi-liquid center-fill |
| WO1994013151A1 (en) * | 1992-12-04 | 1994-06-23 | Wm. Wrigley Jr. Company | Wax-coated tissue with antioxidant to stabilize chewing gum |
| JP2004506434A (en) * | 2000-08-24 | 2004-03-04 | キャドバリー・アダムズ・ユーエスエイ・エルエルシー | Continuous formation of gum products filled and coated in the center |
| WO2004032644A2 (en) * | 2002-09-17 | 2004-04-22 | Spi Pharma, Inc. | Chewing gum formulation and method of making the same |
| WO2005048728A1 (en) * | 2003-11-14 | 2005-06-02 | Cadbury Schweppes Plc | Liquid-filled confectionery compositions |
| US20060024244A1 (en) * | 2004-07-29 | 2006-02-02 | Cadbury Adams, Llc. | Tooth whitening compositions and delivery systems therefor |
| JP2008510491A (en) * | 2004-08-25 | 2008-04-10 | キャドバリー・アダムズ・ユーエスエイ・エルエルシー | Liquid filled chewing gum composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423086A (en) * | 1979-10-17 | 1983-12-27 | Roquette Freres | Process for hard coating with sorbitol and products obtained thereby |
| US4301178A (en) * | 1980-05-02 | 1981-11-17 | Life Savers, Inc. | Liquid-filled chewing gum and method |
| CA1267716C (en) * | 1984-02-23 | 1990-04-10 | LATERAL EMITTING LIGHT EMITTING DIODE | |
| US4803083A (en) * | 1987-03-16 | 1989-02-07 | Wm. Wrigley Jr. Company | Method of optimizing texture and processability of chewing gums and compositions made therefrom |
| US4933188B1 (en) * | 1987-12-31 | 1997-07-15 | Warner Lambert Co | Chewing gum composition with improved physical stability |
| EP1151672A1 (en) * | 2000-05-03 | 2001-11-07 | Societe Des Produits Nestle S.A. | Confectionery product having an enhanced cooling effect |
| MXPA05008187A (en) * | 2003-01-29 | 2006-03-30 | Spi Polyols Inc | Compositions of polyol granules and processes of manufacture. |
| US7727565B2 (en) * | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
-
2007
- 2007-02-26 WO PCT/US2007/004832 patent/WO2007100721A2/en not_active Ceased
- 2007-02-26 CA CA2643017A patent/CA2643017C/en not_active Expired - Fee Related
- 2007-02-26 CN CN200780006532.4A patent/CN101389224B/en not_active Expired - Fee Related
- 2007-02-26 AU AU2007221176A patent/AU2007221176B2/en not_active Ceased
- 2007-02-26 JP JP2008556455A patent/JP4840884B2/en not_active Expired - Fee Related
- 2007-02-26 MX MX2008010795A patent/MX2008010795A/en active IP Right Grant
- 2007-02-26 BR BRPI0708246-0A patent/BRPI0708246A2/en not_active Application Discontinuation
- 2007-02-26 EP EP07751584A patent/EP1998630A4/en not_active Withdrawn
- 2007-02-26 RU RU2008127937/13A patent/RU2398442C2/en not_active IP Right Cessation
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3973041A (en) * | 1976-03-03 | 1976-08-03 | Ici United States Inc. | Sugarless chewing gum having improved shelf life |
| US4250196A (en) * | 1979-10-09 | 1981-02-10 | Life Savers, Inc. | Center-filled chewing gums |
| JPS5668354A (en) * | 1979-11-09 | 1981-06-09 | Lotte Co Ltd | Method for retaining moisture in sugarless chewing gum containing center liquid |
| JPS57163445A (en) * | 1981-02-23 | 1982-10-07 | Nabisco Brands Inc | Simultaneously extruded chewing gum having soft gum core |
| US4466983A (en) * | 1983-02-04 | 1984-08-21 | Warner-Lambert Company | Substantially non-aqueous semi-liquid center-fill |
| WO1994013151A1 (en) * | 1992-12-04 | 1994-06-23 | Wm. Wrigley Jr. Company | Wax-coated tissue with antioxidant to stabilize chewing gum |
| JP2004506434A (en) * | 2000-08-24 | 2004-03-04 | キャドバリー・アダムズ・ユーエスエイ・エルエルシー | Continuous formation of gum products filled and coated in the center |
| WO2004032644A2 (en) * | 2002-09-17 | 2004-04-22 | Spi Pharma, Inc. | Chewing gum formulation and method of making the same |
| WO2005048728A1 (en) * | 2003-11-14 | 2005-06-02 | Cadbury Schweppes Plc | Liquid-filled confectionery compositions |
| US20060024244A1 (en) * | 2004-07-29 | 2006-02-02 | Cadbury Adams, Llc. | Tooth whitening compositions and delivery systems therefor |
| JP2008510491A (en) * | 2004-08-25 | 2008-04-10 | キャドバリー・アダムズ・ユーエスエイ・エルエルシー | Liquid filled chewing gum composition |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1998630A4 (en) | 2010-03-17 |
| BRPI0708246A2 (en) | 2011-05-24 |
| EP1998630A2 (en) | 2008-12-10 |
| CA2643017C (en) | 2012-10-16 |
| CA2643017A1 (en) | 2007-09-07 |
| JP2009527256A (en) | 2009-07-30 |
| RU2398442C2 (en) | 2010-09-10 |
| WO2007100721A2 (en) | 2007-09-07 |
| MX2008010795A (en) | 2008-09-01 |
| CN101389224B (en) | 2013-06-19 |
| AU2007221176B2 (en) | 2011-07-21 |
| WO2007100721A3 (en) | 2008-01-10 |
| AU2007221176A1 (en) | 2007-09-07 |
| CN101389224A (en) | 2009-03-18 |
| RU2008127937A (en) | 2010-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5379108B2 (en) | Chewing gum composition containing suspended saccharide particles and method for preparing center-filled confectionery pieces | |
| JP4988870B2 (en) | Multi-region chewing gum composition comprising isomalt gum region | |
| CN101179945B (en) | Center-filled chewing gum with barrier layer | |
| JP4694620B2 (en) | Confectionery composition comprising an elastomer component and a cooked sugar component | |
| JP4988920B2 (en) | Center-filled gum composition containing triacetin | |
| US20090028998A1 (en) | Multi-region chewing gum composition including saturated particulate polyols | |
| JP4840884B2 (en) | Liquid filled chewing gum composition | |
| JP2011087602A (en) | Center-filled chewing gum composition | |
| JP4988773B2 (en) | Liquid filled chewing gum composition | |
| JP4982485B2 (en) | Liquid filled chewing gum composition | |
| ES2688772T3 (en) | Composition of chewing gum with central filling | |
| JP5009902B2 (en) | Liquid filled chewing gum composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100414 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100720 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101008 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110830 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20110909 Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20110909 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110929 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141014 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |